Back to GetFilings.com



Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K
 
(Mark one)
  x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2004
OR
  o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from                           to                          
Commission File No. 0-22446
DECKERS OUTDOOR CORPORATION
(Exact name of registrant as specified in its charter)
     
Delaware
  95-3015862
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
 
495-A South Fairview Avenue, Goleta, California   93117
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (805) 967-7611
Securities registered pursuant to Section 12(b) of the Act:
     
Title of each class   Name of each exchange on which registered
     
None
  None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 par value
(Title of Class)
     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes x    No o
     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
     Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).    Yes x    No o
     Aggregate market value of the Common Stock of the registrant held by non-affiliates of the registrant on June 30, 2004 based on the closing price of the Common Stock on the NASDAQ National Market System on such date was $278,083,416.
     The number of shares of the registrant’s Common Stock outstanding at March 8, 2005 was 12,303,458.
     Portions of registrant’s definitive proxy statement relating to registrant’s 2005 annual meeting of stockholders, which will be filed pursuant to Regulation 14A within 120 days after the end of registrant’s fiscal year ended December 31, 2004, are incorporated by reference in Part III of this Form 10-K.
 
 


DECKERS OUTDOOR CORPORATION
For the Fiscal Year Ended December 31, 2004
Index to Annual Report on Form 10-K
             
        Page
         
 PART I
   Business     3  
   Properties     15  
   Legal Proceedings     16  
   Submission of Matters to a Vote of Security Holders     16  
 
 PART II
   Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities     17  
   Selected Financial Data     18  
   Management’s Discussion and Analysis of Financial Condition and Results of Operations     20  
   Quantitative and Qualitative Disclosures about Market Risk     47  
   Financial Statements and Supplementary Data     47  
   Changes in and Disagreements with Accountants on Accounting and Financial Disclosure     47  
   Controls and Procedures     47  
   Other Information     48  
 
 PART III
   Directors and Executive Officers of the Registrant     79  
   Executive Compensation     79  
   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters     79  
   Certain Relationships and Related Transactions     79  
   Principal Accountant Fees and Services     79  
 
 PART IV
   Exhibits and Financial Statement Schedules     79  
 Signatures     83  
 EX-10.36
 EX-10.37
 EX-10.38
 EX-21.1
 EX-23.1
 EX-31.1
 EX-31.2
 EX-32.1

2


Table of Contents

PART I
Item 1. Business
General
      We are a leading designer, producer and brand manager of innovative, high-quality footwear and the category creator in the sport sandal and luxury sheepskin footwear segments. Our footwear is distinctive and appeals broadly to men, women and children. We sell our products through quality domestic retailers and international distributors and directly to end-user consumers through our websites and catalogs. Our primary objective is to build our footwear lines into global lifestyle brands with market leadership positions.
      We market our products under three proprietary brands:
        Teva. Teva is our outdoor lifestyle brand and the category creator for the sport sandal segment. Teva was created in the 1980’s to serve the demanding footwear needs of the professional river guide community, and this authentic heritage and commitment to function and performance remain core elements of the Teva brand. We have expanded Teva’s sport sandal line to include casual open-toe footwear, as well as hiking boots, trail running shoes, amphibious footwear and other rugged outdoor footwear styles.
 
        UGG. UGG is our luxury brand and the category creator for luxury sheepskin footwear. Our UGG line has enjoyed several years of strong growth and positive consumer receptivity, driven by consistent introductions of new styles, introductions of UGG products in the fall and spring seasons and geographic expansion of distribution. We carefully manage the distribution of our UGG line within high-end specialty and department store retailers in order to best reach our target consumers, preserve UGG’s retail channel positioning and maintain UGG’s position as a mid- to upper-price luxury brand.
 
        Simple. Simple is our moderately priced “anti-brand,” serving the needs of a youthful, irreverent consumer base seeking the comfort of athletic footwear but the styling of more traditional, understated, “back-to-basics” footwear. We have recently revised the Simple line to focus on its successful legacy models, including sneakers, clogs, sandals and other casual footwear. In addition, Simple enables us to selectively leverage our core footwear design and production competencies for channels of distribution not served by Teva or UGG.
      We believe our ability to continue to grow our future sales, earnings and market share has been significantly enhanced through achievement of three key recent initiatives:
        Teva Rights Acquisition. From 1985 until November 2002, we sold our Teva products under a license arrangement with Teva’s founder, Mark Thatcher. In November 2002, we acquired all of the Teva Rights from Mr. Thatcher and his wholly-owned corporation, Teva Sport Sandals, Inc. The acquisition enabled us to gain ownership of the Teva Internet and catalog business and allowed our brand managers to broaden the Teva line into attractive casual open-toe lines and rugged outdoor closed-toe footwear. This expansion of the Teva product line has increased the appeal of the brand and expanded our overall retail placement. The acquisition also enabled us to:
  •  eliminate significant royalties and other license costs;
 
  •  eliminate product line expansion constraints under our former license agreement;
 
  •  realize license opportunities for the Teva brand into additional brand-appropriate outdoor categories; and
 
  •  enhance our ability to recruit and retain key senior management.
        Organizational Restructuring. In the last several years, we have reorganized our management infrastructure and developed a decentralized approach that gives our brand managers greater control over product development, marketing, and distribution for their respective brands. This approach strengthens our product development efforts and enables each brand manager to react quickly to important market

3


Table of Contents

  trends and concentrate on the footwear demands of our customers and end-user consumers. Our brand teams are highly focused on developing new products and marketing programs that drive strong sales growth but remain true to each brand’s heritage. As a result, we have generated gross margins of 42.4% in 2003 and 42.1% in 2004 and achieved compound annual sales growth of approximately 47.2% since 2002. Our central management team provides important expertise in disciplines common to each of our brands, including sourcing, time-to-market, quality control, credit, information systems technology and overall management of our capital resources.
 
        UGG Repositioning. UGG gained brand recognition in the U.S. beginning in 1979 and was adopted as a favored brand by the California surf community. We acquired UGG in 1995 and have carefully re-positioned the brand as the luxury sheepskin collection sold through high-end retailers. While our sales have grown steadily over the past seven years, over the past few years UGG has benefited from significant national media attention and celebrity endorsement through our marketing programs and product seeding activities, further raising the profile of UGG as a luxury sheepskin brand. We intend to further support UGG’s market positioning by carefully expanding the selection of styles available in order to build consumer interest in our UGG collection. We also remain committed to limiting distribution of UGG through high-end retail channels.

      Largely as a result of these three recent initiatives, our net sales have increased by 77.4%, from $121,055,000 in 2003 to $214,787,000 in 2004 and our income from operations has increased by 118.4% from $19,438,000 in 2003 to $42,462,000 in 2004. For 2004, wholesale shipments of Teva, UGG and Simple represented 38.9%, 47.4% and 4.5% of our total net sales, respectively. Sales of our brands through our Internet and catalog division are in addition to our wholesale shipments and generated 9.2% of total net sales in 2004.
History
      We were founded by Doug Otto in 1973 as a domestic manufacturer of sandals. We originally manufactured a single line of sandals under the Deckers’ brand name in a small factory in Carpinteria, California. Since then, we have grown through the development and licensing of proprietary technology, targeted marketing and selective acquisitions. In 1985, we entered into our first license agreement for Teva sport sandals with Teva’s founder, Mark Thatcher. In 1986, we developed the Universal Strapping System, establishing Teva as the sport sandal category-creator and generating significant national attention for the Teva brand.
      We experienced a period of rapid growth during the late 1980’s and completed our initial public offering in 1993. As our sales grew, we terminated our manufacturing operations in the U.S., Mexico and Costa Rica, and today independent manufacturers in the Far East, Australia and New Zealand manufacture all of our footwear products for us. We maintain our own offices in China and Macau to monitor the operations of our Far East manufacturers.
      In order to diversify our sales and leverage our product development and sourcing capabilities, we completed the acquisition of Simple from its founder in a series of transactions between 1993 and 1996. In 1995, we acquired UGG from its founders. After our acquisition of UGG, we initiated a re-positioning of the line, focusing on comfort, luxury and premium distribution channels and developing products that appeal to consumers in a variety of climates.
      From 1985 until November 2002, we sold our Teva products under a licensing arrangement with Teva’s founder, Mark Thatcher. In November 2002, we acquired all of the Teva Rights from Mr. Thatcher and his wholly owned corporation, Teva Sport Sandals, Inc. The Teva Rights include the Teva Internet and catalog business and all patents, trade names, trademarks and other intellectual property associated with the acquired Teva assets.

4


Table of Contents

Business Strategies
      We seek to differentiate our brands by offering diverse lines that emphasize authenticity, functionality, quality and comfort and products tailored to a variety of activities and demographic groups. Key elements of our business strategies are:
        Build Leading Global Brands. Our mission is to build niche footwear lines into global brands with market leadership positions. Our Teva and UGG brands began as footwear lines appealing to a narrow core enthusiast market. We have since built these lines into substantial global lifestyle brands with significant potential for further growth and line extension. Across our brands, our styles remain true to the brands’ heritage but have been selectively extended over time to broaden their appeal to men, women and children seeking high quality, comfortable styles for everyday use. Furthermore, we actively manage our brands to ensure that we reach brand appropriate retail distribution channels. We believe that building our domestic and international brand image is best accomplished through a decentralized management structure that empowers a single brand manager to coordinate all aspects of brand image, from product development to marketing and retail channel management.
 
        Sustain Brand Authenticity. We believe our ability to grow our brands, sustain strong gross margins and maintain strong market share results, in part, from consumer loyalty to the heritage of our brands. We believe Teva consumers are passionate and serious about the outdoors, and our marketing programs feature national advertising in outdoor-oriented media as well as grass roots marketing through sponsorship of outdoor events and professional athletes. These marketing efforts reinforce the river-guide heritage of Teva and Teva’s positioning as a highly technical, performance-oriented footwear leader. Our UGG marketing strategy highlights the brand’s positioning as functional footwear, but also as a premium, luxury collection. UGG is primarily marketed through national print advertising in major women’s magazines and through our retailers and their catalogs and advertising. We promote our Simple brand by emphasizing Simple’s heritage sneaker and clog businesses in marketing targeted to youth-oriented markets in major U.S. cities. Our key marketing objective for Simple is to reintroduce the brand to the marketplace using a grass roots approach in our marketing and media plan. We have focused our advertising on our “we clog” and “we sneaker” campaigns in alternative weekly publications and other non-mainstream media.
 
        Drive Demand Through Innovation and Technical Leadership. We believe our reputation for innovation and technical leadership distinguishes our Teva and UGG products from those of our competitors and provides us with significant competitive advantages. Our proprietary Universal Strapping System launched Teva’s popularity in the mid-1980’s. Recent technical advances in our Teva footwear include our Liquid Frame Technology, our Wraptor technology and our Wraptor-Lite technology, all designed to provide maximum stability, support and comfort under rugged usage. We recently introduced closed-toe footwear, which represented approximately 12.5% of Teva’s net sales in 2004. In the Fall 2004 season, we introduced new Teva styles that incorporate Vibram® soles and Gore-Tex® fabrics. We continue to develop innovative styles, products and product categories for our UGG collection in order to support UGG’s positioning as a functional lifestyle brand, which can be worn in a variety of climates and weather conditions. UGG has benefited from expansion into non-boot casuals, sheepskin-trimmed footwear and styles combining sheepskin with fine-grade suede and leathers, all designed to expand our market share in new categories and increase our sales in the fall and spring.
 
        Maintain Efficient Development and Production Process. We believe our product development processes enable us to produce leading edge products on a timely and a cost effective basis. We design our products domestically. We maintain on-site supervisory offices in Pan Yu City, China and Macau that serve as local links to our independent manufacturers in the Far East, enabling us to carefully monitor the production process, from receipt of the design brief to production of interim and final samples and shipment of finished product. We believe this local presence provides greater predictability of material availability, product flow and adherence to final design specifications than we could otherwise achieve through an agency arrangement.

5


Table of Contents

Growth Strategies
      Our growth will depend upon our broadening of the products offered under each brand, expanding domestic and international distribution, licensing our brand names and developing or acquiring new brands. Specifically, we intend to:
        Introduce New Categories and Styles under Existing Brands. We intend to increase our sales by developing and introducing additional footwear products under our existing brands that meet our high standards of performance, practicality, authenticity, comfort and quality. We have expanded Teva’s open-toe footwear category by launching new casual styles. We have also introduced several closed-toe lines under the Teva brand, including amphibious footwear, hikers, trail runners and other rugged outdoor footwear. We plan further expansion into the hiking, trail running and rugged outdoor arenas, where the aggregate market is considerably greater than the market size for Teva’s core sport sandals. We have expanded our UGG collection to incorporate additional styles and fabrications in order to further penetrate the fall, spring and winter seasons. We have expanded our men’s and kids’ business for 2005 and have introduced a cold-weather series featuring sheepskin and Gore-Tex®, which will be delivered in Fall 2005. We expect to grow our Simple brand with the re-focus on our heritage clog and sneaker categories for both men and women. Simple has introduced “comfy” sandals, leveraging another of our core competencies. By introducing new categories under our brands, in particular, the closed-toe footwear under Teva and the Spring product offerings under UGG, we believe we have expanded the selling seasons for our brands which has resulted in increased sales and has contributed to a more balanced year round business for each of these brands.
 
        Expand Domestic Distribution. We believe that we have significant opportunities to increase our sales by expanding domestic distribution of our products. Our Teva brand has generally been distributed through the outdoor specialty and sporting goods retail channels. We have identified the potential for expansion into additional retail channels through the development of special make-up styles for retailers who have limited store overlap with our core specialty outdoor and sporting goods customers. UGG has historically realized a substantial portion of its sales in California. Over the past several years we have experienced increasing demand for UGG distribution outside California, and we expect to capitalize on significant demand in the Midwest and East Coast markets. For Simple, we are repositioning the brand by focusing on our legacy styles in order to re-connect with our consumer base and by broadening the appeal of Simple to new channels of distribution. The legacy products are primarily clogs, athletic-inspired sneakers and comfort sandals.
 
        Expand International Distribution. In 2004, our international net sales totaled $39,368,000, representing approximately 18.3% of total net sales. We believe significant opportunities exist to market our products abroad, and we intend to selectively expand their distribution worldwide. We have entered into an agency agreement with a firm in the United Kingdom for the coordination of our sales, distribution, marketing and advertising efforts in the European markets. For UGG, in particular, we have greatly expanded our international efforts, increasing the number of international distributors from six at December 31, 2002 to 13 at December 31, 2004.
 
        Pursue Licensing of Brands in Complementary Product Lines. We are pursuing selective licensing of our brand names in product categories beyond footwear. In 2004, we hired a Vice President of Corporate Licensing, who has extensive licensing experience at several leading companies in our industry, to coordinate the efforts for the licensing of products that complement our trademark-protected products. We successfully launched UGG handbags and outerwear in 2004 and have signed a license for UGG cold weather accessories, which are expected to begin deliveries in the Fall 2005 season. We have also initiated a domestic Teva licensing program, consisting of U.S. licenses for men’s sportswear, headwear, eyewear, timepieces and socks, and have signed a Canadian sportswear license. We expect to begin deliveries for all of these items in 2005. We are developing additional licensing programs carefully to ensure that licensed goods remain consistent with our brands’ heritage. Because this licensing strategy is in its early stages, and due to the lead times required to bring the products to market, we have only recently begun to recognize license revenues and we do not expect significant incremental net sales and profits from

6


Table of Contents

  licensing in the near future. However, we believe licensing revenues may become a more significant portion of our net sales and profits over time if our licensees can sell the licensed products in the quantities they have promised. For the year ended December 31, 2004, our licensees began to ship their products and, accordingly, we recognized net license revenues of $950,000, primarily related to our UGG handbag and outerwear licenses.
 
        Build New Brands. We intend to continue to focus on identifying, developing or acquiring, and building new brands. We have been successful previously in identifying entrepreneurial concepts for innovative, fashionable footwear targeted at niche markets and building these concepts into viable brands utilizing our expertise in product development, production and marketing. We intend to continue to identify and build new brands that demonstrate potential for significant future growth.

Products
      Our primary product lines are:
        Teva Sport Sandals and Footwear. “The brand of choice for the new outdoor athlete.” We believe there has been a general shift in consumer preferences and lifestyles to include more outdoor recreational activities, including hiking, trail running, bouldering, kayaking, kite boarding and whitewater river rafting. These consumers typically seek footwear specifically designed with the same quality and high performance attributes they have come to expect from traditional athletic footwear. The first Teva sport sandal was developed in the 1980’s to meet the demanding needs of professional rafting guides navigating the Colorado River and the rugged Grand Canyon terrain. As our core consumers’ pursuits have evolved, we have retained our outdoor heritage while adding new products to our line, including slides, thongs, amphibious footwear, trail running shoes, hiking boots and rugged closed-toe footwear. Our brand remains popular among professional and amateur outdoorsmen seeking authentic, performance-oriented footwear, as well as general footwear consumers seeking high quality, durable and comfortable styles for everyday use.
      Our Teva line comprises six core footwear collections:
        Originals. The Originals Series is a collection of sandals and thongs utilizing Teva’s classic rugged architecture. The Originals Series leverages the Teva brand heritage as the inventor of the sport sandal and remains a distinctive choice for both performance-oriented users and casual buyers. Our Originals feature our proprietary Universal Strapping System or Wraptor technology as well as cellular rubber, molded EVA or polyurethane mid-soles and high-quality nylon webbing or leather designed to hold the foot firmly in place. Our U.S. patent on our Universal Strapping System, which we utilize in most of our Teva sandals, expires in September 2007.
 
        Hydro. The Hydro Series builds upon our legacy as the category leader in whitewater-designed footwear. Hydro consists of sandals and closed-toe amphibious footwear built for high performance and rugged outdoor use. This series includes men and women’s sport sandals and other outdoor footwear ideal for professional and amateur outdoor enthusiasts and adventurers. Our Hydro Series incorporates many proprietary technologies including our Wraptor, Universal, or Liquid Frame technologies as well as quick draining monofilament mesh, specially formulated sticky rubber outsoles designed to adhere to slippery rocks, form fitting neoprene and water-repelling leathers.
 
        Terrain. The Terrain Series is a line of sandals and closed-toe footwear that incorporates Teva technologies and is designed for use in rugged outdoor environments such as hiking trails and canyons. The Terrain Series includes performance walking sandals and running sandals, as well as hiking boots and trail running shoes. To meet our consumers’ expanded needs and to provide them with the best product possible, we have partnered with many of the world’s leading providers of footwear technology for specialty component materials, including Vibram®, Five Ten® and Gore-Tex®.
 
        Nomadic. Our Nomadic Series is a collection of leather casual sandals and closed-toe footwear true to Teva’s performance-oriented outdoor heritage but designed for more casual use. The Nomadic Series consists of men’s and women’s leather and suede sandals, closed toe shoes, slides and clogs

7


Table of Contents

  featuring rugged, contemporary styles for the traveler and adventurer. Our 2005 line includes several closed-toe styles featuring our patent-pending flipsoletm, a removable insole that can be easily converted to a flip-flop.
 
        Sun and Moon. Our Sun and Moon Series features fun, youthful and colorful slides and thongs in a variety of materials including waterproof leather, nylon, suede and air mesh. The Sun and Moon Series is designed to leverage our sandal-making capabilities and to appeal to fashion-oriented consumers seeking pre-activity and post-activity footwear alternatives that express a casual lifestyle and individual spirit.
 
        Kids and Infants. Our children’s series is an assortment of sandals incorporating a variety of materials including leather, waterproof suede, nylon, neoprene and mesh, as well as slip-on water shoes, hikers and other styles of amphibious footwear. In addition, for the 2005 season, we have expanded our product offering with a variety of styles of sandals and closed-toe footwear, including an assortment of styles that are reflective of our adult offerings.

      We intend to continue to build upon Teva’s broad and deep line of performance and casual footwear. Our Spring 2005 line features 126 different product styles with manufacturer’s suggested domestic retail prices for adult sizes ranging from $20.00 to $120.00.
      UGG Footwear. “The premier brand in luxury and comfort sheepskin.” Beginning in 1979, UGG gained brand recognition in the U.S. for sheepskin boots and slippers and was later adopted as a favored brand by the California surf community. We acquired the brand in 1995 and expanded the collection, offering consumers a luxurious and distinctive look in sheepskin fabrications.
      Our UGG product line comprises seven core footwear collections:
        Classic Collection. We offer a complete line of sheepskin boots built on the heritage and distinctive look of our first product, the Classic Sheepskin boot. Our Classic Collection products are distinctive in styling, featuring an array of neutral and fashion colors. Our Classic Collection includes styles for men, women and children.
 
        Ultra Collection. The Ultra Collection builds upon the heritage of our original Classic. These boots are designed with our comfort system, featuring a multi-surfaced lugged bottom with a heel-cushioning insert that offers enhanced traction, support and comfort. Our Ultra Collection also features a three-part insole designed to provide all-day comfort and support and a reflective barrier that captures body heat to create a natural foot warming mechanism. Our sheepskin products are naturally thermostatic, keeping feet comfortable across a wide range of temperatures. This collection features styles for men, women and children.
 
        Casual Collection. This women’s collection features a more tailored and refined look with sheepskin combined with smooth leather uppers and suede in distinctive patterns and styles. This collection features a variety of shoes, clogs and boots and provides UGG consumers with the versatility to utilize sheepskin styling for a wider variety of occasions and outfits.
 
        Metropolitan Collection. This is a new collection of women’s styles for the Fall 2005 season. The Metropolitan Collection features styles that combine high quality suede uppers with sheepskin linings, including models with high fashion, bohemian and other casual stylings.
 
        Cold Weather Collection. This collection is designed for men and women seeking more rugged styling. The Cold Weather line features a Vibram® outsole and waterproof Gore-Tex® uppers designed to withstand colder, wetter climates.
 
        Fluff Momma Collection. This is our most playful and distinctive style for women. The Fluff Momma features untrimmed and colored sheepskin fleece exposed on the entire boot.
 
        Slipper Collection. Our popular Slipper Collection builds upon the UGG reputation for comfort, warmth and luxury. We offer a wide selection of styles and colors for men, women and children.

8


Table of Contents

      We have expanded our UGG collection from the Classic Sheepskin boot to a broad footwear line for men, women and children in a variety of styles, colors and materials designed for wear in a variety of climates and occasions. Over the last few years, our line expansion strategies have resulted in significantly increased exposure for our UGG collection and have contributed to the growth of UGG’s year round business. The manufacturer’s suggested domestic retail prices for adult sizes for the UGG collection range from $55.00 to $300.00.
      Simple Casual Footwear. “The brand of choice for a simple, uncomplicated lifestyle.” The Simple line of casual shoes combines the comfort of athletic footwear construction with the simple, understated styling of “back-to-basics” casual footwear. Simple was launched in the 1990’s as an anti-brand that catered to 21-35 year old consumers who were looking for an alternative to the flashy athletic footwear brands that were saturating the market. Since then, we’ve expanded into a full line of clogs, sneakers, and sandals; and in 2005, we are introducing our new Unclog and Green Toetm segments to the line.
      Our product line is comprised of these five key categories, which range in price from $20.00 to $80.00:
        Sneakers. We’ve evolved our classic sneaker collection with successful styles like the Sugar. We continue to keep this segment fresh by updating colors and materials seasonally. We’ve introduced several new sneaker styles that incorporate a sneaker specific pedbedtm, durable rubber outsoles, and leather and suede uppers.
 
        Clogs. Building on the heritage of our original clogs, our current clog series features the pedbedtm and updated material and color options.
 
        Unclogs: This collection is our twist on the traditional casual segment. It features oxfords, loafers, and boots that incorporate our comfortable pedbedtm with suede and leather uppers.
 
        Sandals: We offer a range of warm weather footwear for men and women in rich leathers and colorful nubucks. We also offer a flip-flop program that caters to the surf channel of distribution.
 
        Green Toetm: The Green Toetm segment represents an effort on the part of Simple to reduce the ecological footprint made by shoes around the world. All Green Toe products are made with 100% natural materials (textiles and rubbers), use water-based glues, and soy-based dyes. This collection is currently comprised of two styles for men and women.
Licensing
      To capitalize on the strength of our brands, we are pursuing the licensing of our brand names for use in complementary product categories beyond footwear. As part of this approach, in 2004, we hired a Vice President of Corporate Licensing, who has extensive licensing experience at several leading companies in our industry, to coordinate the efforts for the licensing of the Teva, UGG and Simple trademarks on products ranging from sportswear and outerwear to bags, packs and other accessories. Products sold under license began selling at retail in the third quarter of 2004. For the year ended December 31, 2004, we recognized net license revenues of approximately $950,000.
      We have initiated a Teva licensing program with strategic partners, which currently consist of U.S. licenses for men’s sportswear, headwear, eyewear, timepieces, and socks, as well as a Canadian license for men’s sportswear. We are selectively developing additional licensing programs to ensure that licensed goods remain consistent with Teva’s brand heritage. In addition, we have signed license agreements for UGG handbags and related small leather goods, outerwear, and cold weather accessories, and have several other UGG related licensing opportunities under consideration, including “at home” apparel, home accessories and other categories to complement our UGG business. We are also planning to expand our licensing program to the international markets.
      BHPC Global Licensing, Inc. is a full service licensing agency that we initially used to assist us in identifying licensing candidates and coordinating our licensing business until August 2004, when we hired our Vice President of Corporate Licensing to coordinate these efforts for us. We pay BHPC a commission on royalty income that we receive related to licensing agreements that BHPC coordinated on our behalf. In 2004, we paid BHPC approximately $168,000. BHPC is owned by one of our directors, Daniel L. Terheggen.

9


Table of Contents

      Products made under license are sold primarily through the same retail channels as our footwear product offering. Our licensing agreements generally give us the right to terminate the license if specified sales targets are not achieved.
Sales and Distribution
      We distribute our products in the U.S. through a dedicated network of approximately 40 independent sales representatives. Our sales representatives are organized geographically and visit retail stores to communicate the features, styling and technology of our products. In addition, we have five employee sales representatives who serve as key account executives for several of our largest customers.
      Our sales force is divided into two teams, one for Teva and one for UGG and Simple, as the UGG and Simple brands are generally sold through non-outdoor specialty and non-sporting goods distribution channels and are targeted toward a different consumer than our Teva brand. The sales manager for each brand recruits and manages his or her networks of sales representatives and coordinates sales to national accounts. We believe this approach for the U.S. market maximizes the selling efforts to our national retail accounts on a cost-effective basis.
      Internationally, we distribute our products through 35 independent distributors. Shipments to Europe are primarily facilitated through third party distribution in the Netherlands. All other international shipments are made directly from our independent manufacturers.
      Our principal customers include specialty retailers, selected department stores, outdoor retailers, sporting goods retailers and shoe stores. Our five largest customers accounted for approximately 25.2% of our net sales for 2004, compared to 20.5% for 2003. No single customer accounted for more than 10.0% of our net sales in 2004 or 2003, except that a West Coast based upscale department store, which is a significant customer for each of our three brands, accounted for 14.1% of net sales in 2004.
      Teva. We sell our Teva products primarily through specialty outdoor and sporting goods retailers such as REI, Eastern Mountain Sports, L.L. Bean, Dick’s Sporting Goods and The Sports Authority. We believe this retail channel is the first choice for athletes, enthusiasts and adventurers seeking technical and performance-oriented footwear. Furthermore, we believe that our Teva products are best sold by retailers who appreciate and can fully market the technical attributes of our products to the consumer. We also sell a limited selection of styles and special make-up Teva products through selected retailers in order to reach consumers who are less outdoor-oriented but who seek out our products due to their durability, comfort and fit.
      UGG. We sell our UGG products primarily through high-end department stores such as Nordstrom, Neiman Marcus and Marshall Field’s, as well as independent specialty retailers such as Fred Segal, David Z. and Sport Chalet. We believe these retailers support the luxury positioning of our brand and are the destination shopping choice for the consumer who seeks out the fashion and functional elements of our UGG products.
      Simple. Our Simple products are targeted primarily towards independent specialty retailers and select department stores that target consumers seeking comfortable, high quality footwear at a fair price. Key accounts such as J. Jill, Nordstrom, Journeys, and REI cater to consumers in our demographic — men and women between the ages of 21 and 35.
      In 2004, we distributed products sold in the U.S. through our 126,000 square foot distribution center in Ventura, California. In 2005, we are also distributing products from an additional 175,000 square foot U.S. distribution center in Camarillo, California. Our distribution centers feature an inventory management system that enables us to efficiently pick and pack products for direct shipment to retailers across the country. For certain customers requiring special handling, each shipment is pre-labeled and packed to the retailer’s specifications, enabling the retailer to easily unpack our product and immediately display it on the sales floor. All incoming and outgoing shipments must meet our rigorous quality inspection process.
      See the discussion of the cash flow cycle, inventories and other items of working capital under “Liquidity and Capital Resources”.

10


Table of Contents

Consumer Direct
      We acquired the Internet and catalog business as part of the acquisition of the Teva Rights. The consumer direct business enables us to reach consumers through our Internet business under the Teva.com, UGGs.com, UGGAustralia.com and SimpleShoes.com Internet addresses and through direct mailings. Our mailing list includes approximately 300,000 consumers who have purchased at least once in the past 36 months. We currently average approximately 600 direct orders daily. In late 2003 we moved our order fulfillment operations from Flagstaff, Arizona to our distribution center in Ventura, California in order to reduce the cost of order cancellation, minimize out of stock positions and further leverage our distribution center occupancy costs. We generally sell our products through our direct channels at approximate retail prices, enabling us to capture the full retail margin on each direct transaction.
Marketing and Advertising
      Our brands are generally advertised and promoted through a variety of consumer print advertising campaigns. We benefit from highly visible editorial coverage in both consumer and trade publications. Each brand’s dedicated marketing team works closely with targeted accounts to maximize advertising and promotional effectiveness. We incurred approximately $7,456,000, $6,594,000 and $8,687,000 in advertising, marketing and promotion expenses in 2002, 2003 and 2004, respectively.
      Teva. We use several marketing methods to promote the Teva brand, including:
  •  a targeted print advertising campaign;
 
  •  promotions at a variety of festivals, events and competitions;
 
  •  sponsorship of local athletes and national athletes such as the Teva Whitewater Team, the Teva U.S. Mountain Running Team and the Cannondale Mountain Bike Team;
 
  •  discount programs to professional river guides, kayakers, mountain bikers and rock climbers;
 
  •  product seeding with professional athletes; and
 
  •  in-store promotions.
      We advertise the Teva brand through the placement of print advertisements in leading outdoor magazines such as Backpacker, Outside, National Geographic Adventurer, Hooked on the Outdoors and Paddler. As we have added new product categories to the Teva brand, we have broadened our advertising presence to reach new consumers. To support our introduction of Teva trail running shoes, we advertise in Trail Runner and Running Times, among other publications. We also advertise in more mainstream publications such as Men’s Journal, Sports Illustrated, and Organic Style in order to support our casual footwear lines.
      The Teva brand is closely associated with outdoor lifestyle pursuits such as river rafting, kayaking, mountain biking, hiking and trail running. We sponsor outdoor events in the U.S. including the Teva Mountain Games at Vail, the Teva Vail Trail Running Series, the Santa Cruz Surf Kayak Festival in Santa Cruz, California, the Telluride Bluegrass Festival in Telluride, Colorado and the Reggae on the River event in Garberville, California, among others. We believe our sponsorship of these events further links our Teva brand with its outdoor heritage and generates increased product exposure and brand awareness. Internationally, we sponsor outdoor events in France, Switzerland and Italy in order to increase our brand visibility to the core European outdoor consumer.
      We sponsor some of the world’s best male and female professional and amateur athletes across several sports. Our Teva promotional team attends events across the U.S. in dedicated, state-of-the-art promotional vehicles prominently featuring our Teva logo. The promotions team showcases Teva products at events and provides consumers with the opportunity to see and sample our latest styles. We recently initiated a partnership with Volkswagen whereby the Teva technical representatives and Team Teva athletes are outfitted in seven Teva branded Volkswagen Eurovans and seven Volkswagen Touaregs for travels across the U.S. We believe by outfitting and sponsoring these highly visible athletes and teams, we create brand and product awareness among our targeted consumers at a relatively low cost.

11


Table of Contents

      UGG. We seek to build upon the success of our UGG national print advertising campaign. We currently advertise in upscale national magazines such as Vogue, ELLE, and O Magazine. We believe such advertising is an effective means to target our intended consumers and to convey the high quality and luxurious appeal of UGG products. We also benefit from editorial coverage of the UGG collection. Articles have appeared in such magazines as Glamour, InStyle, Cosmopolitan, Marie Claire, People, US Weekly, Maxim, Shape, Self, O Magazine and Real Simple. In 2003, UGG was awarded “Brand of the Year” by Footwear News, a leading industry trade publication. In 2004, UGG was awarded “Brand of the Year” by Footwear Plus, another leading trade publication, and was recognized with the ACE Award for the “it” accessory of the year by the Accessories Council.
      We also actively seek to place UGG products at selected events. During the 2002 Winter Olympic Games we outfitted all of the children in the Children of the Light performance with UGG boots. During the Medal Ceremonies, Olympic staff presenting medals to the Olympic athletes also wore UGG boots. We believe this product placement further strengthened the consumer’s image of UGG products as high quality, luxurious sheepskin goods well-suited for use in cold weather.
      We also have improved visibility of the UGG brand through placement of the product in selected television shows and feature films. UGG products have appeared on numerous shows, including Entourage, Six Feet Under, The Oprah Winfrey Show, Judging Amy, The King of Queens, Still Standing, Will and Grace, Everwood, The George Lopez Show, Jeopardy and Saturday Night Live. Our marketing efforts have also resulted in UGG product appearances in the following recent and upcoming feature films: Fever Pitch starring Drew Barrymore and Jimmy Fallon, White Chicks starring the Wayans Brothers, Surviving Christmas starring Ben Affleck and Christina Applegate, Raising Helen starring Kate Hudson and Wicker Park starring Josh Hartnett. In addition, UGG has been embraced by Hollywood celebrities, who are often seen and photographed wearing UGG boots. This celebrity exposure for UGG has been the subject of recent publicity including articles in US Weekly, USA Today, People and People.com. UGG boots have been a featured item on the Oprah Winfrey gift show in 2000 and 2003 and her surprise baby shower for military families in 2004. We believe our target consumer identifies with celebrities and that greater exposure further heightens awareness of the brand and stimulates sales.
      Simple. The Simple consumer identifies with a certain irreverent culture, and we seek to reach that consumer through a focused grassroots marketing approach that will introduce the brand to influential communities around the country. These marketing efforts will focus on the following cities: Los Angeles, San Francisco, New York City, Chicago, Boulder, Austin and Nashville. In support of our grassroots initiatives, we will focus on advertising in alternative weekly publications, which will provide us with the opportunity to reach a large number of people through a cost efficient, non-mainstream medium.
      Simple will continue to work with its public relations agency to get editorial placement of key styles in youth and trend magazines, television shows, independent films and with cutting-edge influential artists and musicians. Our efforts have resulted in product appearances in Teen People, Maxim, Nylon, Lucky and Surfing Girl, and product appearances on VH1 and MTV.
Product Design and Development
      The design and product development staff for each of our brands creates and introduces new innovative footwear products that combine our standards of high quality, comfort and functionality. The design function for all of our brands is performed by a combination of our internal design and development staff plus outside design firms. By introducing outside firms to the design process, we believe we are able to review a variety of different design perspectives on a cost-efficient basis and anticipate color and style trends more quickly.
      To ensure that Teva’s high performance technical products continue to satisfy the requirements of our historical consumer base of performance-oriented “core enthusiasts,” our design staff solicits input from our Team Teva whitewater athletes, the Teva U.S. Mountain Running Team and other professional outdoorsmen, as well as several of our retailers, including REI, Eastern Mountain Sports, Dick’s Sporting Goods and L.L. Bean. We regularly add new innovations, components and styles to our product line based on their input. For example, our Fall 2005 Teva offering features several styles of casual closed toe footwear with our new

12


Table of Contents

Flipsoletm technology, a removable midsole that can be easily removed and converted to a thong, making it two shoes in one. We have also incorporated our proprietary Wraptor technology into performance running sandals, an assortment of hikers and certain styles of our high performance guide sport sandals specifically targeted at professional outdoorsmen and adventurers. In addition, for added traction and durability, we have incorporated various materials in our Teva sandals, including Spider Rubber — a sticky, non-slip rubber outsole material for use across wet and dry terrain, Traction Rubber — a highly durable and abrasion resistant material designed specifically for the extra rigors of land use, and River Rubber — a non-slip material designed to offer superior grip on smooth wet surfaces such as rocks, fiberglass and raft rubber.
      Our UGG and Simple products are designed to appeal to consumers seeking our distinctive and innovative styling. We strive to be a leader in product uniqueness and appearance by regularly updating our UGG and Simple lines, which also generates further awareness and interest in the UGG and Simple collections. We believe our ability to incorporate up-to-date styles without deviating from UGG’s classic look, combined with performance-oriented features consumers have come to expect, results in continued enthusiasm for our brand in the marketplace.
      In order to ensure quality, consistency and efficiency in our design and product development process, we continually evaluate the availability and cost of raw materials, the capabilities and capacity of our independent contract manufacturers and the target retail price of new models and lines. The design and development staff works closely with brand management to develop new styles of footwear for their various product lines. We develop detailed drawings and prototypes of our new products to aid in the conceptualization and to ensure our contemplated new products meet the standards for innovation and performance our consumers demand. Throughout the development process, members of the design staff coordinate internally and with our domestic and overseas product development, manufacturing and sourcing personnel toward a common goal of developing and producing a high quality product to be delivered on a timely basis.
Manufacturing
      We do not manufacture our footwear. We outsource the manufacturing of our Teva, Simple, and UGG footwear to independent manufacturers in the Far East. We also outsource the manufacturing of our UGG footwear to independent manufacturers in Australia and New Zealand. We have no long-term contracts with our manufacturers. As we grow, we expect to continue to rely exclusively on independent manufacturers for our sourcing needs.
      The production of footwear by our independent manufacturers is performed in accordance with our detailed specifications and is subject to our quality control standards. To ensure the production of high quality products, many of the materials and components used in production of our products by the independent manufacturers are purchased from independent suppliers designated by us. Excluding sheepskin, we believe that substantially all the various raw materials and components used in the manufacture of our footwear, including rubber, leather and nylon webbing are generally available from multiple sources at competitive prices. We outsource our manufacturing requirements on the basis of individual purchase orders rather than maintaining long-term purchase commitments with our independent manufacturers.
      At our direction, our manufacturers currently purchase the majority of the sheepskin used in our products from one tannery in New Zealand and three in China. We maintain a constant dialog with the tanneries to monitor the supply of sufficient high quality sheepskin available for our projected UGG footwear production. To ensure adequate supplies for our manufacturers, we forecast our usage of top grade sheepskin one year in advance at a forward price. We believe supplies are sufficient to meet our needs in the near future but we continue to search for alternate suppliers in order to accommodate any unexpected future growth.
      We have instituted pre-production and post-production inspections to meet or exceed the high quality demanded by consumers of our products. Our quality assurance program includes on-site inspectors at our independent manufacturers who oversee the production process and perform quality assurance inspections. We also inspect our products upon arrival at our U.S. distribution center.

13


Table of Contents

Patents and Trademarks
      We now hold 16 U.S. patents, two patents in each of Australia and China and one patent in each of Canada, New Zealand, South Korea, Germany, France, Japan and the United Kingdom for Teva footwear. In addition, we have pending patent applications in Australia, Hong Kong, Mexico, Germany, France, Belgium, Luxembourg, the Netherlands, Italy, Switzerland, the United Kingdom and the U.S. Our U.S. patent for the Teva Universal Strapping System, which is used in most of our Teva sandals, expires in 2007. As a result of the expiration of the applicable period during which foreign patent applications were required to have been filed by the former licensor, we do not and cannot hold certain patent rights for Teva footwear in certain countries. We also currently hold Teva trademark registrations in the U.S. and in many other countries, including France, Germany, the United Kingdom, Japan and Australia. We regard our proprietary rights as valuable assets and vigorously protect such rights against infringement by third parties. Deckers and its predecessor, Mark Thatcher, have successfully enforced their intellectual property rights in the courts and other forums, obtaining numerous judgments, consent judgments and settlement agreements that uphold the validity of Deckers’ patent, trademark and trade dress rights.
      We currently hold UGG trademark registrations in the U.S. and in more than 40 other countries, including the countries in the European Community, Canada, Japan and Australia, among others. We also hold various Simple trademark registrations around the world, including registrations in the U.S. and in more than 40 foreign countries worldwide. We have also selectively registered style category names and marketing slogans. In addition, we hold two design patents for our Simple footwear products and have two pending design patent applications for UGG footwear products.
Seasonality
      Our business is seasonal, with the highest percentage of Teva net sales occurring in the first and second quarters of each year and the highest percentage of UGG net sales occurring in the third and fourth quarters, while the quarter with the highest percentage of annual net sales for Simple has varied from year to year. With the dramatic growth in UGG in recent years, combined with the introduction of a fall Teva line, net sales in the last half of the year have exceeded that for the first half of the year. Given our expectations for each of our brands in 2005, we currently expect this trend to continue. Nonetheless, actual results could differ materially depending upon consumer preferences, availability of product, competition and our customers continuing to carry and promote our various product lines, among other risks and uncertainties. See “Risk Factors.”
Backlog
      Historically, we have encouraged our customers to place, and we have received, a significant portion of orders as pre-season orders, generally four to eight months prior to shipment date. We provide customers with incentives to participate in such pre-season programs to enable us to better plan our production schedule, inventory and shipping needs. Unfilled customer orders as of any date, which we refer to as backlog, represent orders scheduled to be shipped at a future date and do not represent firm orders. The backlog as of a particular date is affected by a number of factors, including seasonality, manufacturing schedule and the timing of shipments of products as well as variations in the quarter-to-quarter and year-to-year preseason incentive programs. The mix of future and immediate delivery orders can vary significantly from quarter to quarter and year to year. As a result, comparisons of the backlog from period to period may be misleading.
Competition
      The casual, outdoor, athletic and fashion footwear markets are highly competitive. We compete with numerous domestic and foreign footwear designers, manufacturers and marketers. Our Teva footwear line primarily competes with Nike, adidas-Salomon, Timberland, Merrell and Columbia Sportswear. Our UGG footwear line primarily competes with Merrell, Acorn, Aussie Dogs, LB Evans and Timberland, as well as retailers’ own private label footwear. In addition, due to the popularity of our UGG products, we face increasing competition from a significant number of competitors selling “knock-off “products. Our Simple footwear line primarily competes with Steve Madden, Dr. Marten, Camper, Kenneth Cole, Skechers, Diesel,

14


Table of Contents

Guess? and Puma. Some of our competitors are significantly larger and have significantly greater resources than we do.
      Our three footwear lines compete primarily on the basis of brand recognition and authenticity, product quality and design, functionality and performance, fashion appeal and price. Our ability to successfully compete depends on our ability to:
  •  shape and stimulate consumer tastes and preferences by offering innovative, attractive and exciting products;
 
  •  anticipate and respond to changing consumer demands in a timely manner;
 
  •  maintain brand authenticity;
 
  •  develop high quality products that appeal to consumers;
 
  •  appropriately price our products;
 
  •  provide strong and effective marketing support; and
 
  •  ensure product availability.
      We believe we are particularly well positioned to compete in the footwear industry. Our diversified portfolio of footwear brands and products allows us to operate a business that does not depend on any one demographic group, merchandise preference or product trend. We have developed a portfolio of brands that appeals to a broad spectrum of consumers. We continually look to acquire or develop more footwear brands to complement our existing portfolio and grow our existing consumer base.
Employees
      At December 31, 2004, we employed approximately 156 full-time employees in our U.S. facilities and 31 full-time employees located in China and Macau, none of whom is represented by a union. We believe our relationships with our employees are good.
Available Information
      Our internet address is www.deckers.com. We post links to our website to the following filings as soon as reasonably practicable after they are electronically filed with or furnished to the Securities and Exchange Commission (“SEC”): annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendment to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended. All such filings are available through our website free of charge. Our filings may also be read and copied at the SEC’s Public Reference Room at 450 Fifth Street, NW, Washington, DC 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is www.sec.gov.
Item 2. Properties
      Our corporate headquarters is located in Goleta, California. We have two distribution centers in Ventura and Camarillo, California, and our Internet and catalog operations are located in Flagstaff, Arizona. We also have a small office in China to oversee the quality and manufacturing standards of our products and a small office in Macau to coordinate logistics. We have no manufacturing facilities, as all of our products are manufactured by independent manufacturers in the Far East, Australia and New Zealand. We lease, rather than own, all of our facilities. Our facilities are leased from unrelated parties. We consider our facilities to be suitable for our needs.

15


Table of Contents

        The following table reflects the location, use and approximate size of our significant real properties:
             
        Approximate
Facility Location   Description   Square Footage
         
Camarillo, California
  Warehouse Facility     175,000  
Ventura, California
  Warehouse Facility     126,000  
Goleta, California
  Corporate Offices     30,000  
China
  Office Facility     4,200  
Flagstaff, Arizona
  Internet/Catalog Vacant Warehouse     3,000  
Flagstaff, Arizona
  Internet/Catalog Office Facility     2,400  
Macau
  Office Facility     2,000  
Item 3. Legal Proceedings
      We are involved in routine litigation arising in the ordinary course of business. Such routine matters, if decided adversely to us, would not, in the opinion of management, have a material adverse effect on our financial condition or results of operations. Additionally, we have many pending disputes in the U.S. Patent and Trademark Office, foreign trademark offices and U.S. federal and foreign courts regarding unauthorized use or registration of our Teva, UGG and Simple trademarks. We also are aware of many instances throughout the world in which a third party is using our UGG trademark within its Internet domain name, and we have discovered and are investigating several manufacturers and distributors of counterfeit Teva and UGG products. We have contacted a majority of these unauthorized users and counterfeiters and in some instances may have to escalate the enforcement of our rights by filing suit against the unauthorized users and counterfeiters. Any decision or settlement in any of these matters that allowed a third party to continue to use our Teva, UGG or Simple trademarks or a domain name with our UGG trademark in connection with the sale of products similar to our products or to continue to manufacture or distribute counterfeit products could have an adverse effect on our sales and on our intellectual property, which could have a material adverse effect on our results of operations and financial condition.
Item 4. Submission of Matters to a Vote of Security Holders
      None.

16


Table of Contents

PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
      Our common stock is traded on the NASDAQ National Market under the symbol “DECK.” The following table shows the range of low and high closing sale prices per share of our common stock as reported by the NASDAQ National Market for the periods indicated.
                   
    Common Stock
    Price Per Share
     
    Low   High
         
Year ended December 31, 2003:
               
 
First Quarter
    $3.45       $4.99  
 
Second Quarter
    $4.20       $6.69  
 
Third Quarter
    $6.40       $10.13  
 
Fourth Quarter
    $11.22       $20.81  
Year ended December 31, 2004:
               
 
First Quarter
    $17.70       $27.68  
 
Second Quarter
    $22.94       $30.28  
 
Third Quarter
    $26.93       $34.76  
 
Fourth Quarter
    $32.05       $48.02  
      As of March 8, 2005, there were approximately 110 record holders of our common stock.
DIVIDEND POLICY
      We have not declared or paid any cash dividends on our common stock since our inception. We currently anticipate that we will retain all of our earnings for the continued development and expansion of our business and do not anticipate declaring or paying any cash dividends in the foreseeable future. Moreover, our debt facilities contain covenants expressly prohibiting us from paying cash dividends.

17


Table of Contents

Item 6. Selected Consolidated Financial Data
      We derived the following selected consolidated financial data from our consolidated financial statements, which have been audited by KPMG LLP, independent registered public accounting firm. Historical results are not necessarily indicative of the results to be expected in the future. You should read the following consolidated financial information together with our consolidated financial statements and the related notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
                                           
    Years Ended December 31,
     
    2000   2001   2002   2003   2004
                     
    (In thousands, except per share data)
Statement of Operations Data
                                       
Net sales:
                                       
 
Teva wholesale
  $ 79,732     $ 61,221     $ 64,849     $ 72,783     $ 83,477  
 
UGG wholesale
    15,310       19,185       23,491       34,561       101,806  
 
Simple wholesale
    16,328       10,853       10,159       7,210       9,633  
 
Internet/catalog
                608       6,501       19,871  
 
Other
    2,368       202                    
                               
Net sales
    113,738       91,461       99,107       121,055       214,787  
Cost of sales
    63,540       52,903       57,577       69,710       124,354  
                               
 
Gross profit
    50,198       38,558       41,530       51,345       90,433  
Selling, general and administrative expenses
    37,168       33,940       34,954       32,407       47,971  
Litigation expense (income)(1)
    400       2,280       3,228       (500 )      
                               
 
Income from operations
    12,630       2,338       3,348       19,438       42,462  
Other expense (income)
    295       (473 )     504       4,554       2,239  
                               
 
Income before income taxes and cumulative effect of accounting change
    12,335       2,811       2,844       14,884       40,223  
Income taxes
    5,320       1,185       1,224       5,730       14,684  
                               
 
Income before cumulative effect of accounting change
    7,015       1,626       1,620       9,154       25,539  
Cumulative effect of accounting change, net of $843,000 income tax benefit(2)
                (8,973 )            
                               
 
Net income (loss)
  $ 7,015     $ 1,626     $ (7,353 )   $ 9,154     $ 25,539  
                               
Per common share:
                                       
Basic net income before cumulative effect of accounting change
  $ 0.77     $ 0.18     $ 0.17     $ 0.91     $ 2.32  
Cumulative effect of accounting change(2)
                (0.96 )            
                               
 
Basic net income (loss)
  $ 0.77     $ 0.18     $ (0.79 )   $ 0.91     $ 2.32  
                               
Diluted income before cumulative effect of accounting change
  $ 0.74     $ 0.17     $ 0.17     $ 0.77     $ 2.10  
Cumulative effect of accounting change(2)
                (0.92 )            
                               
 
Diluted net income (loss)
  $ 0.74     $ 0.17     $ (0.75 )   $ 0.77     $ 2.10  
                               
Weighted average common shares outstanding:
                                       
 
Basic
    9,093       9,247       9,328       9,610       11,005  
 
Diluted
    9,476       9,661       9,806       11,880       12,142  

18


Table of Contents

                                         
    As of December 31,
     
    2000   2001   2002   2003   2004
                     
    (In thousands)
Balance Sheet Data
                                       
Cash and cash equivalents
  $ 9,057     $ 16,689     $ 3,941     $ 6,662     $ 10,379  
Working capital
  $ 40,482     $ 41,387     $ 22,453     $ 22,803     $ 69,854  
Total assets
  $ 77,712     $ 85,884     $ 122,412     $ 121,026     $ 176,551  
Long-term debt, including current installments
  $ 1,495     $ 449     $ 39,028     $ 30,287     $  
Total stockholders’ equity
  $ 64,095     $ 66,532     $ 65,227     $ 70,524     $ 140,996  
                               
 
(1)  The litigation expense (income) includes: (i) expenses of $2,180,000 in 2001 and $3,228,000 in 2002 related to a lawsuit filed against us in Montana in 1995 which we settled and paid in full in 2002, and (ii) expenses of $400,000 in 2000, expenses of $100,000 in 2001 and income of $500,000 in 2003 related to a European anti-dumping duties matter that was ultimately resolved in our favor in 2003.
 
(2)  Our adoption of Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets, on January 1, 2002 resulted in a goodwill impairment charge of $8,973,000 (net of the related income tax benefit of $843,000), or $0.92 per diluted share, during 2002.

19


Table of Contents

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING STATEMENTS
      This report and the information incorporated by reference in this report contain forward-looking statements. We sometimes use words such as “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “project,” “will” and similar expressions, as they relate to us, our management and our industry, to identify forward-looking statements. Forward-looking statements relate to our expectations, beliefs, plans, strategies, prospects, future performance, anticipated trends and other future events. Specifically, this report and the information incorporated by reference in this report contain forward-looking statements relating to, among other things:
  •  our business, growth, operating and financing strategies;
 
  •  our product mix;
 
  •  the success of new products;
 
  •  our licensing strategy;
 
  •  the impact of seasonality on our operations;
 
  •  expectations regarding our net sales and earnings growth;
 
  •  expectations regarding our liquidity;
 
  •  our future financing plans; and
 
  •  trends affecting our financial condition or results of operations.
      We have based our forward-looking statements largely on our current expectations and projections about future events and financial trends affecting our business. Actual results may differ materially. Some of the risks, uncertainties and assumptions that may cause actual results to differ from these forward-looking statements are described in “Risk Factors.” In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report and the information incorporated by reference in this report might not happen.
      You should completely read this report, the documents that we filed as exhibits to this report and the documents that we incorporate by reference in this report with the understanding that our future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements and we assume no obligation to update such forward-looking statements publicly for any reason.
Overview
      We are a leading producer and brand manager of innovative high-quality footwear and the category creator in the sport sandal and luxury sheepskin footwear segments. Our products are marketed under three recognized brand names that we own:
  •  Teva: High performance sport sandals and rugged outdoor footwear;
 
  •  UGG: Authentic luxury sheepskin boots and other footwear; and
 
  •  Simple: Innovative shoes that combine the comfort elements of athletic footwear with casual styling.
      We sell our three brands through our retail customers and directly to our end-user consumers through our Internet and catalog retailing business. We sell our footwear in both the domestic market and the international markets. Independent third parties manufacture all of our footwear.

20


Table of Contents

      Our business has been impacted by several important trends affecting our end markets:
  •  The markets for casual, outdoor and athletic footwear have grown significantly during the last decade. We believe this growth is a result of the trend toward casual dress in the workplace, increasingly active outdoor lifestyles and a growing emphasis on comfort.
 
  •  Consumers are more often seeking footwear designed to address a broader array of activities with the same quality, comfort, and high performance attributes they have come to expect from traditional athletic footwear.
 
  •  Our customers have narrowed their footwear product breadth, focusing on brands with a rich heritage and authenticity as market creators and leaders.
      By emphasizing our brand image and our focus on comfort, performance and authenticity, we believe we can better maintain a loyal consumer following that is less susceptible to fluctuations caused by changing fashions and changes in consumer preferences.
      Set forth below is an overview of the various components of our business, including some of the important factors that affect each business and some of our strategies for growing each business.
Teva Overview
      Our Teva lines experienced strong market acceptance in recent years. Teva’s products have benefited recently from several factors, but most prominently a general shift in consumer preferences and lifestyles to include more outdoor recreational activities. At the same time, our consumers are increasingly purchasing our Teva products for everyday wear, and our Teva brand now includes several closed-toe footwear lines. As a result, our brand remains popular among professional and amateur outdoorsmen seeking authentic, performance-oriented footwear, as well as general footwear consumers seeking high quality, durable and comfortable styles for everyday use.
      To capitalize on the growth of outdoor recreational activities and the acceptance of certain footwear products for everyday use, we have selectively expanded the distribution of our Teva product lines outside our core outdoor specialty and sporting goods channels. Through effective channel management, we believe we can continue to expand into new distribution channels without diluting our outdoor heritage and our appeal to outdoor enthusiasts. Through channel appropriate product line expansion, we plan to continue to broaden our product offerings beyond sport sandals to new products that meet the style and functional needs of our consumers.
      We initially produced Teva products under license from the inventor of the Teva technology, Mark Thatcher. In November 2002, we purchased from Mr. Thatcher the Teva worldwide assets, including the Teva Internet and catalog business and all patents, trade names, trademarks and other intellectual property associated with the acquired Teva assets, or Teva Rights. As a result of our purchase of the Teva Rights, we have adopted a strategy to expand the Teva brand and more fully develop its potential.
UGG Overview
      Since early 2003, our UGG brand received increased media exposure, which contributed to broader public awareness of the UGG brand and significantly increased demand for the collection. We believe that the increased media focus on UGG was driven by the product’s unique styling and resulting brand name identification, Australian heritage and adoption by high-profile film and television celebrities as a favored footwear brand. We believe this increased media attention has enabled us to introduce the brand to consumers much faster than we would have ordinarily been able to. As a result of the subsequent rapid growth in demand, we were sold out of key UGG products throughout much of 2004, and given the long lead times required to replenish our inventory, we have been unable to fill many retailer reorders and many direct Internet and catalog orders. Continuing a strategy utilized with our UGG casual line, we have been shifting a portion of our UGG sheepskin boot production from factories in Australia to three factories in China where the production capacity is much greater and quality standards are comparable.

21


Table of Contents

      We believe the fundamental comfort and functionality of UGG products will continue to drive long-term consumer demand. Recognizing that there is a significant fashion element to UGG and that footwear fashions fluctuate, our strategy seeks to prolong the longevity of the brand by offering a broader product line suitable for wear in a variety of climates and occasions and by limiting distribution to selected higher-end retailers. As part of this strategy, we have expanded our product line over time from 52 models in 2002 to 86 models in 2005.
      Increased media exposure has also broadened appeal for our UGG products. UGG has been a well-known brand in California for many years and has only recently become a recognized brand across the remainder of the country. We believe that a portion of UGG’s increased demand is due to our continued geographical expansion across the U.S. In addition, we have recently begun to expand our distribution and marketing overseas in order to satisfy virtually untapped international markets. We believe the international markets represent an attractive opportunity to grow UGG’s sales.
      We depend on a limited number of key resources for sheepskin, the principal raw material for our UGG products. Four suppliers currently provide all of the sheepskin purchased by our independent manufacturers. The top grade sheepskin used in UGG footwear is in high demand and limited supply. In addition, sheep are susceptible to hoof and mouth disease, which can result in the extermination of the infected herd and could have a material adverse effect on the availability of sheepskin for our products. The supply of sheepskin can also be adversely impacted by drought conditions. Our potential inability to obtain top grade sheepskin for UGG products could impair our ability to meet our production requirements for UGG in a timely manner and could lead to inventory shortages, which can result in lost potential sales, delays in shipments to customers, strain on our relationships with customers and diminished brand loyalty. There have also been significant increases in the prices of footwear quality sheepskin as the demand for this material has increased. Any further price increases will likely raise our costs, increase our costs of sales and decrease our profitability unless we are able to pass higher prices on to our customers. While we believe the supply of top quality sheepskin has improved for the 2005 season, we still expect the demand for this material to continue to outpace supply, leading to shortages and our inability to produce as much of certain styles as our customers would like to order. Looking beyond the next year, if demand continues to be strong, we would expect the supply of top grade sheepskin to continue to increase in response to the demand. However, we have little control over the supply or the overall demand for top grade sheepskin and, accordingly, can provide no assurances about the sufficiency of future supplies of top grade sheepskin.
Simple Overview
      Following three consecutive years of net sales declines in our Simple product line through 2003, we recently implemented a strategy to improve Simple’s results of operations and generate renewed interest in the Simple brand. As a result, net sales for Simple increased 34% in 2004 leading to slightly positive earnings from operations for the brand, a significant improvement over the 2003 loss from operations for Simple of $1,176,000. Instrumental in this turnaround has been the renewed emphasis on product, where we began a process of repositioning our Simple product line by focusing on our successful legacy collections, including clogs and sneakers, and narrowing the number of styles available. At the same time, we have refocused our sales and distribution efforts. While Simple products are sold through many of the same retailers that carry our Teva and UGG lines, the Simple products will also, in some cases, be sold through distribution channels that are precluded from offering our Teva and UGG brands. We expect our Simple brand to experience growth as we successfully implement our product line rationalization and channel management strategies.
Internet and Catalog Retailing Overview
      We acquired our Internet and catalog retailing business in November 2002 as part of the acquisition of the Teva Rights. Our Internet and catalog retailing business, which today sells all three of our brands, enables us to meet the growing demand for all of these products and, because this business sells its products at retail prices, it also provides us with an opportunity to add significant incremental operating income. Managing our Internet business requires us to focus on generating Internet traffic to our websites, effectively convert website visits into orders and maximize average order sizes. To drive our catalog order business, we distribute approximately 550,000 catalogs every six months. Overall, our consumer direct business benefits from the

22


Table of Contents

strength of our brands and, as we grow our brands over time, we expect our Internet and catalog retailing business to increase.
Licensing Overview
      We have recently embarked on a strategy to license our well-known and respected footwear brands to complementary products outside of footwear, generally in the apparel and accessories categories. To date, we have entered into six licensing agreements for Teva, including domestic licenses for men’s sportswear, timepieces, eyewear, headwear and socks and a Canadian license for sportswear. We also have three licensing arrangements for UGG for handbags and other small leather goods, outerwear and cold weather accessories. We are pursuing additional licensing opportunities for our brands both in the U.S. and abroad. Because this licensing strategy is in its early stages, and due to the lead times required to bring the products to market, we have only recently begun to recognize license revenues and we do not expect significant incremental net sales and profits from licensing in the near future. However, we believe licensing revenues may become a more significant portion of our net sales and profits over time if our licensees can sell the licensed products in the quantities they have promised. For the year ended December 31, 2004, our licensees began to ship their products and, accordingly, we recognized net license revenues of $950,000, primarily related to our UGG handbag and outerwear licenses. The minimum net annual royalties that we are scheduled to receive under the nine existing licensing agreements, assuming renewal options are exercised, are $453,000 in 2005, $978,000 in 2006, $1,281,000 in 2007, $1,344,000 in 2008 and $1,391,000 in 2009. The activity within the licensing segment is very small in relation to the consolidated operations and, therefore, separate segment information is not presented.
Seasonality
      Our business is seasonal, with the highest percentage of Teva net sales occurring in the first and second quarters of each year and the highest percentage of UGG net sales occurring in the third and fourth quarters, while the quarter with the highest percentage of annual net sales for Simple has varied from year to year.
                                 
    2003
     
    First Quarter   Second Quarter   Third Quarter   Fourth Quarter
                 
Net sales
  $ 36,102,000     $ 24,342,000     $ 24,894,000     $ 35,717,000  
Income from operations
  $ 8,087,000     $ 4,678,000     $ 1,782,000     $ 4,891,000  
                                 
    2004
     
    First Quarter   Second Quarter   Third Quarter   Fourth Quarter
                 
Net sales
  $ 44,272,000     $ 40,546,000     $ 55,797,000     $ 74,172,000  
Income from operations
  $ 9,628,000     $ 9,274,000     $ 9,358,000     $ 14,202,000  
      With the dramatic growth in UGG in recent years, combined with the introduction of a fall Teva line, net sales in the last half of the year exceeded that for the first half of the year. Given our expectations for each of our brands in 2005, we currently expect this trend to continue. Nonetheless, actual results could differ materially depending upon consumer preferences, availability of product, competition and our customers continuing to carry and promote our various product lines, among other risks and uncertainties. See “Risk Factors.”

23


Table of Contents

Results of Operations
      The following table sets forth certain operating data for the periods indicated.
                               
    Years Ended December 31,
     
    2002   2003   2004
             
Net sales by location:
                       
United States
  $ 78,278,000     $ 98,710,000     $ 175,419,000  
International
    20,829,000       22,345,000       39,368,000  
                   
   
Total
  $ 99,107,000     $ 121,055,000     $ 214,787,000  
                   
Net sales by product line and consumer direct business:
                       
Teva:
                       
 
Wholesale
  $ 64,849,000     $ 72,783,000     $ 83,477,000  
 
Internet/catalog
    255,000       3,687,000       4,759,000  
                   
   
Total
    65,104,000       76,470,000       88,236,000  
                   
UGG:
                       
 
Wholesale
    23,491,000       34,561,000       101,806,000  
 
Internet/catalog
    310,000       2,300,000       14,415,000  
                   
   
Total
    23,801,000       36,861,000       116,221,000  
                   
Simple:
                       
 
Wholesale
    10,159,000       7,210,000       9,633,000  
 
Internet/catalog
    43,000       514,000       697,000  
                   
   
Total
    10,202,000       7,724,000       10,330,000  
                   
     
Total
  $ 99,107,000     $ 121,055,000     $ 214,787,000  
                   
Income (loss) from operations by product line and consumer direct business:
                       
Teva wholesale
  $ 12,011,000     $ 21,739,000     $ 24,901,000  
UGG wholesale
    6,589,000       10,002,000       31,674,000  
Simple wholesale
    279,000       (1,176,000 )     45,000  
Internet/catalog
    194,000       1,148,000       5,533,000  
Unallocated overhead costs
    (15,725,000 )     (12,275,000 )     (19,691,000 )
                   
   
Total
  $ 3,348,000     $ 19,438,000     $ 42,462,000  
                   

24


Table of Contents

      The following table sets forth certain operating data as a percentage of net sales for the periods indicated, and the increase (decrease) in each item of operating data between the periods.
                                           
    Years Ended December 31,   Percent Increase (Decrease)
         
    2002   2003   2004   2002 to 2003   2003 to 2004
                     
Net sales
    100.0 %     100.0 %     100.0 %     22.1 %     77.4 %
Cost of sales
    58.1       57.6       57.9       21.1       78.4  
                               
 
Gross profit
    41.9       42.4       42.1       23.6       76.1  
Selling, general and administrative expenses
    35.3       26.8       22.3       (7.3 )     48.0  
Litigation expense (income)
    3.2       (0.4 )           *       (100.0 )
                               
 
Income from operations
    3.4       16.0       19.8       480.6       118.4  
Interest expense and other
    0.5       3.7       1.1       803.6       (50.8 )
                               
 
Income before income taxes and cumulative effect of a change in accounting principle
    2.9       12.3       18.7       423.3       170.2  
Income taxes
    1.2       4.7       6.8       368.1       156.3  
                               
 
Income before cumulative effect of a change in accounting principle
    1.7       7.6       11.9       465.1       179.0  
Cumulative effect of a change in accounting principle
    (9.1 )                 *       0.0  
                               
 
Net income (loss)
    (7.4 )%     7.6 %     11.9 %     *       179.0  
                               
 
Calculation of percentage change is not meaningful.
Year Ended December 31, 2003 Compared to Year Ended December 31, 2004
      Overview. In 2004, we had net sales of $214,787,000 and income from operations of $42,462,000 compared to net sales of $121,055,000 and income from operations of $19,438,000 in 2003. These results were primarily due to increased demand for all three of our product lines during the year.
      Net Sales. Net sales increased by $93,732,000, or 77.4%, from $121,055,000 in 2003 to $214,787,000 in 2004. Net sales increased in 2004 due primarily to: (1) an increase in the number of units sold for each of our three brands, resulting in a 51.6% overall increase in the volume of footwear sold from 5,063,000 pairs in 2003 to 7,678,000 pairs in 2004, and (2) the expansion of the Internet and catalog retailing business. In addition, the weighted average wholesale selling price per unit increased 13.3% from $23.03 in 2003 to $26.10 in 2004, caused by an increase in sales of UGG products, which generally carry higher average selling prices, partially offset by increased sales of Teva thongs, which generally carry a lower average selling price than sales of our other products, and lower average selling prices on the closeout sales in 2004 compared to 2003.
      Net wholesale sales of Teva increased by $10,694,000, or 14.7%, from $72,783,000 in 2003 to $83,477,000 in 2004. This increase was primarily due to increased sales volume of sport sandals resulting from an improvement in retail sell-through, increased sales in the international markets, selective addition of new distribution channels in our domestic market, increased sales volume of thongs and slides and increased sales volume of certain styles of the recently introduced closed-toe footwear offerings. See “— Overview — Teva Overview” above.
      Net wholesale sales of UGG increased by $67,245,000, or 194.6%, from $34,561,000 in 2003 to $101,806,000 in 2004. This was largely as a result of the growing popularity of the brand, significantly increased brand awareness and considerable celebrity exposure, as well as the fulfillment of the pent-up demand for the UGG product in the first half of 2004. We also increased our sales of UGG products to the international markets, resulting in an increase in international UGG sales of $12,326,000, or 1269.4%, from $971,000 in 2003 to $13,297,000 in 2004. The UGG sales volume increase was also due to strong retail sell-through, expansion of the product line to include more women’s and kids’ boot styles and continued geographical expansion across the U.S. See “— Overview — UGG Overview” above.

25


Table of Contents

      Net wholesale sales of Simple increased by $2,423,000, or 33.6%, from $7,210,000 in 2003 to $9,633,000 in 2004. This increase was due to several factors, including strong initial sales to retailers (sell-in) of the Simple shearling boots in the third quarter of 2004. The increase in Simple sales in 2004 was also due to a renewed interest in the Simple brand, including continued growth in the sales of the Sugar and other sneaker styles, and the successful introduction of the new line of Simple clogs. The Simple sneaker and clog styles have continued to retail well; however, while initial sell-in of the Simple shearling boots was strong, the sell-through to consumers of this type of boot at these price points, including sell-through of similarly-priced products offered by competitors, was slow and accordingly these shearling styles will not be carried forward in the 2005 Simple product line. The sell-through of these shearling boots, as well as similar products offered by competitors, was not strong as the boots were mid-priced boots with retail selling prices in the $50 to $80 range, which was too close to the $110 selling price of the similar Classic boot offering from UGG, which was by far the preferred brand by consumers. See “— Overview — Simple Overview” above.
      Net sales of the Internet and catalog retailing business increased by $13,370,000, or 205.7%, from $6,501,000 in 2003 to $19,871,000 in 2004. In 2003, net sales of the Internet and catalog retailing business included retail sales of Teva of $3,687,000, UGG of $2,300,000 and Simple of $514,000. In 2004, net sales of the Internet and catalog retailing business included retail sales of Teva of $4,759,000, UGG of $14,415,000 and Simple of $697,000. The increase in net sales of the Internet and catalog retailing business was due to the increased demand for the underlying brands, increased awareness of the Internet site and increased consumer acceptance of online purchasing. Our Internet sales for UGG were especially strong, increasing 526.7% in 2004 compared to 2003, as consumers who were unable to find the UGG products at their local retailers frequently searched the Internet for availability of the UGG products, which further contributed to increased sales for our Internet and catalog retailing business. See “— Overview — Internet and Catalog Retailing Overview” above.
      International sales for all of our products increased by $17,023,000, or 76.2%, from $22,345,000 in 2003 to $39,368,000 in 2004, representing 18.5% of net sales in 2003 and 18.3% of net sales in 2004. The higher dollar amount of international sales resulted from our sales of more UGG product to the international markets in order to begin to expand in those territories, our international expansion strategy and the lower relative pricing to European customers due to the strength of the Euro.
      Gross Profit. Gross profit increased by $39,088,000, or 76.1%, from $51,345,000 in 2003 to $90,433,000 in 2004. As a percentage of net sales, gross profit margin decreased slightly from 42.4% in 2003 to 42.1% in 2004. The decrease in gross profit margin was due in part to the significant increase in UGG sales during 2004, which generally carry a lower gross margin than Teva, an increase in airfreight costs in our efforts to improve deliveries of UGG products, and the non-recurrence of last year’s gain caused by the favorable impact of selling in Euros in the European markets in 2003, whereas all sales were denominated in U.S. dollars in 2004. These factors were partially offset by a higher volume of Internet sales, which carry a higher gross margin than items sold at wholesale prices, a reduced impact of closeout sales, lower overhead costs per pair, and the addition of approximately $950,000 of net license revenues, primarily related to UGG handbags and outerwear.
      Selling, General and Administrative Expenses. Selling, general and administrative expenses, or SG&A, increased by $15,564,000, or 48.0%, from $32,407,000 in 2003 to $47,971,000 in 2004. As a percentage of net sales, SG&A decreased from 26.8% in 2003 to 22.3% in 2004 largely due to the continued leverage of operating costs on the increased sales volume. The increase in the dollar amount of SG&A expenses was due to a combination of factors, including increased sales commissions of $3,817,000 on the higher sales volume; increased payroll costs of $3,764,000 attributed to increased performance compensation on the significantly improved operating results combined with an increase in headcount to support the substantial growth; increased warehouse and distribution costs of $1,563,000; higher legal costs associated with increased efforts to protect our intellectual property rights of $1,523,000; increased costs of our growing Internet and catalog retailing business of $1,442,000; increased marketing and advertising costs of $1,067,000; and, other general increases in costs to support the increased sales.

26


Table of Contents

      Litigation Income. In 2003, we received a favorable resolution in a European anti-dumping duties matter in the amount of $500,000.
      Income from Operations. Income from operations increased by $23,024,000, or 118.4%, from $19,438,000 in 2003 to $42,462,000 in 2004. This was due primarily to the factors discussed above.
      Income from operations of Teva wholesale increased by $3,162,000, or 14.5%, from $21,739,000 in 2003 to $24,901,000 in 2004. This increase was largely due to the $10,694,000, or 14.7%, increase in net sales and a reduction in bad debt expense of $547,000. These were partially offset by increases in Teva selling commissions of $593,000 on the higher sales volume, increased payroll costs of $256,000 and the non-recurrence of last year’s gain caused by the favorable impact of selling in Euros in the European markets in 2003, whereas all sales were denominated in U.S. dollars in 2004.
      Income from operations of UGG wholesale increased by $21,672,000, or 216.7%, from $10,002,000 in 2003 to $31,674,000 in 2004. This was largely due to the $67,245,000, or 194.6% increase in net sales, partially offset by a $3,190,000 increase in sales commissions on the higher sales volume, increased airfreight costs of $3,374,000, increased payroll costs of $985,000 and increased advertising and marketing costs of $1,161,000.
      Income from operations of Simple wholesale increased by $1,221,000 from a loss from operations of $1,176,000 in 2003 to income from operations of $45,000 in 2004. This was primarily due to a $2,423,000, or 33.6%, increase in net sales during the period combined with an increase in gross margin resulting from a reduced impact of inventory write-downs and closeout sales in 2004 compared to 2003.
      Income from operations of our Internet and catalog business increased by $4,385,000, or 382.0%, from $1,148,000 in 2003 to $5,533,000 in 2004. This was largely due to the $13,370,000, or 205.7%, increase in sales during the period, partially offset by a corresponding increase in related costs.
      Unallocated overhead costs increased by $7,416,000, or 60.4%, from $12,275,000 in 2003 to $19,691,000 in 2004. These costs included increased payroll costs, increased warehouse and distribution costs and increased legal costs associated with protection of our intellectual property rights that support our business segments.
      Other Expense (Income). Net interest expense was $4,557,000 in 2003 compared with $2,236,000 in 2004. The interest expense resulted principally from the borrowings incurred to finance our purchase of the Teva Rights in November 2002. The decrease in interest expense for 2004 reflects the repayment of outstanding borrowings, partially through the equity offering in May 2004, offset by the prepayment penalties and the write-off of a pro rata share of the previously capitalized loan costs incurred as a result of paying down our debt early. Other expense (income) exclusive of net interest expense was not material in either period.
      Income Taxes. In 2003, income tax expense was $5,730,000, representing an effective income tax rate of 38.5%. In 2004, income tax expense was $14,684,000 representing an effective income tax rate of 36.5%. The decrease in the effective tax rate was primarily due to the restructuring our international operations, which resulted in a reduced effective tax rate.
      Net Income. In 2003, net income was $9,154,000, or $0.77 per diluted share. In 2004, net income was $25,539,000, or $2.10 per diluted share. The dramatic increases in net income and earnings per diluted share resulted from the factors discussed above.
Year Ended December 31, 2002 Compared to Year Ended December 31, 2003
      Overview. In 2003, we had net sales of $121,055,000 and income from operations of $19,438,000 compared to net sales of $99,107,000 and income from operations of $3,348,000 in 2002. These results were due in part to increased demand for our Teva and UGG product lines, partially offset by a decline in net sales of our Simple product line. In addition, 2003 was the first full year of operations following our acquisition in November 2002 of the Teva Rights, which resulted in the elimination of royalty and other license costs of $4,495,000 and resulted in net sales of $6,501,000 attributed to our Internet and catalog retailing business that was a part of the Teva Rights acquisition. The acquisition of the Teva Rights resulted in significant new borrowings and incremental interest expense in 2003 of $4,557,000.

27


Table of Contents

      Net Sales. Net sales increased by $21,948,000, or 22.1%, from $99,107,000 in 2002 to $121,055,000 in 2003. Net sales increased in 2003 due primarily to: (1) an increase in the number of units sold of Teva and UGG offset in part by a decline in the number of units sold of Simple, resulting in a 22.9% overall increase in the volume of footwear sold from 4,120,000 pairs in 2002 to 5,063,000 pairs in 2003, and (2) the inclusion of the Internet and catalog retailing business obtained as part of the Teva Rights acquisition. This increase in unit sales volume was partially offset by a 2.7% decline in average selling price per unit from $23.66 in 2002 to $23.03 in 2003.
      Net wholesale sales of Teva increased by $7,934,000, or 12.2%, from $64,849,000 in 2002 to $72,783,000 in 2003. This increase was primarily due to increased sales volume of sport sandals resulting from an improvement in retail sell-through, the favorable impact of the strong Euro on European sales, selective addition of new distribution channels in our domestic market, increased sales volume of thongs and slides and increased sales volume of certain styles of the recently introduced closed-toe footwear offerings. See “— Overview — Teva Overview” above.
      Net wholesale sales of UGG increased by $11,070,000, or 47.1%, from $23,491,000 in 2002 to $34,561,000 in 2003. This was largely as a result of heightened demand in 2003 caused by the growing popularity of the brand, significantly increased brand awareness and considerable celebrity exposure. The UGG sales volume increase was also due to strong retail sell-through, expansion of the product line to include more casual footwear styles and continued geographical expansion across the U.S. See “— Overview — UGG Overview” above.
      Net wholesale sales of Simple decreased by $2,949,000, or 29.0%, from $10,159,000 in 2002 to $7,210,000 in 2003. This decline was caused by a variety of factors, including competition in the casual footwear market and a $668,000 decline in sales volume in the international markets. These volume declines were partially offset by a $469,000 increase in sales volume of the moderately priced Simple suede, fleece-lined boot, which we introduced in the fourth quarter of 2003. See “— Overview — Simple Overview” above.
      For the period from the November 25, 2002 acquisition date through December 31, 2002, net sales of the Internet and catalog retailing business totaled $608,000, including retail sales of Teva of $255,000, UGG of $310,000 and Simple of $43,000. In 2003, net sales of the Internet and catalog retailing business aggregated $6,501,000, including retail sales of Teva of $3,687,000, UGG of $2,300,000 and Simple of $514,000. See “— Overview — Internet and Catalog Retailing Overview” above.
      International sales for all of our products increased by $1,516,000, or 7.3%, from $20,829,000 in 2002 to $22,345,000 in 2003, representing 21.0% of net sales in 2002 and 18.5% of net sales in 2003. The higher dollar amount of international sales resulted from our international expansion strategy in 2003 combined with the favorable impact of the strong Euro while the lower percentage of international sales to net sales for 2003 reflects the growth of our domestic business.
      Gross Profit. Gross profit increased by $9,815,000, or 23.6%, from $41,530,000 in 2002 to $51,345,000 in 2003. As a percentage of net sales, gross profit margin increased from 41.9% in 2002 to 42.4% in 2003. The increase in gross margin was due to several factors, including an above average gross margin at the newly acquired Internet and catalog retailing business, the favorable impact of the strong Euro and lower production overhead costs per pair, partially offset by an increase in closeout sales.
      Selling, General and Administrative Expenses. Selling, general and administrative expenses, or SG&A, decreased by $2,547,000, or 7.3%, from $34,954,000 in 2002 to $32,407,000 in 2003. As a percentage of net sales, SG&A decreased from 35.3% in 2002 to 26.8% in 2003. The decrease in the dollar amount of SG&A expenses was primarily due to the elimination of Teva royalty expenses and related Teva license cost amortization of $4,495,000. In addition, we had a $1,281,000 decrease in bad debt expense which was largely due to improvements in our credit and collections staff, improvements in our credit and collections policies and procedures and the non-recurrence of the 2002 collections difficulties encountered during the initial stages of the implementation of a new enterprise resource planning, or ERP, computer system. While we believe these improvements will continue to benefit our future collections efforts, we can provide no assurances about the levels of future bad debt expenses, as many other factors contribute to our overall bad debt risk including

28


Table of Contents

the future financial strength of our customers, which is difficult to predict. We also experienced a reduction in overall advertising expenses of $862,000. These cost reductions were partially offset by increased operating expenses related to the newly acquired Internet and catalog retailing business of $1,715,000. SG&A expenses as a percentage of net sales decreased in 2003 due to the overall reduction in SG&A expenses as discussed above as well as the leverage of our fixed costs over a larger revenue base.
      Litigation Expense (Income). In 2002, we recorded special litigation charges of $3,228,000 related to a lawsuit filed against us in the state of Montana in 1995. The case was settled and paid in full in November 2002. In 2003, we received a favorable $500,000 resolution in a European anti-dumping duties matter.
      Income from Operations. Income from operations increased by $16,090,000, or 480.6%, from $3,348,000 in 2002 to $19,438,000 in 2003. This was due primarily to: (1) increased gross profit contribution of $9,815,000, (2) elimination of the Teva royalty expenses and related Teva license cost amortization of $4,495,000, (3) the non-recurrence of the 2002 litigation costs of $3,228,000 and (4) improved profitability resulting from the acquisition of the Internet and catalog retailing business in November 2003 of approximately $954,000.
      Income from operations of Teva wholesale increased by $9,728,000, or 81.0%, from $12,011,000 in 2002 to $21,739,000 in 2003. This increase was largely due to the $7,934,000 increase in net sales, the elimination of $3,739,000 of Teva royalty expense and $756,000 of Teva license cost amortization, a decrease in Teva advertising and marketing costs, and a reduction in bad debt expense of $965,000. These were partially offset by increases in Teva selling commissions on the higher sales volume and increased payroll costs of $783,000.
      Income from operations of UGG wholesale increased by $3,413,000, or 51.8%, from $6,589,000 in 2002 to $10,002,000 in 2003. This was largely due to the $11,070,000 increase in net sales, partially offset by a $583,000 increase in sales commissions on the higher sales volume, increased payroll costs of $232,000, increased advertising and marketing costs and the non-recurrence of a $300,000 chargeback received from a factory in 2002.
      Income from operations of Simple wholesale decreased by $1,455,000 from income from operations of $279,000 in 2002 to a loss from operations of $1,176,000 in 2003. This was primarily due to a $2,949,000 decline in net sales during the period attributed to both the domestic and international markets. In addition, the Simple brand was negatively affected by the increased impact of closeout sales and increased payroll costs in 2003.
      Income from operations of our Internet and catalog business increased by $954,000, or 491.8%, from $194,000 for the period from the November 25, 2002 acquisition date through December 31, 2002 to $1,148,000 in 2003. This was largely due to the full year impact during 2003 and the general continued growth in popularity of online sales.
      Unallocated overhead costs decreased by $3,450,000, or 21.9%, from $15,725,000 in 2002 to $12,275,000 in 2003. This was largely due to the net change in litigation expense (income) of $3,728,000 between 2002 and 2003.
      Other Expense (Income). Net interest expense was $406,000 in 2002 compared with a net interest expense of $4,557,000 in 2003. This was primarily due to our significantly increased borrowings in order to finance our purchase of the Teva Rights in November 2002. In addition, in connection with early repayments of $2,000,000 of subordinated notes in June 2003 and $2,000,000 in December 2003, we incurred approximately $380,000 of expenses, including prepayment penalties and the write-off of a pro rata share of the previously capitalized loan costs. Other expense (income) exclusive of interest expense (income) was not material in either year.
      Income Taxes. In 2002, income tax expense was $1,224,000, representing an effective income tax rate of 43.0%. In 2003, income tax expense was $5,730,000 representing an effective income tax rate of 38.5%. The decrease in the effective tax rate was primarily due to two factors. First, the rate reduction occurred as certain non-deductible Teva license amortization costs were eliminated in connection with the Teva Rights

29


Table of Contents

acquisition. Second, we restructured our international operations, which resulted in a reduced effective tax rate.
      Net Income. On January 1, 2002, we implemented Statement of Financial Accounting Standards, or SFAS, No. 142, Goodwill and Other Intangible Assets, which requires that goodwill and intangible assets with indefinite useful lives no longer be amortized to earnings but instead be reviewed periodically for impairment. The implementation of SFAS No. 142 resulted in a goodwill impairment charge of $8,973,000 (net of the related income tax benefit of $843,000), or $0.92 per diluted share, during 2002. This non-cash impairment charge included a write down of approximately $1,200,000, on an after tax basis, for Simple goodwill and approximately $7,800,000 for UGG goodwill. We recorded the impairment charge as a cumulative effect of a change in accounting principle in the accompanying consolidated statement of operations for 2002. In 2002, net income before cumulative effect of a change in accounting principle was $1,620,000, or $0.17 per diluted share, and the net loss after the cumulative effect of a change in accounting principle was $7,353,000, or $0.75 per diluted share. In 2003, net income was $9,154,000, or $0.77 per diluted share.
Off-Balance Sheet Arrangements
      We have no off-balance sheet arrangements other than operating leases. See “— Contractual Obligations” below. We do not believe that these operating leases are material to our current or future financial condition, results of operations, liquidity, capital resources or capital expenditures.
Liquidity and Capital Resources
      In May 2004, we completed a follow-on public stock offering and used a portion of the proceeds to repay all outstanding borrowings, including all debt associated with the acquisition of the Teva Rights. We finance our working capital and operating needs using a combination of the proceeds from the 2004 stock offering, cash generated from operations and the credit availability under our $20,000,000 revolving credit facility.
      The seasonality of our business requires us to build inventory levels in anticipation of the sales for the coming season. Teva generally begins to build inventory levels beginning in the fourth quarter and first quarter in anticipation of the spring selling season that occurs in the first and second quarters, whereas UGG generally begins to build its inventories in the second quarter and third quarter to support sales for the fall and winter selling seasons, which historically occur during the third and fourth quarters. However, given the currently increased demand for UGG products, we have also built our December 31, 2004 inventory levels to support the increased sales expectations for UGG’s Spring 2005 season. Our Simple product line is less seasonal and less significant to total inventory than our Teva and UGG lines.
      Our cash flow cycle includes the purchase of these inventories, the subsequent sale of the inventories and the eventual collection of the resulting accounts receivable. As a result, our working capital requirements begin when we purchase the inventories and continue until we ultimately collect the resulting receivables. Given the seasonality of our Teva and UGG brands, our working capital requirements fluctuate significantly throughout the year. The cash required to fund these working capital fluctuations is generally provided using a combination of our internal cash flows and borrowings under our revolving credit facility.
      Cash from Operating Activities. Net cash provided by operating activities decreased from $17,627,000 in 2003 to $12,416,000 in 2004. The decrease in net cash provided by operating activities in 2004 was largely due to a larger increase in trade accounts receivable of $25,394,000 resulting from significant year end sales and a larger increase in inventory of $16,420,000 in 2004, partially offset by an improvement in net earnings of $16,385,000, a larger increase in trade accounts payable and accrued expenses of $10,328,000 and the $6,030,000 income tax benefit attributable to the exercise of stock options in 2004. Net working capital at December 31, 2004 improved by $47,051,000, or 206.3%, from $22,803,000 in 2003 to $69,854,000 in 2004, primarily as a result of the sale of common stock in our follow-on public stock offering in May 2004.
      Cash from Investing Activities. Net cash used in investing activities was $705,000 in 2003 and $16,873,000 in 2004. Net cash used in investing activities in 2004 was primarily a result of $15,475,000 of net purchases of short-term investments in order to improve the yield on available cash, and $1,441,000 of

30


Table of Contents

purchases of property and equipment. In 2003, net cash used in investing activities was comprised almost entirely of purchases of property and equipment. The increase in purchases of property and equipment in 2004 compared to 2003 occurred as we replaced tradeshow booths and our phone system in 2004 and we began the expansion and build out of our distribution center.
      Cash from Financing Activities. In 2003, net cash used in financing activities aggregated $14,091,000, including the repayment of long-term debt of $8,934,000 and the repurchase of all outstanding convertible preferred stock for $5,938,000, offset by proceeds from stock issuances of $781,000. In 2004, net cash provided by financing activities aggregated $8,213,000, including cash received from the issuances of common stock of $38,500,000, primarily in connection with the follow-on public stock offering in May 2004, which was used, in part, to pay off all remaining long-term debt.
      Our liquidity consists primarily of cash, short-term investments, trade accounts receivable, inventories and a revolving credit facility. At December 31, 2004, working capital was $69,854,000 including $10,379,000 of cash and $15,475,000 of short-term investments. Cash provided by operating activities aggregated $12,416,000 in 2004. Trade accounts receivable increased by 123.8% from $18,745,000 at December 31, 2003 to $41,957,000 at December 31, 2004 largely due to the 107.7% increase in net sales during the fourth quarter ended December 31, 2004 compared to the fourth quarter of last year. In addition, the fourth quarter sales were weighted more heavily toward the end of the fourth quarter, with a 130.5% increase in sales in the month of December of 2004 compared to December 2003, which further contributed to the increase in trade accounts receivable at year end. Accounts receivable turnover improved from 6.1 times in 2003 to 7.7 times in 2004. This improvement resulted from the hiring of more qualified credit and collections staff, the improvement in collections policies and procedures and the strength of our brands, which provides strong incentive for customers to pay us timely so that we can avoid placing then on credit hold, which would delay shipments of their future orders.
      During the same period, inventories increased by 68.1% from $18,004,000 at December 31, 2003 to $30,260,000 at December 31, 2004, reflecting a $1,703,000 increase in Teva inventory, an $11,083,000 increase in UGG inventory and a $530,000 decrease in Simple inventory at year end. Overall, inventory turnover improved from 3.6 times in 2003 to 5.5 times in 2004. The $1,703,000 increase in Teva inventory occurred because the factories delivered more Teva products in 2004 for the 2005 season than they did in 2003 for the 2004 season, due to our efforts to improve our on-time deliveries of complete orders to our customers earlier for the 2005 spring season. The increase in Teva inventory was also needed to support an expected increase in Teva sales for the first quarter of 2005 compared to actual sales for the first quarter of 2004. The $11,083,000 increase in UGG inventory at December 31, 2004 is in support of our expectations for significantly higher UGG sales in the first quarter of 2005, resulting from the carryover of holiday sales as well as the deliveries of the first Spring product offering for UGG. The $530,000 decrease in Simple inventory at December 31, 2004 reflects our continuing efforts to reduce the levels of our closeout inventories, to bring our Simple inventory into stock closer to when we expect it to be shipped to our customers, and to refocus the line and the related inventory levels on a fewer number of core styles.
      Our revolving credit facility with Comerica Bank-California provides for a maximum availability of $20,000,000 subject to a borrowing base. In general, the borrowing base is equal to 75% of eligible accounts receivable, as defined, and 50% of eligible inventory, as defined. Up to $10,000,000 of borrowings may be in the form of letters of credit. The facility bears interest at the lender’s prime rate (5.25% at December 31, 2004) or, at our option, at LIBOR (2.40% at December 31, 2004) plus 1.00% to 2.50%, depending on our ratio of liabilities to earnings before interest, taxes, depreciation and amortization, or EBITDA, and is secured by substantially all of our assets. The facility includes annual commitment fees, which were $100,000 for 2004 and $60,000 for 2005. The facility expires on June 1, 2006. At December 31, 2004, we had no outstanding borrowings under the facility, no foreign currency reserves for outstanding forward contracts and no outstanding letters of credit. We had credit availability under the facility of $20,000,000 at December 31, 2004.
      On November 25, 2002, we completed the acquisition of the Teva Rights from Mark Thatcher and his wholly owned company, Teva Sport Sandals, Inc., for approximately $62,300,000, including transaction costs

31


Table of Contents

of approximately $300,000. We paid cash in the amount of $43,000,000 and issued to Mr. Thatcher a junior subordinated note in the principal amount of $13,000,000, convertible preferred stock of $5,500,000, 100,000 shares of common stock valued at approximately $368,000 and options to purchase 100,000 shares of common stock valued at approximately $187,000. The $13,000,000 junior subordinated note included a coupon interest rate of 7.00% and an additional interest rate of 2.00%, which was to be accrued and paid at the maturity date in 2008. The note allowed prepayment without penalty. Concurrent with the acquisition, we entered into an employment agreement for advice on Teva matters with Mr. Thatcher through November 2007, which provides for an annual base salary of $276,875, and we received a non-compete agreement from Mr. Thatcher, which expires two years after termination of employment.
      In connection with the Teva Rights acquisition, we entered into two additional financing arrangements, including a $7,000,000 term loan from Comerica Bank-California and a $14,000,000 subordinated note from The Peninsula Fund III Limited Partnership, both unrelated parties.
      As mentioned above, in May 2004 we completed a follow-on public offering of our common stock in which we sold 1,500,000 shares of newly issued common stock and 2,000,000 shares of our common stock were sold by selling stockholders. Using a portion of the proceeds from this stock offering, as well as the cash flow from operations, between January 2003 and June 2004 we repurchased all of the outstanding convertible preferred stock and repaid all of the outstanding debt incurred for the acquistion of the Teva Rights.
      Upon the completion of the public offering and repayment of our outstanding debt, the borrowing availability under our revolving credit facility became the full $20,000,000 amount of the facility, subject to the borrowing base lending requirements.
      The agreements underlying the bank credit facility contain several financial covenants including a quick ratio requirement, profitability requirements and a tangible net worth requirement, among others, as well as a prohibition on the payment of dividends. We were in compliance with all covenants at December 31, 2004, and remain so as of the date of this report.
      Capital expenditures totaled $1,441,000 in 2004 and related primarily to the replacement of certain computer equipment and trade show booths, the upgrade of our phone system and the build out of our newly leased distribution center. We currently have no material commitments for future capital expenditures but estimate that the capital expenditures for 2005 will range from $2,500,000 to $3,500,000 and will include further distribution center expansion, a new UGG trade show booth and upgrades of certain other computer equipment. The actual amount of capital expenditures for 2005 may differ from this estimate, largely depending on any unforeseen needs to replace existing assets.
      Contractual Obligations. The following table summarizes our contractual obligations at December 31, 2004 and the effects such obligations are expected to have on liquidity and cash flow in future periods.
                                         
    Payments Due by Period
     
        Less than       More than
    Total   1 Year   1-3 Years   3-5 Years   5 Years
                     
Operating lease obligations
  $ 8,144,000     $ 2,274,000     $ 3,690,000     $ 2,180,000        
      We previously had significant interest payment requirements on the long-term debt obligations discussed above. However, since we paid off all the outstanding balances on our long-term debt, we have no future interest payments scheduled.
      We believe that internally generated funds, the available borrowings under our existing credit facilities and cash on hand will provide sufficient liquidity to enable us to meet our current and foreseeable working capital requirements. However, risks and uncertainties that could impact our ability to maintain our cash position include our growth rate, the continued strength of our brands, our ability to respond to changes in consumer preferences, our ability to collect our receivables in a timely manner, our ability to effectively manage our inventories and the volume of letters of credit used to purchase product, among others. See “Risk Factors” for a discussion of additional factors that may affect our working capital position.

32


Table of Contents

Impact of Inflation
      We believe that the relatively moderate rates of inflation in recent years have not had a significant impact on our net sales or profitability.
Critical Accounting Policies
      Revenue Recognition. We recognize revenue when products are shipped and the customer takes title and assumes risk of loss, collection of relevant receivable is probable, persuasive evidence of an arrangement exists, and the sales price is fixed or determinable. Allowances for estimated returns, discounts, and bad debts are provided for when related revenue is recorded. Amounts billed for shipping and handling costs are recorded as a component of net sales, while the related costs paid to third-party shipping companies are recorded as a cost of sales.
      In addition, the preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures about contingent liabilities and the reported amounts of net sales and expenses during the reporting period. Management bases these estimates and assumptions upon historical experience, existing, known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable under the circumstances. Management reasonably could use different estimates and assumptions, and changes in estimates and assumptions could occur from period to period, with the result in each case being a potential material change in the financial statement presentation of our financial condition or results of operations. We have historically been accurate in our estimates used for the reserves and allowances below. We believe that the estimates and assumptions below are among those most important to an understanding of our consolidated financial statements contained in this report.
      Allowance for Doubtful Accounts. We provide a reserve against trade accounts receivable for estimated losses that may result from customers’ inability to pay. We determine the amount of the reserve by analyzing known uncollectible accounts, aged trade accounts receivables, economic conditions, historical experience and the customers’ credit-worthiness. Trade accounts receivable that are subsequently determined to be uncollectible are charged or written off against this reserve. The reserve includes specific reserves for accounts, which are identified as potentially uncollectible, plus a general reserve for the balance of accounts. Reserves have been fully established for all expected or probable losses of this nature. The gross trade accounts receivable balance was $45,238,000 and the allowance for doubtful accounts was $1,796,000 at December 31, 2004, compared to gross trade accounts receivable of $20,871,000 and allowance for doubtful accounts of $1,581,000 at December 31, 2003. Our use of different estimates and assumptions could produce different financial results. For example, a 1.0% change in the rate used to estimate the reserve for the accounts not specifically identified as uncollectible would change the allowance for doubtful accounts at December 31, 2004 by $390,000.
      Reserve for Sales Discounts. A significant portion of our domestic net sales and resulting trade accounts receivable reflects a discount that the customers may take, generally based upon meeting certain order, shipment and payment timelines. We estimate the amount of the discounts that are expected to be taken against the period-end trade accounts receivable and we record a corresponding reserve for sales discounts. We determine the amount of the reserve for sales discounts considering the amounts of available discounts in the period-end accounts receivable aging and historical discount experience, among other factors. The reserve for sales discounts was approximately $1,485,000 at December 31, 2004 and $545,000 at December 31, 2003. Our use of different estimates and assumptions could produce different financial results. For example a 10.0% change in the estimate of the percentage of accounts that will ultimately take their discount would change the reserve for sales discounts at December 31, 2004 by $148,000.
      Allowance for Estimated Returns. We record an allowance for anticipated future returns of goods shipped prior to period-end. In general, we accept returns for damaged or defective products but discourage returns for other reasons. We base the amount of the allowance on any approved customer requests for returns, historical returns experience and any recent events that could result in a change in historical returns rates, among other factors. The allowance for returns was $1,731,000 at December 31, 2004 and $1,245,000 at

33


Table of Contents

December 31, 2003. Our use of different estimates and assumptions could produce different financial results. For example, a 1.0% change in the rate used to estimate the percentage of sales expected to ultimately be returned would change the reserve for returns at December 31, 2004 by approximately $595,000.
      Inventory Write-Downs. Inventories are stated at lower of cost or market. We review the various items in inventory on a regular basis for excess, obsolete and impaired inventory. In doing so, we write the inventory down to the lower of cost or estimated future net selling prices. At December 31, 2004, inventories were stated at $30,260,000, net of inventory write-downs of $1,176,000. At December 31, 2003, inventories were stated at $18,004,000, net of inventory write-downs of $882,000. Our use of different estimates and assumptions could produce different financial results. For example, a 10.0% change in the estimated selling prices of our potentially obsolete inventory would change the inventory write-down amount at December 31, 2004 by approximately $310,000.
      Valuation of Goodwill, Intangible and Other Long-Lived Assets. We periodically assess the impairment of goodwill, intangible and other long-lived assets based on assumptions and judgments regarding the carrying value of these assets. We test goodwill and nonamortizable intangible assets for impairment on an annual basis based on the fair value of the reporting unit (goodwill) or assets (nonamortizable intangibles) compared to its carrying value. We consider other long-lived assets to be impaired if we determine that the carrying value may not be recoverable. Among other considerations, we consider the following factors:
  •  the assets’ ability to continue to generate income from operations and positive cash flow in future periods;
 
  •  our future plans regarding utilization of the assets;
 
  •  any changes in legal ownership of rights to the assets; and
 
  •  changes in consumer demand or acceptance of the related brand names, products or features associated with the assets.
      If we consider the assets to be impaired, we recognize an impairment loss equal to the amount by which the carrying value of the assets exceeds the estimated fair value of the assets. In addition, as it relates to long-lived assets, we base the useful lives and related amortization or depreciation expense on the estimate of the period that the assets will generate sales or otherwise be used by us.
      In 2002, SFAS No. 142, “Goodwill and Other Intangible Assets,” became effective and as a result, we recorded a goodwill impairment charge in the first quarter of 2002. See note 13 to the accompanying consolidated financial statements.
Recent Accounting Pronouncements
      In January 2003, the Financial Accounting Standards Board, or FASB, issued FASB Interpretation, or FIN No. 46, Consolidation of Variable Interest Entities, an interpretation of Accounting Research Bulletin, or ARB No. 51. FIN No. 46 addresses the consolidation by business enterprises of variable interest entities as defined in the Interpretation. FIN No. 46 generally applies immediately to variable interests in variable interest entities created after January 31, 2003 and to variable interests in variable interest entities obtained after January 31, 2003. The application of FIN No. 46 did not have a material effect on our consolidated financial statements. In December 2003, the FASB revised FIN No. 46 to exempt certain entities from its requirements and to clarify certain issues arising during the implementation of FIN No. 46. The adoption of this revised interpretation in the first quarter of 2004 did not have any impact on our consolidated financial statements.
      On October 22, 2004, the American Jobs Creation Act (AJCA) was signed into law. The AJCA includes a special one-time 85 percent dividends received deduction for certain foreign earnings that are repatriated. In December 2004, the FASB issued FASB Staff Position No. FAS 109-2 (FSP FAS 109-2), “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004.” FSP FAS 109-2 provides accounting and disclosure guidance for this repatriation provision. We have begun our evaluation of the effects of this provision. Although FSP FAS 109-2 is effective immediately,

34


Table of Contents

we will not be able to complete our evaluation until after Congress or the Treasury Department provides additional clarifying language on key elements of the provision. We expect to complete our evaluation of the effects of the repatriation provision within a reasonable period of time following the publication of the additional clarifying language.
      In November 2004, the FASB issued Statement of Financial Accounting Standards, or SFAS No. 151, “Inventory Costs — An Amendment of ARB No. 43, Chapter 4”. SFAS No. 151 amends the guidance in ARB No. 43, Chapter 4, “Inventory Pricing”, to clarify the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage). SFAS No. 151 is effective for fiscal years beginning after June 15, 2005 and is required to be adopted in the first quarter of fiscal 2006. We do not expect the adoption of SFAS No. 151 to have a material impact on our consolidated financial statements.
      In December 2004, the FASB issued SFAS No. 123R (revised 2004), “Share-Based Payment”. SFAS No. 123R supersedes APB Opinion No. 25, and requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values beginning with the first interim or annual period after June 15, 2005. The pro forma disclosure permitted under SFAS No. 123 will no longer be an alternative to financial statement recognition. SFAS No. 123R requires the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests. We are required to adopt the provisions of SFAS No. 123R effective July 1, 2005. The adoption of this Statement is expected to result in an additional expense for the year ending December 31, 2005 of approximately $400,000, which will be recorded in the third and fourth quarters of 2005.

35


Table of Contents

RISK FACTORS
      Our short- and long-term success is subject to many factors beyond our control. Stockholders and potential stockholders should carefully consider the following risk factors in addition to the other information contained in this report and the information incorporated by reference in this report. If any of the following risks occur, our business, financial condition or results of operations could be adversely affected. In that case, the value of our common stock could decline and stockholders and potential stockholders may lose all or part of their investment.
Risks Relating to Our Business
Our success depends on our ability to anticipate fashion trends.
      Our success depends largely on the continued strength of our Teva, UGG and Simple brands and on our ability to anticipate, understand and react to the rapidly changing fashion tastes of footwear consumers and to provide appealing merchandise in a timely manner. Our products must appeal to a broad range of consumers whose preferences cannot be predicted with certainty and are subject to rapid change. We are also dependent on customer receptivity to our products and marketing strategy. There can be no assurance that consumers will continue to prefer our brands, that we will respond quickly enough to changes in consumer preferences or that we will successfully introduce new models and styles of footwear. Achieving market acceptance for new products also will likely require us to exert substantial marketing and product development efforts and expend significant funds to create consumer demand. A failure to introduce new products that gain market acceptance would erode our competitive position, which would reduce our profits and could adversely affect the image of our brands, resulting in long-term harm to our business.
Our UGG brand may not continue to grow at the same rate it has experienced in the recent past.
      Our UGG brand has experienced strong growth over the past few years, with net wholesale sales of UGG products having increased from $23,491,000 in 2002 to $101,806,000 in 2004, representing a compound annual growth rate of 108.2%. We do not expect to sustain this growth rate in the future. UGG may be a fashion item that could go out of style at any time. UGG represents a significant portion of our business, and if UGG sales were to decline or to fail to increase in the future, our overall financial performance would be adversely affected.
We may experience shortages of top grade sheepskin, which could interrupt product manufacturing and increase product costs.
      We depend on a limited number of key resources for sheepskin, the principal raw material for our UGG products. In 2004, four suppliers provided all of the sheepskin purchased by our independent manufacturers. The top grade sheepskin used in UGG footwear is in high demand and limited supply. In addition, sheep are susceptible to hoof and mouth disease, which can result in the extermination of an infected herd and could have a material adverse effect on the availability of top grade sheepskin for our products. Additionally, the supply of sheepskin can be adversely impacted by drought conditions. Our potential inability to obtain top grade sheepskin for UGG products could impair our ability to meet our production requirements for UGG in a timely manner and could lead to inventory shortages, which can result in lost potential sales, delays in shipments to customers, strain on our relationships with customers and diminished brand loyalty. Additionally, there have been significant increases in the prices of top grade sheepskin as the demand for this material has increased. Any further price increases will likely raise our costs, increase our costs of sales and decrease our profitability unless we are able to pass higher prices on to our customers.
If we do not accurately forecast consumer demand, we may have excess inventory to liquidate or have difficulty filling our customers’ orders.
      Because the footwear industry has relatively long lead times for design and production, we must commit to production tooling and production volumes many months before consumer tastes become apparent. The

36


Table of Contents

footwear industry is subject to fashion risks and rapid changes in consumer preferences, as well as the effects of weather, general market conditions and other factors affecting demand. Our large number of models, colors and sizes in our three product lines exacerbates these risks. As a result, we may fail to accurately forecast styles and features that will be in demand. If we overestimate demand for our products, we may be forced to liquidate excess inventories at a discount to customers, resulting in higher markdowns and lower gross margins. Further, the excess inventories may prolong our cash flow cycle, resulting in reduced cash flow and increased liquidity risks. Conversely, if we underestimate consumer demand, we could have inventory shortages, which can result in lost potential sales, delays in shipments to customers, strains on our relationships with customers and diminished brand loyalty. This may be particularly true with regard to our UGG product line, which continues to experience strong consumer demand and rapid sales growth.
We may not succeed in implementing our growth strategy.
      As part of our growth strategy, we seek to enhance the positioning of our brands, extend our brands into complementary product categories and markets through licensing, expand geographically and improve our operational performance. Another element of our growth strategy is our licensing initiatives. We may not be able to successfully implement any or all of these strategies. If we fail to do so, our rate of growth may slow or our results of operations may decline, which in turn could have a negative effect on the value of our stock.
Our financial success is limited to the success of our customers.
      Our financial success is directly related to the success of our customers and the willingness of our customers to continue to buy our products. We do not have long-term contracts with any of our customers. Sales to our customers are generally on an order-by-order basis and are subject to rights of cancellation and rescheduling by our customers. If we cannot fill our customers’ orders in a timely manner, our relationships with our customers may suffer, and this could have a material adverse effect on us. Furthermore, if any of our major customers experiences a significant downturn in its business, or fails to remain committed to our products or brands, then these customers may reduce or discontinue purchases from us, which could have a material adverse effect on our business, results of operations and financial condition.
Establishing and protecting our trademarks, patents and other intellectual property is costly and difficult. If our efforts to do so are unsuccessful, the value of our brands could suffer.
      We believe that our trade names, copyrights, trade secrets, trademarks, patents, trade dress and designs are of value and are integral to our success and our competitive position. Some countries’ laws do not protect proprietary intellectual property rights to the same extent as do U.S. laws. From time to time, we discover products in the marketplace that infringe upon our trade name, trademark, patent, trade dress, design rights and other intellectual property. If we are unsuccessful in challenging a third party’s products on the basis of patent and trade dress rights, continued sales of such competing products by third parties could adversely impact our business, financial condition and results of operations. Furthermore, our efforts to enforce our trademark and other intellectual property rights are typically met with defenses and counterclaims attacking the validity and enforceability of our trademark and other intellectual property rights. Similarly, from time to time we may be the subject of litigation challenging our ownership of intellectual property. Loss of our Teva, UGG or Simple trade name, trademark, patent, trade dress or other intellectual property rights could have a material adverse effect on our business.
      We face particularly strong challenges to our UGG trademark in Australia, where many Australian manufacturers sell competitive footwear on the Internet. Our trademark registrations in Australia are subject to challenge, which we are contesting. In addition, certain Australian sheepskin boot manufacturers are alleging that the UGH, UGG-BOOT and the UGG Australia trademarks are not valid as being generic terms for sheepskin boots. If the challenges are successful, our rights in the trademarks, including our ability to prevent Australian competitors from using these trademarks in commerce in Australia, will be adversely affected. Although we derived less than 1% of our revenue in the UGG product line from Australian sales in 2004, our ability to prevent Australian competitors from using the marks on the Internet and in other channels

37


Table of Contents

of trade that may reach consumers in other countries, including the United States, could also be adversely affected and the integrity of our UGG brand could be harmed by the association with inferior products.
We may lose pending litigation and the rights to certain of our intellectual property.
      We are currently involved in several informal disputes, disputes in the U.S. Patent and Trademark Office and foreign trademark offices, and disputes in U.S. federal and foreign courts regarding infringement by third parties of our trade names, trademarks, trade dress, copyrights, patents and other intellectual property and the validity of our intellectual property. Any decision or settlement in any of these disputes that renders our intellectual property invalid or unenforceable, or that allows a third party to continue to use our intellectual property in connection with products that are similar to ours could have an adverse effect on our sales and on our intellectual property, which could have a material adverse effect on our results of operations and financial condition.
Counterfeiting of our brands can divert sales and damage our brand image.
      Our brands and designs are constantly at risk for counterfeiting and infringement of our intellectual property rights, and we frequently find counterfeit products and products that infringe on our intellectual property rights in our markets as well as domain names that use our trade names or trademarks without our consent. We have not always been successful, particularly in some foreign countries, in combating counterfeit products and stopping infringement of our intellectual property rights. Counterfeit and infringing products not only cause us to lose significant sales, but also can harm the integrity of our brands by associating our trademarks or designs with lesser quality or defective goods.
      In particular, we are experiencing more infringers of our UGG trademark and more counterfeit products seeking to benefit from the consumer demand for our UGG products. Enforcement of our rights to the UGG trademarks faces many challenges due in part to the proliferation of the term UGG in third party domain names that promote counterfeit products or otherwise use the trademark UGG without our permission. In spite of our enforcement efforts, we expect such unauthorized use to continue, which could result in a loss of sales for authorized UGG products and a diminution in the goodwill associated with the UGG trademarks.
As our patents expire, our competitors will be able to copy our technology or incorporate it in their products without paying royalties.
      Patents generally have a life of 20 years from filing, and some of our patents will expire in the next ten years. For example, the patent for our Universal Strapping System used in Teva sandals will expire in September 2007. Our Universal Strapping System is currently used in most of our Teva sandals. Once patent protection has expired, our competitors can copy our products or incorporate our innovations in their products without paying royalties. To combat this, we must continually create new designs and technology, obtain patent protection and incorporate the new technology or design in our footwear. We cannot provide assurance that we will be able to do so. Sales of our Teva sandals may decline significantly if we incorporate substitute technologies in lieu of our Universal Strapping System for our Teva sandals.
Because we depend on independent manufacturers, we face challenges in maintaining a continuous supply of goods that meet our quality standards.
      We use independent manufacturers to produce all of our products, with almost all of the production occurring among four manufacturers in China. We depend on these manufacturers’ ability to finance the production of goods ordered and to maintain manufacturing capacity. The manufacturers in turn depend upon their suppliers of raw materials. We do not exert direct control over either the independent manufacturers or their raw materials suppliers, so we may be unable to obtain timely delivery of acceptable products.
      In addition, we do not have long-term contracts with these independent manufacturers, and any of them may unilaterally terminate their relationship with us at any time or seek to increase the prices they charge us. As a result, we are not assured of an uninterrupted supply of products of an acceptable quality from our independent manufacturers. If there is an interruption, we may not be able to substitute suitable alternative

38


Table of Contents

manufacturers because substitutes may not be available or they may not be able to provide us with products or services of a comparable quality, at an acceptable price or on a timely basis. If a change in our independent manufacturers becomes necessary, we would likely experience increased costs, as well as substantial disruption of our business and a resulting loss of sales.
      Similarly, if we experience a significant increase in demand and a manufacturer is unable to ship orders of our products in accordance with our timing demands and our quality standards, we could miss customer delivery date requirements. This in turn could result in cancellation of orders, customer refusals of shipments or a reduction in purchase prices, any of which could have a material adverse effect on our sales and financial condition. We compete with other companies for the production capacity and the import quota capacity of our manufacturers. Accordingly, our independent manufacturers may not produce and ship some or all of any orders placed by us.
If raw materials do not meet our specifications or if the prices of raw materials increase, we could experience a high return rate, a loss of sales or a reduction in our gross margins.
      Our independent manufacturers use various raw materials in the manufacture of our footwear that must meet our specifications generally and, in some cases, additional technical requirements for performance footwear. If these raw materials and the end product do not perform to our specifications or consumer satisfaction, we could experience a higher rate of customer returns and a diminution in the image of our brands, which could have a material adverse effect on our business, financial condition and results of operations.
      There may be significant increases in the prices of the raw materials used in our footwear, which would increase the cost of our products from our independent manufacturers. Our gross profit margins are adversely affected to the extent that the selling prices of our products do not increase proportionately with increases in their costs. Any significant unanticipated increase in the prices of raw materials could materially affect our results of operations. No assurances can be given that we will be protected from future changes in the prices of such raw materials.
Our independent manufacturers are located outside the U.S., where we are subject to the risks of international commerce.
      All of our third party manufacturers are in the Far East, Australia and New Zealand, with the vast majority of production performed by four manufacturers in China. Foreign manufacturing is subject to numerous risks, including the following:
  •  tariffs, import and export controls and other non-tariff barriers such as quotas and local content rules;
 
  •  increasing transportation costs due to energy prices or other factors;
 
  •  poor infrastructure and shortages of equipment, which can delay or interrupt transportation and utilities;
 
  •  foreign currency fluctuations;
 
  •  restrictions on the transfer of funds;
 
  •  changing economic conditions;
 
  •  changes in governmental policies;
 
  •  environmental regulation;
 
  •  labor unrest, which can lead to work stoppages and interruptions in transportation or supply;
 
  •  political unrest, which can interrupt commerce and make travel dangerous; and
 
  •  expropriation and nationalization.

39


Table of Contents

      In particular, because most of our products are manufactured in China, adverse change in trade or political relations with China or political instability in the Far East could severely interfere with the manufacture of our products and could materially adversely affect our results of operations. Uncertainty regarding the short-term and long-term effects of the severe acute respiratory syndrome, or SARS, and the outbreak of avian influenza in China and elsewhere in the Far East could disrupt the manufacture and transportation of our products, which would harm our results of operations.
      We are also subject to general risks associated with managing foreign operations effectively and efficiently from the U.S. and understanding and complying with local laws, regulations and customs in foreign jurisdictions. These factors and the failure to properly respond to them could make it difficult to obtain adequate supplies of quality products when we need them, resulting in reduced sales and harm to our business.
Our business could suffer if our independent manufacturers, their suppliers or our licensees violate labor laws or fail to conform to our ethical standards.
      We require our independent contract manufacturers, their suppliers and our licensees to meet our standards for working conditions, environmental protection and other matters before we are willing to place business with them. As a result, we do not always obtain the lowest cost production. We do not control our independent manufacturers, their suppliers or their respective labor practices. If one of our independent contract manufacturers or one of their suppliers violates our labor standards by, for example, using convicted, forced or indentured labor or child labor, fails to pay compensation in accordance with local law or fails to operate its factories in compliance with local safety regulations, we likely would immediately cease dealing with that manufacturer (or, in the case of a supplier, we would likely require our manufacturer to immediately cease using that supplier), and we could suffer an interruption in our product supply. In addition, the manufacturers’ or their suppliers’ actions could damage our reputation and the value of our brands, resulting in negative publicity and discouraging customers and consumers from buying our products.
      Similarly, we do not control our licensees or any of their suppliers or their respective labor practices. If one of our licensees violates our labor standards or local laws, we would immediately terminate the license agreement, which would reduce our license revenue. In addition, the licensee’s actions could damage our reputation and the value of our brands. We also may not be able to replace the licensee.
If our licensing partners are unable to meet our expectations regarding the quality of their products or the conduct of their business, the value of our brands could suffer.
      One element of our growth strategy depends on our ability to successfully enter into and maintain license agreements with manufacturers and distributors of products in complementary categories. We will be relying on our licensees to maintain our standards with their manufacturers in the future, and any failure to do so could harm our reputation and the value of the licensed brand. The interruption of the business of any one of our material licensing partners due to any of the factors discussed immediately below could also adversely affect our future licensing sales and net income. The risks associated with our own products will also apply to our licensed products in addition to any number of possible risks specific to a licensing partner’s business, including, for example, risks associated with a particular licensing partner’s ability to:
  •  obtain capital;
 
  •  manage manufacturing and product sourcing activities;
 
  •  manage labor relations;
 
  •  maintain relationships with suppliers;
 
  •  manage credit risk effectively; and
 
  •  maintain relationships with customers.
      Our licensing agreements generally do not preclude our licensing partners from offering, under other brands, products similar to those covered by their license agreements with us, which could reduce the sales of

40


Table of Contents

our licensed products. In addition, if we cannot replace existing licensing partners who fail to perform adequately, our net sales, both directly from reduced licensing revenue and indirectly from reduced sales of our other products, will suffer.
If our brand managers cannot properly manage the licensees of their respective brands, our growth strategy could be impaired.
      Our growth strategy and future profits depend upon each of our brand managers finding and successfully managing licensees for each of their respective brands. Our brand managers may not be able to successfully implement the licensing aspect of our growth strategy and to develop and manage profitable license arrangements. We compete for opportunities to license our brands with other companies who have greater resources than we do and who may have more valuable brands and more licensing experience than we do. As a result, even if we do identify a suitable licensee, we may lose the opportunity to a competitor. Our brand managers’ failure to execute our licensing strategy successfully could negatively impact our results from operations.
We may be unable to successfully identify, develop or acquire, and build new brands.
      We intend to continue to focus on identifying, developing or acquiring and building new brands. Our search may not yield any complementary brands, and even if we do find a suitable brand we may not be able to obtain sufficient financing to fund the development or acquisition of the brand. We may not be able to successfully integrate the management of a new brand into our existing operations, and we cannot assure you that any developed or acquired brand will achieve the results we expect. We compete with other companies who have greater resources than we do for the opportunities to license brands or buy other brands. As a result, even if we do identify a suitable license or acquisition, we may lose the opportunity to a competitor who offers a more attractive price. In such event, we may incur significant costs in pursuing a license or an acquisition without success.
Our quarterly sales and operating results may fluctuate in future periods, and if we fail to meet expectations the price of our common stock may decline.
      Our quarterly sales and operating results have fluctuated significantly in the past and are likely to do so in the future due to a number of factors, many of which are not within our control. If our quarterly sales or operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. Factors that might cause quarterly fluctuations in our sales and operating results include the following:
  •  variation in demand for our products, including variation due to changing consumer tastes and seasonality;
 
  •  our ability to develop, introduce, market and gain market acceptance of new products and product enhancements in a timely manner;
 
  •  our ability to manage inventories, accounts receivable and cash flows;
 
  •  our ability to control costs;
 
  •  the size, timing, rescheduling or cancellation of orders from customers;
 
  •  the introduction of new products by competitors;
 
  •  the availability and reliability of raw materials used to manufacture our products;
 
  •  changes in our pricing policies or those of our independent manufacturers and competitors, as well as increased price competition in general;
 
  •  the mix of our domestic and international sales, and the risks and uncertainties associated with our international business;

41


Table of Contents

  •  our ability to forecast future sales and operating results and subsequently attain them;
 
  •  developments concerning the protection of our intellectual property rights; and
 
  •  general global economic and political conditions, including international conflicts and acts of terrorism.
      In addition, our expenses depend, in part, on our expectations regarding future sales. In particular, we expect to continue incurring substantial expenses relating to the marketing and promotion of our products. Since many of our costs are fixed in the short term, if we have a shortfall in sales, we may be unable to reduce expenses quickly enough to avoid losses. Accordingly, you should not rely on quarter-to-quarter comparisons of our operating results as an indication of our future performance.
Loss of the services of our key personnel could adversely affect our business.
      Our future success and growth depend on the continued services of Doug Otto, our Chairman of the Board, Chief Executive Officer and President, Scott Ash, our Chief Financial Officer, Bob Orlando, the President of the Teva Division, Connie Rishwain, the President of the UGG and Simple Divisions, Pat Devaney, Senior Vice President of Global Sourcing, Production and Development, Janice Howell, Vice President of Operations, John Kalinich, Vice President of Consumer Direct, and Tracey Nelson, Vice President of Corporate Licensing, as well as other key officers and employees. The loss of the services of any of these individuals or any other key employee could materially affect our business. Our future success also depends on our ability to identify, attract and retain additional qualified personnel. Competition for employees in our industry is intense and we may not be successful in attracting or retaining them.
We conduct business outside the U.S., which exposes us to foreign currency and other risks.
      Our products are manufactured outside the U.S., and our independent manufacturers procure most of their supplies outside the U.S. We sell our products in the U.S. and internationally. Although we pay for the purchase and manufacture of our products primarily in U.S. dollars and we sell our products primarily in U.S. dollars, we are routinely subject to currency rate movements on non-U.S. denominated assets, liabilities and income since our foreign distributors sell in local currencies, which impacts the price to foreign customers. We currently do not use currency hedges since substantially all our transactions are in U.S. dollars. Future changes in foreign currency exchange rates may cause changes in the dollar value of our purchases or sales and materially affect our results of operations.
Our most popular products are seasonal, and our sales are sensitive to weather conditions.
      Sales of our products, particularly those under the Teva and UGG brands, are highly seasonal and are sensitive to weather conditions. Extended periods of unusually cold weather during the spring and summer can reduce demand for Teva footwear. Likewise, unseasonably warm weather during the fall and winter months may reduce demand for our UGG products. The effect of favorable or unfavorable weather on sales can be significant enough to affect our quarterly results, with a resulting effect on our common stock price.
We depend on independent distributors to sell our products in international markets.
      We sell our products in international markets through independent distributors. If a distributor fails to meet annual sales goals, it may be difficult and costly to locate an acceptable substitute distributor. If a change in our distributors becomes necessary, we may experience increased costs, as well as substantial disruption and a resulting loss of sales.

42


Table of Contents

Our sales in international markets are subject to a variety of laws and political and economic risks that may adversely impact our sales and results of operations in certain regions.
      Our ability to capitalize on growth in new international markets and to maintain the current level of operations in our existing international markets is subject to risks associated with international sales operations. These include:
  •  changes in currency exchange rates which impact the price to international consumers;
 
  •  the burdens of complying with a variety of foreign laws and regulations;
 
  •  unexpected changes in regulatory requirements; and
 
  •  the difficulties associated with promoting products in unfamiliar cultures.
      We are also subject to general political and economic risks in connection with our international sales operations, including:
  •  political instability;
 
  •  changes in diplomatic and trade relationships; and
 
  •  general economic fluctuations in specific countries or markets.
      Any of the abovementioned factors could adversely affect our sales and results of operations in international markets.
International trade regulations may impose unexpected duty costs or other non-tariff barriers to markets while the increasing number of free trade agreements has the potential to stimulate increased competition; security procedures may cause significant delays.
      Products manufactured overseas and imported into the U.S. and other countries are subject to import duties. While we have implemented internal measures to comply with applicable customs regulations and to properly calculate the import duties applicable to imported products, customs authorities may disagree with our claimed tariff treatment for certain products, resulting in unexpected costs that may not have been factored into the sales price of the products.
      We cannot predict whether future domestic laws, regulations or trade remedy actions or international agreements may impose additional duties or other restrictions on the importation of products from one or more of our sourcing venues. Such changes could increase the cost of our products, require us to withdraw from certain restricted markets or change our business methods, and could generally make it difficult to obtain products of our customary quality at a desired price. Meanwhile, the continued negotiation of bilateral and multilateral free trade agreements by the U.S. and our other market countries with countries other than our principal sourcing venues may stimulate competition from manufacturers in these other sourcing venues, which now export, or may seek to export, footwear to our market countries at preferred rates of duty, though we are uncertain precisely what effect these new agreements may have on our operations.
      Finally, the increased threat of terrorist activity and the law enforcement responses to this threat have required greater levels of inspection of imported goods and have caused delays in bringing imported goods to market. Any tightening of security procedures, for example, in the aftermath of a terrorist incident, could worsen these delays.
We depend on our computer and communications systems.
      We extensively utilize computer and communications systems to operate our Internet and catalog business and manage our internal operations. Any interruption of this service from power loss, telecommunications failure, failure of our computer system, failure due to weather, natural disasters or any similar event could disrupt our operations and result in lost sales. In addition, hackers and computer viruses have disrupted operations at many major companies. We may be vulnerable to similar acts of sabotage, which could have a material adverse effect on our business and operations.

43


Table of Contents

      We rely on our management information systems to operate our business and to track our operating results. Our management information systems will require modification and refinement as we grow and our business needs change. If we experience a significant system failure or if we are unable to modify our management information systems to respond to changes in our business needs, then our ability to properly run our business could be adversely affected.
Risks Related to Our Industry
Because the footwear market is sensitive to decreased consumer spending and slow economic cycles, if general economic conditions deteriorate many of our customers may significantly reduce their purchases from us or may not be able to pay for our products in a timely manner.
      The footwear industry historically has been subject to cyclical variation and decline in performance when consumer spending decreases or softness appears in the retail market. Many factors affect the level of consumer spending in the footwear industry, including:
  •  general business conditions;
 
  •  interest rates;
 
  •  the availability of consumer credit;
 
  •  weather;
 
  •  taxation; and
 
  •  consumer confidence in future economic conditions.
      Consumer purchases of discretionary items, including our products, may decline during recessionary periods and also may decline at other times when disposable income is lower. A downturn in economies where our licensing partners or we sell products, whether in the U.S. or abroad, may reduce sales.
      In addition, we extend credit to our customers based on an evaluation of each customer’s financial condition. Many retailers, including some of our customers, have experienced financial difficulties during the past several years, thereby increasing the risk that such customers may not be able to pay for our products in a timely manner. Our bad debt expense may increase relative to net sales in the future. Any significant increase in our bad debt expense relative to net sales would adversely impact our net income and cash flow and could affect our ability to pay our own obligations as they become due.
We face intense competition, including competition from companies with significantly greater resources than ours, and if we are unable to compete effectively with these companies, our market share may decline and our business could be harmed.
      The footwear industry is highly competitive, and the recent growth in the market for sport sandals, casual footwear and other products manufactured by our licensees has encouraged the entry of many new competitors into the marketplace as well as increased competition from established companies. A number of our competitors have significantly greater financial, technological, engineering, manufacturing, marketing and distribution resources than we do, as well as greater brand awareness in the footwear market. Our competitors include athletic and footwear companies, branded apparel companies and retailers with their own private labels. Their greater capabilities in these areas may enable them to better withstand periodic downturns in the footwear industry, compete more effectively on the basis of price and production and more quickly develop new products. In addition, access to offshore manufacturing has made it easier for new companies to enter the markets in which we compete, further increasing competition in the footwear industry.
      Additionally, efforts by our competitors to dispose of their excess inventories may significantly reduce prices that we can expect to receive for the sale of our competing products and may cause our customers to shift their purchases away from our products.

44


Table of Contents

      We believe that our ability to compete successfully depends on a number of factors, including the quality, style and authenticity of our products and the strength of our brands, as well as many factors beyond our control. Maintaining our competitiveness depends on our ability to defend our products from infringement, our continued ability to anticipate and react to consumer tastes and our continued ability to deliver quality products at an acceptable price. If we fail to compete successfully in the future, our sales and profits will decline, as will the value of our business, financial condition and common stock.
Consolidations, restructurings and other ownership changes in the retail industry could affect the ability of our wholesale customers to purchase and market our products.
      In the future, retailers in the U.S. and in foreign markets may undergo changes that could decrease the number of stores that carry our products or increase the concentration of ownership within the retail industry, including:
  •  consolidating their operations;
 
  •  undergoing restructurings;
 
  •  undergoing reorganizations; or
 
  •  realigning their affiliations.
      These consolidations could result in a shift of bargaining power to the retail industry and in fewer outlets for our products. Further consolidations could result in price and other competition that could reduce our margins and our net sales.
Terrorism, government response to terrorism and other world events could affect our ability to do business.
      We market and sell our products and services throughout the world. The September 11, 2001 terrorist attacks disrupted commerce across the U.S. and in many other parts of the world. World events, including the threat of similar attacks in the future, and the impact of the U.S.’s military campaigns may cause significant disruption to commerce throughout the world. We are unable to predict whether the threat of new attacks or the resulting response will result in any long-term commercial disruptions or do long-term harm to our business, results of operations or financial condition. To the extent that future disruptions further slow the global economy or, more particularly, result in delays or cancellations of purchase orders for our products or delays in shipping, our business and results of operations could suffer material damage.
Risks Relating to Our Common Stock
Members of management own sufficient shares to substantially control our company.
      At March 8, 2005, Doug Otto beneficially owned approximately 15.2% of our common stock and all of our executive officers and directors as a group beneficially owned approximately 17.8%. The ownership positions of Mr. Otto and our executive officers as a group, together with the anti-takeover effects of the Delaware General Corporation Law and provisions of our certificate of incorporation, our bylaws and our stockholder rights plan, would likely delay, defer or prevent a change in control of our company, may deprive our stockholders of an opportunity to receive a premium for their common stock as part of a change in control and could have a negative effect on the market price of our common stock.
Our common stock price has been volatile, which could result in substantial losses for stockholders.
      Our common stock is traded on the NASDAQ National Market. While our average daily trading volume for the 52-week period ended March 8, 2005 was approximately 402,000 shares, we have experienced more limited volume in the past and may do so in the future. The trading price of our common stock has been and may continue to be volatile. The closing sale prices of our common stock, as reported by the NASDAQ National Market, have ranged from $22.94 to $48.02 for the 52-week period ended March 8, 2005. The

45


Table of Contents

trading price of our common stock could be affected by a number of factors, including, but not limited to the following:
  •  changes in expectations of our future performance;
 
  •  changes in estimates by securities analysts (or failure to meet such estimates);
 
  •  quarterly fluctuations in our sales and financial results;
 
  •  broad market fluctuations in volume and price; and
 
  •  a variety of risk factors, including the ones described elsewhere in this report.
      Accordingly, the price of our common stock is volatile and any investment in our securities is subject to risk of loss.
Future sales of our common stock could adversely affect our stock price.
      Future sales of substantial amounts of shares of our common stock in the public market, or the perception that these sales could occur, may cause the market price of our common stock to decline. In addition, we may be required to issue additional shares upon exercise of previously granted options that are currently outstanding.
Anti-takeover provisions of our certificate of incorporation, bylaws, stockholder rights plan and Delaware law could prevent or delay a change in control of our company, even if such a change of control would benefit our stockholders.
      Provisions of our certificate of incorporation and bylaws, as well as provisions of Delaware law, could discourage, delay or prevent a merger, acquisition or other change in control of our company, even if such a change in control might benefit our stockholders. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors and take other corporate actions. As a result, these provisions could limit the price that investors are willing to pay in the future for shares of our common stock. These provisions might also discourage a potential acquisition proposal or tender offer, even if the acquisition proposal or tender offer is at a price above the then current market price for our common stock. These provisions include the following:
  •  a board of directors that is classified so that only one-third of directors stand for election each year;
 
  •  authorization of “blank check” preferred stock, which our board of directors could issue with provisions designed to thwart a takeover attempt;
 
  •  limitations on the ability of stockholders to call special meetings of stockholders;
 
  •  a prohibition against stockholder action by written consent and a requirement that all stockholder actions be taken at a meeting of our stockholders; and
 
  •  advance notice requirements for nominations for election to our board of directors or for proposing matters that can be acted upon by stockholders at stockholder meetings.
      We adopted a stockholder rights plan in 1998 under a stockholder rights agreement intended to protect stockholders against unsolicited attempts to acquire control of our company that do not offer what our board of directors believes to be an adequate price to all stockholders or that our board of directors otherwise opposes. As part of the plan, our board of directors declared a dividend that resulted in the issuance of one preferred share purchase right for each outstanding share of our common stock. Unless extended, the preferred share purchase rights will terminate on November 11, 2008. If a bidder proceeds with an unsolicited attempt to purchase our stock and acquires 20% or more (or announces its intention to acquire 20% or more) of our outstanding stock, and the board of directors does not redeem the preferred stock purchase right, the right will become exercisable at a price that significantly dilutes the interest of the bidder in our common stock.

46


Table of Contents

      The effect of the stockholder rights plan is to make it more difficult to acquire our company without negotiating with the board of directors. However, the stockholder rights plan could discourage offers even if made at a premium over the market price of our common stock, and even if the stockholders might believe the transaction would benefit them.
      In addition, we are subject to Section 203 of the Delaware General Corporation Law, which limits business combination transactions with 15% or greater stockholders that our board of directors has not approved. These provisions and other similar provisions make it more difficult for a third party to acquire us without negotiation. These provisions apply even if some stockholders would consider the transaction beneficial.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
      Derivative Instruments. Although we have used foreign currency hedges in the past, we no longer utilize forward contracts or other derivative instruments to mitigate exposure to fluctuations in the foreign currency exchange rate as all of our purchases and sales for the foreseeable future will be denominated in U.S. currency.
      Although our sales are denominated in U.S. currency, our sales may be impacted by fluctuations in the exchange rates between the U.S. dollar and the local currencies in the international markets where our products are sold. If the United States dollar strengthens, it may result in increased pricing pressure on our distributors, which may have a negative impact on our net sales. We are unable to estimate the amount of any impact on sales attributed to pricing pressures caused by fluctuations in exchange rates.
      Market Risk. Our market risk exposure with respect to financial instruments is to changes in the “prime rate” in the U.S. and changes in LIBOR. Our revolving line of credit provides for interest on outstanding borrowings at rates tied to the prime rate or at our election tied to LIBOR. At December 31, 2004, we had no outstanding borrowings under the revolving line of credit. A 1.00% increase in interest rates on our current borrowings would have no impact on income before income taxes.
Item 8. Financial Statements and Supplementary Data
      See Item 15 and page 49 for an index to the consolidated financial statements and supplementary information included herein.
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
      None.
Item 9A. Controls and Procedures
      The Company’s Chief Executive Officer, Douglas B. Otto, and Chief Financial Officer, M. Scott Ash, with the participation of the Company’s management, carried out an evaluation of the effectiveness of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(e). Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer believe that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures are effective in making known to them material information relating to the Company (including its consolidated subsidiaries) required to be included in this report.
      Disclosure controls and procedures, no matter how well designed and implemented, can provide only reasonable assurance of achieving an entity’s disclosure objectives. The likelihood of achieving such objectives is affected by limitations inherent in disclosure controls and procedures. These include the fact that human judgment in decision-making can be faulty and that breakdowns in internal control can occur because of human failures such as simple errors, mistakes or intentional circumvention of the established processes.
      Although there were no significant changes to our internal controls or in other factors that could significantly affect our internal controls subsequent to the Evaluation Date, we have completed our efforts regarding compliance with Section 404 of the Sarbanes- Oxley Act of 2002 for our fiscal year ending

47


Table of Contents

December 31, 2004. The results of our evaluation are discussed below in the Report of Management on Internal Control Over Financial Reporting.
      This effort included internal control documentation and review under the direction of senior management. During the course of our evaluation, we reviewed identified data errors and control problems and confirmed that appropriate corrective actions, including process improvements, were undertaken. These improvements included formalization of policies and procedures, improved segregation of duties and additional monitoring controls. Many of the components of our internal controls are also evaluated on an ongoing basis by members of our organization. The overall goals of these various evaluation activities are to monitor our internal controls, and to modify them as necessary. Our intent is to maintain the internal controls as dynamic systems that change as conditions warrant.
REPORT OF MANAGEMENT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
      Management of Deckers Outdoor Corporation (the “Company”) is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. The Company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes those written policies and procedures that:
  •  pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
 
  •  provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America;
 
  •  provide reasonable assurance that receipts and expenditures of the Company are being made only in accordance with authorization of management and directors of the Company; and
 
  •  provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the consolidated financial statements.
      Internal control over financial reporting includes the controls themselves, as well as the monitoring of practices and actions taken to correct deficiencies as identified.
      Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
      Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2004. Management based this assessment on criteria for effective internal control over financial reporting described in “Internal Control — Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management’s assessment included an evaluation of the design of the Company’s internal control over financial reporting and testing of the operational effectiveness of its internal control over financial reporting. Management reviewed the results of its assessment with the Audit Committee of our Board of Directors.
      Based on this assessment, management determined that, as of December 31, 2004, the Company maintained effective internal control over financial reporting.
      KPMG LLP, independent registered public accounting firm, who audited and reported on the consolidated financial statements of the Company included in this report, has issued an attestation report on management’s assessment of internal control over financial reporting.
Item 9B. Other Information
      None.

48


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND
FINANCIAL STATEMENT SCHEDULE
         
    Page
     
Consolidated Financial Statements
       
    50  
    53  
    54  
    55  
    56  
    57  
 
Consolidated Financial Statement Schedule
       
Valuation and Qualifying Accounts
    78  
      All other schedules are omitted because they are not applicable or the required information is shown in the Company’s consolidated financial statements or the related notes thereto.

49


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Deckers Outdoor Corporation:
      We have audited the accompanying consolidated financial statements of Deckers Outdoor Corporation and subsidiaries as listed in the accompanying index. In connection with our audits of the consolidated financial statements, we also have audited the financial statement schedule as listed in the accompanying index. These consolidated financial statements and financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audits.
      We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
      In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Deckers Outdoor Corporation and subsidiaries as of December 31, 2003 and 2004, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2004, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the related consolidated financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.
      As discussed in note 13 to the consolidated financial statements, the Company adopted Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets, on January 1, 2002.
      We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the effectiveness of the Company’s internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated March 11, 2005 expressed an unqualified opinion on management’s assessment of, and the effective operation of, internal control over financial reporting.
  /s/ KPMG LLP
Los Angeles, California
March 11, 2005

50


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Deckers Outdoor Corporation:
      We have audited management’s assessment, included in the accompanying Report of Management on Internal Control Over Financial Reporting appearing under Item 9A, that Deckers Outdoor Corporation maintained effective internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Deckers Outdoor Corporation’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express an opinion on management’s assessment and an opinion on the effectiveness of the Company’s internal control over financial reporting based on our audit.
      We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
      A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A companys internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
      Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
      In our opinion, management’s assessment that Deckers Outdoor Corporation maintained effective internal control over financial reporting as of December 31, 2004, is fairly stated, in all material respects, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Also, in our opinion, Deckers Outdoor Corporation maintained, in all material respects, effective internal control over financial reporting as of December 31, 2004, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
      We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Deckers Outdoor Corporation and subsidiaries as of December 31, 2003 and 2004, and the related consolidated statements of operations, stockholders’ equity and comprehensive income (loss), and cash flows for each of the years in the three-year period ended December 31, 2004, and the related financial statement schedule, and our report dated March 11, 2005 expressed an unqualified opinion on those consolidated financial statements and financial statement schedule.

51


Table of Contents

Our report also refers to the Company’s adoption of Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets, on January  1, 2002.
  /s/ KPMG LLP
Los Angeles, California
March 11, 2005

52


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31, 2003 and 2004
                     
    2003   2004
         
Assets
               
Current assets:
               
 
Cash and cash equivalents
  $ 6,662,000     $ 10,379,000  
 
Short-term investments
          15,475,000  
 
Trade accounts receivable, less allowance for doubtful accounts and sales discounts of $2,126,000 and $3,281,000 as of December 31, 2003 and 2004, respectively
    18,745,000       41,957,000  
 
Inventories
    18,004,000       30,260,000  
 
Prepaid expenses and other current assets
    694,000       1,491,000  
 
Deferred tax assets
    2,137,000       3,240,000  
             
   
Total current assets
    46,242,000       102,802,000  
Property and equipment, at cost, net
    2,969,000       2,838,000  
Trademarks
    51,152,000       51,152,000  
Goodwill
    18,030,000       18,030,000  
Intangible assets, net
    1,390,000       1,137,000  
Other assets, net
    1,243,000       592,000  
             
    $ 121,026,000     $ 176,551,000  
             
 
Liabilities and Stockholders’ Equity
               
Current liabilities:
               
 
Notes payable and current installments of long-term debt
  $ 3,792,000     $  
 
Trade accounts payable
    11,220,000       16,524,000  
 
Reserve for returns
    1,245,000       1,731,000  
 
Accrued sales commissions
    623,000       1,714,000  
 
Accrued payroll
    2,657,000       3,623,000  
 
Other accrued expenses
    434,000       2,631,000  
 
Income taxes payable
    3,468,000       6,725,000  
             
   
Total current liabilities
    23,439,000       32,948,000  
             
Long-term debt, less current installments
    26,495,000        
Deferred tax liabilities
    568,000       2,607,000  
Commitments and contingencies
               
Stockholders’ equity:
               
 
Series A preferred stock at liquidation preference, $0.01 par value. Authorized 5,000,000 shares (1,375,000 designated as Series A); no shares issued and outstanding at December 31, 2003 and 2004
           
 
Common stock, $0.01 par value. Authorized 20,000,000 shares; issued 10,703,433 shares and outstanding 9,730,481 shares at December 31, 2003; issued and outstanding 12,183,080 at December 31, 2004
    97,000       122,000  
 
Additional paid-in capital
    27,115,000       71,959,000  
 
Retained earnings
    43,052,000       68,591,000  
 
Accumulated other comprehensive income
    260,000       324,000  
             
   
Total stockholders’ equity
    70,524,000       140,996,000  
             
    $ 121,026,000     $ 176,551,000  
             
See accompanying notes to consolidated financial statements.

53


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Years Ended December 31, 2002, 2003 and 2004
                             
    2002   2003   2004
             
Net sales
  $ 99,107,000     $ 121,055,000     $ 214,787,000  
Cost of sales
    57,577,000       69,710,000       124,354,000  
                   
   
Gross profit
    41,530,000       51,345,000       90,433,000  
Selling, general and administrative expenses
    34,954,000       32,407,000       47,971,000  
Litigation expense (income)
    3,228,000       (500,000 )      
                   
   
Income from operations
    3,348,000       19,438,000       42,462,000  
Other expense (income):
                       
 
Interest expense, net
    406,000       4,557,000       2,236,000  
 
Other expense (income)
    98,000       (3,000 )     3,000  
                   
      504,000       4,554,000       2,239,000  
                   
   
Income before income taxes and cumulative effect of a change in accounting principle
    2,844,000       14,884,000       40,223,000  
Income taxes
    1,224,000       5,730,000       14,684,000  
                   
   
Income before cumulative effect of a change in accounting principle
    1,620,000       9,154,000       25,539,000  
Cumulative effect of a change in accounting principle, net of income tax benefit of $843,000
    (8,973,000 )            
                   
   
Net income (loss)
    (7,353,000 )     9,154,000       25,539,000  
Less preferred stock redemption premium
          (438,000 )      
                   
   
Income (loss) applicable to common stockholders
  $ (7,353,000 )   $ 8,716,000     $ 25,539,000  
                   
Basic income per common share before cumulative effect of a change in accounting principle
  $ 0.17     $ 0.91     $ 2.32  
Cumulative effect of a change in accounting principle
    (0.96 )            
                   
   
Basic net income (loss) per common share
  $ (0.79 )   $ 0.91     $ 2.32  
                   
Diluted income per common share before cumulative effect of a change in accounting principle
  $ 0.17     $ 0.77     $ 2.10  
Cumulative effect of a change in accounting principle
    (0.92 )            
                   
   
Diluted net income (loss) per common share
  $ (0.75 )   $ 0.77     $ 2.10  
                   
Weighted average common shares:
                       
 
Basic
    9,328,000       9,610,000       11,005,000  
 
Diluted
    9,806,000       11,880,000       12,142,000  
See accompanying notes to consolidated financial statements.

54


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY AND COMPREHENSIVE INCOME (LOSS)
Years Ended December 31, 2002, 2003 and 2004
                                                                                   
                                Note        
                    Accumulated   Receivable        
    Preferred Stock   Common Stock   Additional       Other   From   Total   Comprehensive
            Paid-In   Retained   Comprehensive   Stockholder/   Stockholders’   Income
    Shares   Amount   Shares   Amount   Capital   Earnings   Income   Former Officer   Equity   (Loss)
                                         
Balance at December 31, 2001
                9,324,357     $ 93,000     $ 25,689,000     $ 41,251,000     $ 123,000     $ (624,000 )   $ 66,532,000          
Fair value of equity issued as consideration in the acquisition of Teva (note 12)
    1,375,000     $ 5,500,000       100,000       1,000       554,000                         6,055,000          
Fair value of options issued under Teva license agreement (note 7)
                            111,000                         111,000          
Common stock issued under stock incentive plan
                124,896       2,000       442,000                         444,000          
Common stock issued under the employee stock purchase plan
                11,870             37,000                         37,000          
Net loss
                                  (7,353,000 )                 (7,353,000 )   $ (7,353,000 )
Write off of note receivable from stockholder/former officer
                (100,000 )     (1,000 )     (623,000 )                 624,000                
Foreign currency translation adjustment
                                        130,000             130,000       130,000  
Unrealized losses on hedging derivatives
                                        (729,000 )           (729,000 )     (729,000 )
                                                             
 
Total comprehensive loss
                                                                          $ (7,952,000 )
                                                             
Balance at December 31, 2002
    1,375,000       5,500,000       9,461,123       95,000       26,210,000       33,898,000       (476,000 )           65,227,000          
Repurchase preferred stock (note 6)
    (1,375,000 )     (5,500,000 )                 (438,000 )                       (5,938,000 )        
Common stock issued under stock incentive plan
                262,577       2,000       874,000                         876,000          
Tax benefit attributable to stock options
                            445,000                         445,000          
Common stock issued under the employee stock purchase plan
                6,781             24,000                         24,000          
Net income
                                  9,154,000                   9,154,000     $ 9,154,000  
Foreign currency translation adjustment and reversal of unrealized hedging losses
                                        736,000             736,000       736,000  
                                                             
 
Total comprehensive income
                                                                          $ 9,890,000  
                                                             
Balance at December 31, 2003
                9,730,481       97,000       27,115,000       43,052,000       260,000             70,524,000          
Common stock issued under follow-on offering
                1,500,000       15,000       34,446,000                         34,461,000          
Compensation expense from nonvested stock units
                            61,000                         61,000          
Common stock issued under stock incentive plan
                910,262       10,000       4,083,000                         4,093,000          
Tax benefit attributable to stock options
                            6,030,000                         6,030,000          
Common stock issued under the employee stock purchase plan
                42,337             224,000                         224,000          
Net income
                                  25,539,000                   25,539,000     $ 25,539,000  
Foreign currency translation adjustment
                                        64,000             64,000       64,000  
                                                             
 
Total comprehensive income
                                                                          $ 25,603,000  
                                                             
Balance at December 31, 2004
        $       12,183,080     $ 122,000     $ 71,959,000     $ 68,591,000     $ 324,000     $     $ 140,996,000          
                                                             
See accompanying notes to consolidated financial statements.

55


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years Ended December 31, 2002, 2003 and 2004
                                   
    2002   2003   2004
             
Cash flows from operating activities:
                       
 
Net income (loss)
  $ (7,353,000 )   $ 9,154,000     $ 25,539,000  
 
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
                       
   
Cumulative effect of accounting change
    8,973,000              
   
Depreciation and amortization of property and equipment
    1,535,000       1,463,000       1,534,000  
   
Amortization of intangible assets
    1,049,000       276,000       253,000  
   
Provision for doubtful accounts
    1,785,000       504,000       580,000  
   
Write-off of inventory
    1,099,000       1,329,000       1,898,000  
   
Loss (gain) on disposal of assets
    23,000       3,000       (5,000 )
   
Loss on write-down of assets
          59,000        
   
Deferred tax provision
    656,000       1,752,000       936,000  
   
Stock compensation
    192,000       119,000       339,000  
   
Write-down of debt issuance costs
          287,000       671,000  
   
Tax benefit attributable to stock options
          445,000       6,030,000  
   
Changes in operating assets and liabilities, net of acquisitions:
                       
     
(Increase) decrease in:
                       
       
Trade accounts receivable
    (2,224,000 )     1,602,000       (23,792,000 )
       
Inventories
    650,000       (2,266,000 )     (14,154,000 )
       
Prepaid expenses and other current assets
    943,000       89,000       (832,000 )
       
Refundable income taxes
    995,000              
       
Other assets
    286,000       256,000       15,000  
     
Increase (decrease) in:
                       
       
Trade accounts payable
    (844,000 )     (1,696,000 )     5,304,000  
       
Accrued expenses
    (506,000 )     1,515,000       4,843,000  
       
Income taxes payable
    732,000       2,736,000       3,257,000  
                   
         
Net cash provided by operating activities
    7,991,000       17,627,000       12,416,000  
                   
Cash flows from investing activities:
                       
 
Cash paid for acquisition of Teva
    (43,254,000 )     (75,000 )      
 
Purchases of short-term investments
                (31,250,000 )
 
Proceeds from sales of short-term investments
                15,775,000  
 
Proceeds from sale of property and equipment
          33,000       43,000  
 
Purchase of property and equipment
    (1,477,000 )     (663,000 )     (1,441,000 )
                   
         
Net cash used in investing activities
    (44,731,000 )     (705,000 )     (16,873,000 )
                   
Cash flows from financing activities:
                       
 
Borrowings under line of credit
    19,075,000       42,706,000        
 
Repayments under line of credit
    (14,300,000 )     (47,481,000 )      
 
Proceeds from issuance of long-term debt
    21,000,000              
 
Repayments of long-term debt
    (290,000 )     (4,159,000 )     (30,287,000 )
 
Loan fees paid
    (1,343,000 )            
 
Cash paid for repurchase of preferred stock
          (5,938,000 )      
 
Cash received from issuances of common stock
    400,000       781,000       38,500,000  
                   
         
Net cash provided by (used in) financing activities
    24,542,000       (14,091,000 )     8,213,000  
                   
Effect of exchange rates on cash
    (550,000 )     (110,000 )     (39,000 )
                   
         
Net change in cash and cash equivalents
    (12,748,000 )     2,721,000       3,717,000  
                   
Cash and cash equivalents at beginning of year
    16,689,000       3,941,000       6,662,000  
                   
Cash and cash equivalents at end of year
  $ 3,941,000     $ 6,662,000     $ 10,379,000  
                   
Supplemental disclosure of cash flow information:
                       
 
Cash paid during the year for:
                       
   
Interest
  $ 264,000     $ 3,640,000     $ 1,512,000  
   
Income taxes
  $ 836,000     $ 1,607,000     $ 4,597,000  
      Supplemental disclosure of noncash investing and financing activities:
      In 2002, the Company issued to the seller 1,375,000 shares of Series A preferred stock with a value of $5,500,000, 100,000 shares of common stock with a value of $368,000, options to purchase 100,000 shares of common stock with a value of $187,000 and $13,000,000 of long-term debt in connection with the acquisition of Teva.
See accompanying notes to consolidated financial statements.

56


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
December 31, 2003 and 2004
(1)  The Company and Summary of Significant Accounting Policies
     (a) The Company and Basis of Presentation
      The consolidated financial statements include the accounts of Deckers Outdoor Corporation and its wholly owned subsidiaries (collectively referred to as the “Company”). All intercompany balances and transactions have been eliminated in consolidation.
      The Company builds niche products into global lifestyle brands by designing and marketing innovative, functional and fashion-oriented footwear, developed for both high performance outdoor activities and everyday casual lifestyle use.
     (b) Inventories
      Inventories, principally finished goods, are stated at the lower of cost (first-in, first-out) or market (net realizable value). Market values are determined by historical experience with discounted sales, industry trends and the retail environment.
     (c) Revenue Recognition
      The Company recognizes revenue when products are shipped and the customer takes title and assumes risk of loss, collection of relevant receivable is probable, persuasive evidence of an arrangement exists, and the sales price is fixed or determinable. Allowances for estimated returns, discounts, and bad debts are provided for when related revenue is recorded. Amounts billed for shipping and handling costs are recorded as a component of net sales, totaling $993,000, $2,041,000, and $3,863,000 for the years ended December 31, 2002, 2003, and 2004, respectively. Related costs paid to third-party shipping companies are recorded as a cost of sales, totaling $1,124,000, $2,057,000, and $4,094,000 for the years ended December 31, 2002, 2003, and 2004, respectively.
     (d) Goodwill and Other Intangibles Assets
      Intangible assets consist primarily of goodwill, trademarks, patents, and noncompete covenants arising from the application of purchase accounting. On January 1, 2002, the Company adopted Statement of Financial Accounting Standards (“SFAS”) No. 142, Goodwill and Other Intangible Assets (“SFAS 142”). Accordingly, goodwill and intangible assets with indefinite useful lives are no longer amortized, but instead tested for impairment at least annually, on December 31 of each year, in accordance with the provisions of SFAS No. 142. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment in accordance with SFAS No. 144, Accounting for Impairment or Disposal of Long-Lived Assets (“SFAS 144”).
      In connection with the implementation of SFAS 142, a goodwill impairment charge of $8,973,000 (net of related income tax benefit of $843,000) was recorded for the year ended December 31, 2002. There were no impairments during the years ended December 31, 2003 and 2004.
     (e) Impairment of Long-Lived Assets
      SFAS 144 provides a single accounting model for long-lived assets to be disposed of. SFAS 144 also changes the criteria for classifying an asset as held for sale and broadens the scope of businesses to be disposed of that qualify for reporting as discontinued operations and changes the timing of recognizing losses on such operations. The Company adopted SFAS 144 on January 1, 2002. The adoption of SFAS 144 did not have a significant impact on the Company’s consolidated financial statements.

57


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
      In accordance with SFAS 144, long-lived assets, such as property and equipment, and purchased intangibles subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
     (f)  Depreciation and Amortization
      Depreciation of property and equipment is computed using the straight-line method based on estimated useful lives ranging from one to seven years. Leasehold improvements are amortized on the straight-line basis over their estimated economic useful lives or the lease term, whichever is shorter.
     (g)  Fair Value of Financial Instruments
      The fair values of the Company’s cash equivalents, trade accounts receivable, prepaid expenses and other current assets, refundable income taxes, trade accounts payable, accrued expenses, and income taxes payable approximate the carrying values due to the relatively short maturities of these instruments.
      The fair value of the Company’s revolving credit line approximates the carrying value due to variable interest rates associated with the credit line.
      The fair values of the Company’s other notes payable are estimated by discounting future cash flows of each instrument at rates currently available to the Company for similar debt instruments of comparable maturities by the Company’s bankers. The fair values of these notes approximate the carrying value.
     (h)  Stock Compensation
      The Company accounts for stock-based compensation under the provisions of Statement of Financial Accounting Standards No. 123, Accounting for Stock-Based Compensation (“SFAS 123”), as amended by SFAS 148. Under the provisions of SFAS 123 and SFAS 148, the Company has elected to continue to measure compensation cost for employees and nonemployee directors of the Company under the intrinsic value method of APB No. 25 and comply with the pro forma disclosure requirements under SFAS 123 and SFAS 148. The Company applies the fair value techniques of SFAS 123 and SFAS 148 to measure compensation cost for options/ warrants granted to nonemployees.
      As discussed in note 1(u), the Financial Accounting Standards Board, or FASB, recently issued SFAS No. 123R (revised 2004), “Share-Based Payment” which supersedes APB Opinion No. 25, and requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values beginning with the first interim or annual period after June 15, 2005.

58


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
      The following table illustrates the effects on net income (loss) if the fair value-based method had been applied to all outstanding and unvested awards in each period. See assumptions used to determine the fair value of the awards in note 6.
                             
    2002   2003   2004
             
Net income (loss), as reported
  $ (7,353,000 )   $ 9,154,000     $ 25,539,000  
Add stock-based employee compensation expense included in reported net income, net of tax
    109,000       73,000       215,000  
Deduct total stock-based employee compensation expense under fair value-based method for all awards, net of tax
    (494,000 )     (596,000 )     (1,015,000 )
                   
   
Pro forma net income (loss)
  $ (7,738,000 )   $ 8,631,000     $ 24,739,000  
                   
Pro forma net income per share:
                       
 
Basic
  $ (0.83 )   $ 0.85     $ 2.25  
 
Diluted
  $ (0.79 )   $ 0.74     $ 2.05  
     (i) Use of Estimates
      Management of the Company has made a number of estimates and assumptions relating to the reporting of assets, liabilities, net sales, and expenses and the disclosure of contingent assets and liabilities to prepare these consolidated financial statements in conformity with accounting principles generally accepted in the U.S. Significant areas requiring the use of management estimates relate to inventory reserves, allowances for bad debts, returns and discounts, impairment assessments and charges, deferred taxes, depreciation and amortization, litigation reserves, fair value of financial instruments, fair value of acquired intangibles, assets and liabilities, and hedging activities. Actual results could differ from these estimates.
     (j) Research and Development Costs
      Research and development costs are charged to expense as incurred. Such costs amounted to $1,092,000, $1,099,000, and $1,438,000 in 2002, 2003, and 2004, respectively.
     (k) Advertising, Marketing, and Promotion Costs
      Advertising production costs are expensed the first time the advertisement is run. All other costs of advertising, marketing and promotion are expensed as incurred. These expenses charged to operations for the years ended 2002, 2003, and 2004 were $7,456,000, $6,594,000, and $8,687,000, respectively. Included in prepaid and other current assets at December 31, 2003 and 2004 were $221,000 and $851,000, respectively, related to prepaid advertising and promotion expenses for programs to take place after December 31, 2003 and 2004, respectively.
     (l) Income Taxes
      Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred taxes of a change in tax rates is recognized in income in the period that includes the enactment date.

59


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
     (m) Income (Loss) per Share
      Basic income (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution from securities that could share in the earnings of the Company. Antidilutive securities are excluded from diluted EPS.
      The reconciliations of basic to diluted weighted average shares are as follows:
                             
    2002   2003   2004
             
Income (loss) used for basic and diluted income (loss) per share:
                       
 
Income before cumulative effect of a change in accounting principle
  $ 1,620,000     $ 9,154,000     $ 25,539,000  
 
Cumulative effect of a change in accounting principle, net of income tax benefit
    (8,973,000 )            
                   
   
Net income (loss) — diluted
    (7,353,000 )     9,154,000       25,539,000  
 
Less redemption premium on preferred stock
          (438,000 )      
                   
   
Net income (loss) available for common stockholders — basic
  $ (7,353,000 )   $ 8,716,000     $ 25,539,000  
                   
Weighted average shares used in basic computation
    9,328,000       9,610,000       11,005,000  
Dilutive effect of stock options
    327,000       882,000       1,137,000  
Dilutive effect of convertible preferred stock
    151,000       1,388,000        
                   
   
Weighted average shares used for diluted computation
    9,806,000       11,880,000       12,142,000  
                   
      The dilutive effect of convertible preferred stock above relates to preferred stock that was outstanding between November 25, 2002 and December 3, 2003. The Company repurchased all of the outstanding preferred stock on December 3, 2003.
      Options to purchase 286,000, 217,000 and 10,000 shares of common stock at prices ranging from $4.80 to $9.88, $9.88 to $19.00 and $33.10 were outstanding during 2002, 2003 and 2004, respectively, but were not included in the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares during the respective periods, and therefore their inclusion would be antidilutive. Nonvested stock units in the amount of 59,750 shares were outstanding at December 31, 2004 but were not included in the computation of diluted earnings per share because they were antidilutive.
     (n)  Foreign Currency Translation
      The Company considers the U.S. dollar as the functional currency. Assets and liabilities of the foreign operations denominated in local currencies are translated at the rate of exchange at the balance sheet date. Net sales and expenses are translated at the weighted average rate of exchange during the period. The effects of translation are recorded in other comprehensive income as currency translation adjustment.
     (o)  Hedging Activities
      The Company may enter into foreign currency forward contracts in the ordinary course of business to mitigate the risk associated with foreign exchange rate fluctuations related to sales of goods in Eurodollars. Derivative financial instruments are not used for speculative purposes. At December 31, 2004, the Company had no foreign currency forward contracts.

60


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
      In accordance with Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activities, these foreign currency cash flow hedges are recorded at fair value in the accompanying balance sheet with unrealized gains and losses on outstanding foreign currency forward contracts recorded in the financial statements as a component of other comprehensive income, net of deferred taxes, to the extent they are effective hedges. When the transaction occurs, the effective portion of the gain or loss from the derivative designated as a hedge of the transaction is reclassified from accumulated other comprehensive income to the same statement of operations line item affected by the hedged forecasted transaction due to foreign currency fluctuations. Any terminated derivatives or ineffective portion of gains and losses resulting from changes in the fair value of the derivatives is recognized in current earnings. The ineffective portion of these gains and losses, which results primarily from the time value component of gains and losses on forward contracts, was immaterial for all periods presented.
     (p) Comprehensive Income (Loss)
      Comprehensive income is the total of net earnings (loss) and all other nonowner changes in equity. Except for net income (loss), foreign currency translation adjustments, and unrealized gains and losses as a result of hedging activities, the Company does not have any transactions and other economic events that qualify as comprehensive income as defined under SFAS No. 130.
     (q) Business Segment Reporting
      Management of the Company has determined its reportable segments are strategic business units. The four reportable segments are the Teva, UGG and Simple wholesale divisions and the Company’s Internet and catalog retailing business. Information related to these segments is summarized in note 10.
     (r) Cash Equivalents
      The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.
     (s) Short-term Investments
      Short-term investments, which consist of market auction rate preferred securities are classified as “available for sale” under the provisions of SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities.” Accordingly, the short-term investments are reported at fair value, with any unrealized gains and losses included as a separate component of stockholders’ equity, net of applicable taxes. Realized gains and losses, interest and dividends are included in interest expense, net. The fair value of the short-term investments approximated cost at December 31, 2004, based on quoted market prices.
     (t) Reclassifications
      Certain reclassifications have been made to the 2002 and 2003 balances to conform to the 2004 presentation.
     (u) New Accounting Standards
      In January 2003, the Financial Accounting Standards Board, or FASB, issued FASB Interpretation, or FIN No. 46, Consolidation of Variable Interest Entities, an interpretation of Accounting Research Bulletin, or ARB No. 51. FIN No. 46 addresses the consolidation by business enterprises of variable interest entities as defined in the Interpretation. FIN No. 46 generally applies immediately to variable interests in variable interest entities created after January 31, 2003 and to variable interests in variable interest entities obtained after January 31, 2003. The application of FIN No. 46 did not have a material effect on the Company’s

61


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
consolidated financial statements. In December 2003, the FASB revised FIN No. 46 to exempt certain entities from its requirements and to clarify certain issues arising during the implementation of FIN No. 46. The adoption of this revised interpretation in the first quarter of 2004 did not have any impact on the Company’s consolidated financial statements.
      On October 22, 2004, the American Jobs Creation Act (AJCA) was signed into law. The AJCA includes a special one-time 85 percent dividends received deduction for certain foreign earnings that are repatriated. In December 2004, the FASB issued FASB Staff Position No. FAS 109-2 (FSP FAS 109-2), “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004.” FSP FAS 109-2 provides accounting and disclosure guidance for this repatriation provision. The Company has begun its evaluation of the effects of this provision. Although FSP FAS 109-2 is effective immediately, the Company will not be able to complete its evaluation until after Congress or the Treasury Department provides additional clarifying language on key elements of the provision. The Company expects to complete its evaluation of the effects of the repatriation provision within a reasonable period of time following the publication of the additional clarifying language.
      In November 2004, the FASB issued Statement of Financial Accounting Standard, or SFAS No. 151, “Inventory Costs — An Amendment of ARB No. 43, Chapter 4”. SFAS No. 151 amends the guidance in ARB No. 43, Chapter 4, “Inventory Pricing”, to clarify the accounting for abnormal amounts of idle facility expense, freight, handling costs, and wasted material (spoilage). SFAS No. 151 is effective for fiscal years beginning after June 15, 2005 and is required to be adopted by us in the first quarter of fiscal 2006. The Company does not expect the adoption of SFAS No. 151 to have a material impact on its consolidated financial statements.
      In December 2004, the FASB issued SFAS No. 123R (revised 2004), “Share-Based Payment”. SFAS No. 123R supersedes APB Opinion No. 25, and requires all share-based payments to employees, including grants or employee stock options, to be recognized in the financial statements based on their fair values beginning with the first interim or annual period after June 15, 2005. The pro forma disclosure permitted under SFAS No. 123 will no longer be an alternative to financial statement recognition. SFAS No. 123R requires the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests. The Company is required to adopt the provisions of SFAS No. 123R effective July 1, 2005. The adoption of this Statement is expected to result in an additional expense for the year ending December 31, 2005 of approximately $400,000, which will be recorded in the third and fourth quarter of 2005.
(2)  Retirement Plan
      Effective August 1, 1992, the Company established a 401(k) defined contribution plan. Substantially all employees are eligible to participate in the plan through tax-deferred contributions. The Company matches 50% of an employee’s contribution up to $1,200 per year. Matching contributions totaled $90,000, $67,000 and $92,000 during 2002, 2003 and 2004, respectively. In addition, the Company may also make discretionary profit sharing contributions to the plan. The Company did not make profit sharing contributions for the years ended December 31, 2002, 2003 or 2004.

62


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
(3)  Property and Equipment
      Property and equipment is summarized as follows:
                   
    2003   2004
         
Machinery and equipment
  $ 5,602,000     $ 6,441,000  
Furniture and fixtures
    663,000       666,000  
Leasehold improvements
    724,000       927,000  
             
      6,989,000       8,034,000  
Less accumulated depreciation and amortization
    4,020,000       5,196,000  
             
 
Net property and equipment
  $ 2,969,000     $ 2,838,000  
             
      During 2004, the Company wrote-off certain fully depreciated assets with an original cost of $395,000.
(4)  Notes Payable and Long-Term Debt
      Notes payable and long-term debt consists of the following:
                 
    2003   2004
         
Revolving line of credit with Comerica Bank (described below)
  $     $  
Term loan with Comerica Bank, secured by all assets of the Company, interest (4.37% at December 31, 2003) at Bank’s base rate or LIBOR plus a margin, as defined, principal payment of $1,750,000 due on May 31, 2004 with equal monthly payments of $292,000 beginning June 30, 2004, with final payment due on November 25, 2005, fully repaid in 2004
    7,000,000        
Secured subordinated note, payable in quarterly principal installments of $1,500,000 beginning November 2007, interest at a rate of 16.75%, of which 12.00% is payable monthly and 4.75% is payable at maturity, compounded monthly, due November 2008. A prepayment penalty ranging from 4.00% to 5.00% is incurred for any portion repaid prior to November 2004, fully repaid in 2004
    10,000,000        
Unsecured junior subordinated 9.00% note payable to the seller of Teva, interest payable in annual installments at a rate of 7.00% through November 2008. Principal and additional interest of 2.00% are due in November 2008, compounded annually, fully repaid in 2004
    13,287,000        
             
      30,287,000        
Less current installments
    3,792,000        
             
    $ 26,495,000     $  
             
      We amended the Facility with Comerica Bank-California (the “Bank”) in March 2005. As amended, the Facility expires June 1, 2006 and provides for a maximum availability of $20,000,000 subject to a borrowing base. In general, the borrowing base is equal to 75% of eligible accounts receivable, as defined, and 50% of eligible inventory, as defined. The accounts receivable advance rate can increase or decrease depending on our

63


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
accounts receivable dilution, which is calculated periodically. Up to $10,000,000 of borrowings may be in the form of letters of credit. The Facility bears interest at the Bank’s prime rate (5.25% at December 31, 2004) or at our option, at LIBOR (2.40% at December 31, 2004) plus 1.00% to 2.50%, depending on our ratio of liabilities to earnings before interest, taxes, depreciation and amortization (“EBITDA”), and is secured by substantially all assets. The Facility included an upfront fee of $230,000 and includes subsequent annual commitment fees of $100,000 for 2004 and $60,000 for 2005. At December 31, 2004, the Company had no outstanding borrowings under the Facility, no foreign currency reserves for outstanding forward contracts and no outstanding letters of credit. We had credit availability under the Facility of $20,000,000 at December 31, 2004.
      The agreements underlying the Facility prohibit the payment of dividends and contain several financial covenants including a quick ratio requirement, profitability requirements and a tangible net worth requirement, among others. The Company was in compliance with all covenants at December 31, 2004.
(5) Income Taxes
      Components of income taxes are as follows.
                                   
    Federal   State   Foreign   Total
                 
2002:
                               
 
Current
  $ 53,000     $ (7,000 )   $ 522,000     $ 568,000  
 
Deferred
    493,000       163,000             656,000  
                         
    $ 546,000     $ 156,000     $ 522,000     $ 1,224,000  
                         
2003:
                               
 
Current
  $ 2,043,000     $ 483,000     $ 1,452,000     $ 3,978,000  
 
Deferred
    1,334,000       418,000             1,752,000  
                         
    $ 3,377,000     $ 901,000     $ 1,452,000     $ 5,730,000  
                         
2004:
                               
 
Current
  $ 9,930,000     $ 2,073,000     $ 1,745,000     $ 13,748,000  
 
Deferred
    629,000       293,000       14,000       936,000  
                         
    $ 10,559,000     $ 2,366,000     $ 1,759,000     $ 14,684,000  
                         
      Foreign income before income taxes and cumulative effect of a change in accounting principle was $1,310,000, $4,220,000 and $7,261,000 during the years ended December 31, 2002, 2003 and 2004, respectively.

64


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
      Actual income taxes differed from that obtained by applying the statutory federal income tax rate to earnings before income taxes as follows:
                         
    2002   2003   2004
             
Computed “expected” income taxes
  $ 967,000     $ 5,060,000     $ 14,078,000  
State income taxes, net of federal income tax benefit
    166,000       623,000       1,895,000  
Other
    91,000       47,000       (1,289,000 )
                   
    $ 1,224,000     $ 5,730,000     $ 14,684,000  
                   
      The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities at December 31, 2003 and 2004 are presented below:
                       
    2003   2004
         
Deferred tax assets, current:
               
 
Uniform capitalization adjustment to inventory
  $ 483,000     $ 487,000  
 
Bad debt and other reserves
    1,576,000       2,725,000  
 
State taxes
    78,000       557,000  
 
Prepaid expenses
          (529,000 )
             
   
Total deferred tax assets, current
    2,137,000       3,240,000  
             
Deferred tax liabilities, noncurrent:
               
 
Amortization of intangible assets
    (224,000 )     (1,896,000 )
 
Depreciation of property and equipment
    (344,000 )     (711,000 )
             
   
Total deferred tax liabilities, noncurrent
    (568,000 )     (2,607,000 )
             
     
Net deferred tax assets
  $ 1,569,000     $ 633,000  
             
      In order to fully realize the deferred tax assets, the Company will need to generate future taxable income of approximately $8,000,000. The deferred tax assets are primarily related to the Company’s domestic operations. Domestic taxable income for the years ended December 31, 2003 and 2004 was approximately $1,272,000 and $15,879,000, respectively. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that the results of future operations will generate sufficient taxable income to realize the net deferred tax assets and, accordingly, no valuation allowance has been recorded.
      As of December 31, 2004, withholding and U.S. taxes have not been provided on approximately $12 million of unremitted earnings of our non-U.S. subsidiaries because the Company has currently reinvested these earnings permanently in such operations. Such earnings would become taxable upon the sale or liquidation of these subsidiaries or upon remittance of dividends.
      In December 2004, the FASB issued FASB Staff Position No. FAS 109-2 (“FAS 109-2”), “Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creations Act of 2004 (“AJCA”).” The AJCA introduces a limited time 85% dividends received deduction on the repatriation of certain foreign earnings to a U.S. taxpayer (repatriation provision), provided certain criteria are met. FAS109-2 provides accounting and disclosure guidance for the repatriation provision. Although FAS 109-2 is effective immediately, we do not expect to be able to complete our evaluation of the repatriation

65


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
provision until after Congress or the Treasury Department provides additional clarifying language on key elements of the provision. In January 2005, the Treasury Department began to issue the first of a series of clarifying guidance documents related to this provision. We expect to complete our evaluation of the effects of the repatriation provision in 2005. The range of possible amounts that we are considering for repatriation under this provision is between zero and $12 million. The Company is currently unable to reasonably estimate the related range of income tax effects of the potential repatriation.
(6)  Stockholders’ Equity
      The Company is authorized to issue 5,000,000 shares of preferred stock with a par value of $0.01, of which 1,375,000 shares are designated as Series A Preferred Stock. The 1,375,000 shares of Series A Preferred Stock were issued to Mark Thatcher in connection with the acquisition of Teva (note 12). In December 2003, the Company redeemed all of the outstanding Preferred Stock. In connection with the redemption, the Company paid Mr. Thatcher a premium of approximately $438,000, which was recorded as a reduction of additional paid-in capital. The premium reduced income applicable to common stockholders and, therefore, is reflected in the income per share calculations.
      The Company’s 1993 Stock Incentive Plan (the “1993 Plan”) provides for 3,000,000 shares of common stock that are reserved for issuance to officers, directors, employees, and consultants of the Company. Awards to 1993 Plan participants are not restricted to any specified form and may include stock options, securities convertible into or redeemable for stock, stock appreciation rights, stock purchase warrants, or other rights to acquire stock. Under the 1993 Plan, 124,896, 262,577 and 910,262 shares of common stock were issued to employees in 2002, 2003, and 2004, respectively.

66


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
      Common stock option activity under the 1993 Plan for the years ended December 31, 2002, 2003 and 2004 is as follows:
                 
        Weighted
        Average
        Exercise
    Shares   Price
         
Outstanding at December 31, 2001
    1,580,800     $ 3.80  
Granted
    624,400       4.13  
Exercised
    (107,900 )     2.32  
Canceled
    (165,300 )     3.26  
             
Outstanding at December 31, 2002
    1,932,000       4.04  
Granted
    206,000       18.75  
Exercised
    (238,100 )     3.19  
Canceled
    (125,400 )     7.51  
             
Outstanding at December 31, 2003
    1,774,500       5.62  
Granted
    26,000       29.04  
Exercised
    (899,600 )     4.24  
Canceled
    (10,800 )     11.31  
             
Outstanding at December 31, 2004
    890,100       7.62  
             
Options exercisable at December 31, 2002
    1,245,900       4.07  
Options exercisable at December 31, 2003
    1,168,800       4.36  
Options exercisable at December 31, 2004
    517,000       6.79  
      The per share weighted average fair value of stock options granted during 2002, 2003, and 2004 was $2.25, $10.83, and $16.83, respectively, on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions: 2002 — expected dividend yield of 0%, stock volatility of 48.46%, risk-free interest rate of 3.70%, and an expected life of seven years; 2003 — expected dividend yield of 0%, stock volatility of 51.70%, risk-free interest rate of 3.70%, and an expected life of seven years; 2004 — expected dividend yield of 0%, stock volatility of 52.85%, risk-free interest rate of 3.97%, and an expected life of seven years.

67


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
      The following table summarizes information about stock options outstanding and exercisable at December 31, 2004.
                                         
    Options Outstanding   Options Exercisable
         
        Weighted   Weighted       Weighted
    Number   Average   Average   Number   Average
Range of   Outstanding   Remaining   Exercise   Exercisable at   Exercise
Exercise Price   December 31, 2004   Contractual Life   Price   December 31, 2004   Price
                     
$1.56 to $3.12
    155,100       4.08 years     $ 1.82       155,100     $ 1.82  
$3.60 to $3.71
    131,600       7.09 years       3.61       67,200       3.60  
$4.03 to $4.80
    315,700       7.21 years       4.24       124,100       4.22  
$6.21 to $8.50
    89,000       3.06 years       7.37       89,100       7.37  
$19.00
    172,700       8.92 years       19.00       55,500       19.00  
$24.17 to $33.10
    26,000       8.19 years       29.04       26,000       29.04  
                               
      890,100       6.59 years       7.62       517,000       6.79  
                               
      In December 2004, the Company replaced its annual employee stock option grant with a grant of Nonvested Stock Units (“NSU’s”), which are accounted for as variable awards under APB 25. The NSU’s entitle the employee recipients to receive shares of common stock in the Company, which vest in quarterly increments during the year ended December 31, 2008, subject to achievement of certain performance targets. For the 2004 grant, the maximum quantity that is available to vest is 59,750 for all participants in the aggregate. The fair value of the aggregate NSU’s granted in 2004 was $2,808,000 as of December 31, 2004, of which approximately $61,000 was recorded as an expense in 2004. The Company currently intends to use NSU’s rather than stock options in its future compensation programs.
      In August 1995, the Company adopted the 1995 Employee Stock Purchase Plan (the “1995 Plan”). The 1995 Plan is intended to qualify as an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code. Under the terms of the 1995 Plan, as amended, 300,000 shares of common stock are reserved for issuance to employees who have been employed by the Company for at least six months. The 1995 Plan provides for employees to purchase the Company’s common stock at a discount below market value, as defined by the 1995 Plan. Under the 1995 Plan, 11,870, 6,781 and 42,337 shares were issued in 2002, 2003, and 2004, respectively. Consistent with the application of APB Opinion No. 25, no compensation has been recorded for stock purchases.
      The Company adopted a stockholder rights plan in 1998 to protect stockholders against unsolicited attempts to acquire control of the Company that do not offer what the Company believes to be an adequate price to all stockholders. As part of the plan, the board of directors of the Company declared a dividend of one preferred share purchase right (a “Right”) for each outstanding share of common stock, par value $0.01 per share (the “Common Shares”), of the Company. The dividend was payable to stockholders of record on December 1, 1998 (the “Record Date”). In addition, one Right shall be issued with each Common Share that becomes outstanding (i) between the Record Date and the earliest of the Distribution Date, the Redemption Date, and the Final Expiration Date (as such terms are defined in the Rights Agreement) or (ii) following the Distribution Date and prior to the Redemption Date or Final Expiration Date, pursuant to the exercise of stock options or under any employee plan or arrangement or upon the exercise, conversion, or exchange of other securities of the Company, which options or securities were outstanding prior to the Distribution Date, in each case upon the issuance of the Company’s common stock in connection with any of the foregoing. Each right entitles the registered holder to purchase from the Company one one-hundredth of a share of Series B

68


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
Junior Participating Preferred Stock, par value $0.01 per share (the “Preferred Shares”), of the Company, at a price of $50.00, subject to adjustment.
      The rights have no voting power and expire on November 11, 2008. The Company may redeem the rights for $0.01 per right until the right becomes exercisable.
(7)  Licensing Agreement
      As discussed in note 12, on November 25, 2002, the Company acquired the worldwide Teva patents, trademarks and other assets. Prior to the acquisition, the Company had been selling its Teva line of sport sandals and other footwear since 1985, pursuant to various license arrangements with Mark Thatcher, the inventor of the Teva sport sandal and previous holder of the Teva patents and trademarks.
      In 1999, the Company signed a new license agreement (the “License Agreement”) for Teva, which was effective January 1, 2000. Under the License Agreement, the Company received the exclusive worldwide rights for the manufacture and distribution of Teva footwear through 2004. In connection with the License Agreement, the Company paid the licensor a licensing fee of $1,000,000 and issued the licensor 428,743 shares of its previously unissued common stock with a fair value of $1,608,000. The Company recorded the license as an intangible asset for the value of the cash and common stock issued pursuant to the License Agreement. In addition, the Company agreed to grant the licensor not less than 50,000 stock options on the Company’s common stock annually, with an exercise price at the market value on the date of grant. The fair value of options granted under the License Agreement aggregated $111,000 in 2002.
      In connection with the 1999 Teva license renewal, the Company received an option to buy Teva from Mr. Thatcher, which was subsequently renegotiated in 2001. On November 25, 2002, the Company completed the acquisition of Teva.
      The License Agreement provided for royalties using a sliding scale ranging from 5.0% to 6.5% of annual sales, depending upon sales levels, and included minimum annual royalties ranging from $4,400,000 in 2002 to $7,600,000 in 2011. The agreement also required minimum advertising and promotional expenditures of 5.0% of annual sales for domestic sales and 6.5% for international sales. In addition to the minimum advertising and promotional costs, the Company and the licensor had agreed to each contribute annually 0.5% of annual sales toward the promotion of the Teva brand and trademark, with or without particular reference to individual styles.
      Royalty expense related to Teva sales was included in selling, general, and administrative expenses in the accompanying consolidated financial statements and was $3,739,000 during the year ended December 31, 2002.
      Subsequent to acquiring Teva on November 25, 2002, the Company ceased granting stock options and paying royalties on Teva footwear sales and owns all Teva rights and assets worldwide.

69


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
(8)  Commitments and Contingencies
        The Company leases office facilities under operating lease agreements, which expire through December 2009. Future minimum commitments under the lease agreements are as follows:
           
Year ending December 31:
       
 
2005
  $ 2,274,000  
 
2006
    2,198,000  
 
2007
    1,492,000  
 
2008
    1,163,000  
 
2009
    1,017,000  
       
    $ 8,144,000  
       
      Total rent expense for the years ended December 31, 2002, 2003, and 2004 was approximately $1,188,000, $1,271,000 and $1,341,000, respectively.
      An action was brought against the Company in 1995 by Molly Strong-Butts and Yeti by Molly, Ltd. (collectively, Molly) which alleged, among other things, that the Company violated a certain nondisclosure agreement and obtained purported trade secrets regarding a line of winter footwear which Deckers stopped producing in 1994. A jury verdict was obtained against the Company in district court in March 1999 aggregating $1,785,000 for the two plaintiffs. In August 2001 the U.S. Court of Appeals for the Ninth Circuit affirmed the district court’s decision for a judgment against the Company, resulting in a settlement of approximately $2,000,000, including interest, which the Company paid in November 2001. In addition, the court of appeals reversed the district court’s refusal to consider an award of exemplary damages or attorney fees and remanded to the district court for further proceedings. On September 30, 2002, a federal judge ruled that the Company must pay an additional $4,290,000 to Molly, including $2,450,000 of exemplary damages and $1,840,000 to cover the plaintiff’s attorney fees. Deckers and Molly agreed to settle without going to appeal for the total sum of $4,000,000 in 2002. The accompanying consolidated statement of operations for the year ended December 31, 2002, the final year of this litigation, included litigation costs of $3,228,000 related to this matter.
      In 1997, the European Commission enacted anti-dumping duties of 49.2% on certain types of footwear imported into Europe from China and Indonesia. Dutch Customs had issued an opinion to the Company that certain popular Teva styles were covered by this anti-dumping duty legislation. Based on this opinion, Dutch Customs sought anti-dumping duties of approximately $500,000 from the Company, which the Company had appealed. Nevertheless, the Company expensed the $500,000 prior to 2002 in accordance with SFAS 5, Accounting for Contingencies. In 2003, an appeals court ruled that the duties were not levied by the appropriate governing body and nullified the entire claim. As a result of this favorable final ruling, the Company reversed the previously established $500,000 accrual in 2003, which is reflected as an increase to income from operations in the accompanying consolidated statement of operations for the year ended December 31, 2003.

70


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
      Overall, the litigation expense (income) in the accompanying consolidated statement of operations for the years ended December 31, 2002, 2003 and 2004 includes the following:
                         
    2002   2003   2004
             
Molly litigation
  $ 3,228,000     $     $  
Anti-dumping duties matter
        $ (500,000 )      
                   
    $ 3,228,000     $ (500,000 )   $  
                   
      The Company is currently involved in various other legal claims arising from the ordinary course of business. Management does not believe that the disposition of these matters will have a material effect on the Company’s financial position or results of operations.
(9)  Foreign Currency Forward Contracts
      The Company uses foreign currency forward contracts to hedge the foreign currency exposure associated with a portion of its forecasted transactions in foreign currency. These forward contracts are designated as foreign currency cash flow hedges and are recorded at fair value in the accompanying consolidated balance sheet. The effective portion of gains and losses resulting from recording forward contracts at fair value are deferred in accumulated other comprehensive income in the accompanying consolidated balance sheet until the underlying forecasted foreign currency transaction occurs. When the transaction occurs, the effective portion of the gain or loss from the derivative designated as a hedge of the transaction is reclassified from accumulated other comprehensive income to the same statement of earnings line item affected by the hedged forecasted transaction due to foreign currency fluctuations.
      Because the amounts and the maturities of the derivatives approximate those of the forecasted transactions, changes in the fair value of the derivatives are expected to be highly effective in offsetting changes in the cash flows of the hedged items. Any terminated derivatives or ineffective portion of gains and losses resulting from changes in the fair value of the derivatives is recognized in current earnings. The ineffective portion of these gains and losses, which results primarily from the time value component of gains and losses on forward contracts, was immaterial for all periods presented.
      At December 31, 2004, the Company had no foreign currency forward contacts.
(10)  Business Segments, Concentration of Business, and Credit Risk and Significant Customers
      The Company’s accounting policies of the segments below are the same as those described in the summary of significant accounting policies, except that the Company does not allocate interest, income taxes, or unusual items to segments. The Company evaluates performance based on net sales and profit or loss from operations. The Company’s reportable segments are strategic business units responsible for the worldwide operations of each of its brands. They are managed separately because each business requires different marketing, research and development, design, sourcing and sales strategies. The earnings from operations for each of the segments includes only those costs which are specifically related to each brand, which consist primarily of cost of sales, costs for research and development, design, marketing, sales, commissions, royalties, bad debts, depreciation, amortization and the costs of employees directly related to the brands. The unallocated corporate overhead costs are the shared costs of the organization and include, among others, the following costs: costs of the distribution center, information technology, human resources, accounting and finance, credit and collections, executive compensation, facilities costs and the 2002 and 2003 litigation expense (income). The operating income derived from Internet and catalog sales to third parties is separated into two components: (i) the wholesale profit is included in the operating income of each of the three brands, and (ii) the retail profit is included in the operating income of the Internet/catalog segment.

71


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
      Business segment information is summarized as follows:
                           
    2002   2003   2004
             
Net sales to external customers:
                       
 
Teva wholesale
  $ 64,849,000     $ 72,783,000     $ 83,477,000  
 
UGG wholesale
    23,491,000       34,561,000       101,806,000  
 
Simple wholesale
    10,159,000       7,210,000       9,633,000  
 
Internet/catalog
    608,000       6,501,000       19,871,000  
                   
    $ 99,107,000     $ 121,055,000     $ 214,787,000  
                   
Income from operations:
                       
 
Teva wholesale
  $ 12,011,000     $ 21,739,000     $ 24,901,000  
 
UGG wholesale
    6,589,000       10,002,000       31,674,000  
 
Simple wholesale
    279,000       (1,176,000 )     45,000  
 
Internet/catalog
    194,000       1,148,000       5,533,000  
 
Unallocated overhead
    (15,725,000 )     (12,275,000 )     (19,691,000 )
                   
    $ 3,348,000     $ 19,438,000     $ 42,462,000  
                   
Depreciation and amortization:
                       
 
Teva wholesale
  $ 1,217,000     $ 502,000     $ 401,000  
 
UGG wholesale
    13,000       21,000       30,000  
 
Simple wholesale
    57,000       42,000       31,000  
 
Internet/catalog
    2,000       41,000       92,000  
 
Unallocated overhead
    1,295,000       1,133,000       1,233,000  
                   
    $ 2,584,000     $ 1,739,000     $ 1,787,000  
                   
Capital expenditures:
                       
 
Teva wholesale
  $ 142,000     $ 64,000     $ 226,000  
 
UGG wholesale
    16,000       30,000       19,000  
 
Simple wholesale
    69,000       4,000       111,000  
 
Internet/catalog
          151,000       151,000  
 
Unallocated overhead
    1,250,000       414,000       934,000  
                   
    $ 1,477,000     $ 663,000     $ 1,441,000  
                   

72


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
                   
    2003   2004
         
Total assets from reportable segments:
               
 
Teva wholesale
  $ 85,491,000     $ 87,640,000  
 
UGG wholesale
    18,033,000       51,407,000  
 
Simple wholesale
    4,231,000       4,538,000  
 
Internet/catalog
    440,000       446,000  
             
    $ 108,195,000     $ 144,031,000  
             
      The assets allocable to each reporting segment generally include accounts receivable, inventory, intangible assets and certain other assets, which are specifically identifiable with one of the Company’s business segments. Unallocated corporate assets are the assets not specifically related to one of the segments and generally include the Company’s cash, refundable and deferred tax assets, and various other assets shared by the Company’s brands.
      Reconciliations of total assets from reportable segments to the consolidated financial statements are as follows:
                   
    2003   2004
         
Total assets from reportable segments
  $ 108,195,000     $ 144,031,000  
Unallocated refundable income taxes and deferred tax assets
    2,107,000       3,225,000  
Other unallocated corporate assets
    10,724,000       29,295,000  
             
 
Consolidated total assets
  $ 121,026,000     $ 176,551,000  
             
      The Company sells its footwear products principally to customers throughout the U.S. The Company also sells its footwear products to foreign customers located in Europe, Canada, Australia, and Asia, among other regions. International sales to unaffiliated customers were 21.0%, 18.5%, and 18.3% of net sales for the years ended December 31, 2002, 2003, and 2004, respectively. The Company does not consider international operations a separate segment. The Chief Operating Decision Maker does not review such operations separately, but rather in the aggregate with the aforementioned segments. Management performs regular evaluations concerning the ability of its customers to satisfy their obligations and records a provision for doubtful accounts based upon these evaluations. For the years ended December 31, 2002, 2003 and 2004, no single customer exceeded 10% of consolidated net sales, except that one customer, which is a customer of the Company’s Teva, UGG and Simple segments, accounted for 14.1% of consolidated net sales for the year ended December 31, 2004. As of December 31, 2003, the Company had one customer representing 13.8% of net trade accounts receivable. As of December 31, 2004, the Company had one customer representing 22.0% of net trade accounts receivable.
      Approximately $17,000,000 of trademarks and $466,000 of goodwill is held in Hong Kong by a subsidiary of the Company. Substantially all other long-lived assets are held in the United States.
      The Company’s production and sourcing is concentrated primarily in the Far East, with the vast majority being produced at four independent contractor factories in China. The Company’s operations are subject to the customary risks of doing business abroad, including, but not limited to, currency fluctuations, customs duties, and related fees, various import controls and other nontariff barriers, restrictions on the transfer of funds, labor unrest and strikes and, in certain parts of the world, political instability.

73


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
(11)  Quarterly Summary of Information (Unaudited)
      Summarized unaudited quarterly financial data are as follows:
                                   
    2003
     
    March 31   June 30   September 30   December 31
                 
Net sales
  $ 36,102,000     $ 24,342,000     $ 24,894,000     $ 35,717,000  
Gross profit
    16,240,000       11,832,000       9,502,000       13,771,000  
Net income
    4,203,000       2,006,000       481,000       2,464,000  
Net income per share:
                               
 
Basic
  $ 0.44     $ 0.21     $ 0.05     $ 0.21  
 
Diluted
  $ 0.37     $ 0.17     $ 0.04     $ 0.19  
                                   
    2004
     
    March 31   June 30   September 30   December 31
                 
Net sales
  $ 44,272,000     $ 40,546,000     $ 55,797,000     $ 74,172,000  
Gross profit
    20,406,000       18,906,000       22,235,000       28,886,000  
Net income
    5,382,000       5,087,000       5,822,000       9,248,000  
Net income per share:
                               
 
Basic
  $ 0.55     $ 0.47     $ 0.50     $ 0.78  
 
Diluted
  $ 0.49     $ 0.43     $ 0.46     $ 0.72  
(12)  Acquisition of Teva
      On November 25, 2002, the Company completed an acquisition of the worldwide Teva patents, trademarks, and other assets from Mark Thatcher, the Company’s former licensor and the holder of the Teva patents and trademarks and his wholly-owned corporation, Teva Sport Sandals, Inc., the owner of the Teva Internet and catalog business. As a result of the acquisition, the Company now owns all of the Teva worldwide assets including all patents, tradenames, trademarks and all other intellectual property, as well as Teva’s existing catalog and Internet retailing business, which includes the operations of Teva Sport Sandals, Inc. As a result of the acquisition, the Company will experience cost savings by not having to pay royalties and is able to control and build the Teva brand.
      The aggregate purchase price was approximately $62,300,000. The Company paid cash in the amount of $43,300,000, including transaction costs of $300,000, and issued junior subordinated notes of $13,000,000, preferred stock with a fair value of $5,500,000, 100,000 shares of common stock valued at approximately $300,000 and options to purchase 100,000 shares of common stock valued at approximately $200,000. The preferred stock was valued based on its redemption value, and stock options were valued based on the Black-Scholes valuation model.
      The results of the operations of Teva Sport Sandals, Inc. are included in the consolidated statement of operations from the acquisition date.

74


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
      The following table summarizes the fair value of the assets and liabilities assumed at the date of acquisition:
           
Net current assets
  $ 357,000  
Property and equipment
    88,000  
Trademarks
    51,000,000  
Intangible assets
    1,580,000  
Goodwill
    11,174,000  
       
 
Net assets acquired
  $ 64,199,000 (1)
       
 
(1)  Includes $1,899,000 of amounts previously capitalized, primarily for payments to Mark Thatcher for contract extensions of the option to purchase the Teva patents and trademarks.
      Intangibles of $51,000,000 were assigned to registered trademarks that are not amortized for financial reporting purposes, but are expected to be amortized and fully deductible for income tax reporting purposes. The remaining $1,580,000 of acquired intangible assets consists primarily of patents and has a weighted average useful life of approximately seven years. The $11,174,000 of goodwill is expected to be fully deductible for income tax purposes but is not amortizable for financial reporting purposes. The entire goodwill balance was recorded to the Teva segment. Such allocations were based upon an independent appraisal of the assets acquired in accordance with SFAS No. 141, Business Combinations.
      The following table summarizes supplemental statement of income (loss) information for the year ended December 31, 2002 on a pro forma basis as if the acquisition had occurred on January 1, 2002, along with the actual results for the years ended December 31, 2003 and 2004 for comparison purposes.
                             
    2002   2003   2004
             
Pro forma net sales
  $ 101,267,000     $ 121,055,000     $ 214,787,000  
Pro forma net income before cumulative effect of a change in accounting principle
    1,341,000       9,154,000       25,539,000  
Cumulative effect of a change in accounting principle, net of tax benefit
    (8,973,000 )            
                   
   
Pro forma net income (loss)
  $ (7,632,000 )   $ 9,154,000     $ 25,539,000  
                   
Basic income (loss) per share:
                       
 
Pro forma net income before cumulative effect of a change in accounting principle
  $ 0.14     $ 0.91     $ 2.32  
 
Cumulative effect of a change in accounting principle
    (0.95 )            
                   
   
Pro forma net income (loss)
  $ (0.81 )   $ 0.91     $ 2.32  
                   

75


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
                             
    2002   2003   2004
             
Diluted income (loss) per share:
                       
 
Pro forma net income before cumulative effect of a change in accounting principle
  $ 0.14     $ 0.77     $ 2.10  
 
Cumulative effect of a change in accounting principle
    (0.91 )            
                   
   
Pro forma net income (loss)
  $ (0.77 )   $ 0.77     $ 2.10  
                   
(13)  Goodwill and Other Intangible Assets
      In July 2001, The Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 142 (SFAS 142), Goodwill and Other Intangible Assets. SFAS 142 requires that goodwill and intangible assets with indefinite useful lives no longer be amortized to earnings but instead be reviewed periodically for impairment, including an annual test performed on December 31. The Company implemented this accounting standard on January 1, 2002, resulting in a goodwill impairment charge of $8,973,000 (net of the related income tax benefit of $843,000) during the year ended December 31, 2002, based on a relief from royalty valuation analysis. This noncash impairment charge included a write-down of approximately $7,800,000 for UGG goodwill and approximately $1,200,000 on an after-tax basis for Simple goodwill. As a result of these write-downs, UGG has approximately $6,100,000 of goodwill remaining at December 31, 2002 and Simple has no remaining goodwill, which has been included in intangible assets in the accompanying consolidated balance sheets. The impairment charge has been recorded as a cumulative effect of a change in accounting principle in the Company’s consolidated statement of operations for the year ended December 31, 2002.
      In accordance with SFAS 142, the Company did not record any goodwill amortization for the years ended December 31, 2002, 2003 or 2004.
     Summary of Intangible Assets
                                   
    As of December 31, 2004
     
        Weighted    
    Gross   Average       Net
    Carrying   Amortization   Accumulated   Carrying
    Amount   Period   Amortization   Amount
                 
Amortizable intangible assets
  $ 1,858,000       6 years     $ 721,000     $ 1,137,000  
Nonamortizable intangible assets:
                               
 
Trademark
  $ 51,152,000                          
 
Goodwill
    18,030,000                          
                         
    $ 69,182,000                          
                         
      Aggregate amortization expense for amortizable intangible assets for the years ended December 31, 2002, 2003 and 2004 was $1,049,000, $276,000 and $253,000, respectively. Estimated amortization expense for the next five years is: $310,000 in 2005, $310,000 in 2006, $268,000 in 2007, $129,000 in 2008 and $119,000 in 2009.

76


Table of Contents

DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements — (Continued)
(14)  Licensing
      The Company has initiated a program to selectively license its brand names in product categories beyond footwear. The Company currently has three domestic licenses for UGG, consisting of licenses for handbags, outerwear and cold weather accessories. The handbag and outerwear licensees began delivering products in 2004, whereas the cold weather accessories licensee is expected to begin deliveries in the Fall 2005 season. The Company has also initiated a Teva license program, which currently includes five domestic license agreements, consisting of U.S. licenses for men’s sportswear, headwear, eyewear, timepieces and socks, and has signed a Canadian sportswear license. The Teva licensees are expected to begin delivering products in 2005.
      For several of its initial licensing arrangements, the Company used BHPC Global Licensing, Inc. (“BHPC”), a full service licensing agency, to identify candidates and coordinate its licensing business. The Company pays BHPC a commission on license income related to the licensing agreements that BHPC coordinated on its behalf. In 2004, The Company paid BHPC approximately $168,000. BHPC is owned by one of our directors, Daniel L. Terheggen.
      The Company recognizes license income upon shipment of the products by the licensees and records a corresponding fee to BHPC for the underlying shipments. License income, net of any fees to BHPC, is included in net sales in the accompanying statement of operations. For the year ended December 31, 2004, the Company recognized net license revenues of approximately $950,000, primarily related to our UGG handbag and outerwear licenses.

77


Table of Contents

Schedule II
DECKERS OUTDOOR CORPORATION AND SUBSIDIARIES
VALUATION AND QUALIFYING ACCOUNTS
Three Years Ended December 31, 2002, 2003 and 2004
                                   
    Balance at           Balance at
    Beginning           End of
    of Year   Additions   Deductions   Year
                 
Year ended December 31, 2002:
                               
 
Allowance for doubtful accounts
  $ 2,014,000       1,785,000       1,846,000       1,953,000  
 
Reserve for sales discounts
    806,000       713,000       837,000       682,000  
 
Reserve for sales returns
    1,235,000       2,293,000       2,273,000       1,255,000  
Year ended December 31, 2003:
                               
 
Allowance for doubtful accounts
  $ 1,953,000       504,000       876,000       1,581,000  
 
Reserve for sales discounts
    682,000       741,000       878,000       545,000  
 
Reserve for sales returns
    1,255,000       3,791,000       3,801,000       1,245,000  
Year ended December 31, 2004:
                               
 
Allowance for doubtful accounts
  $ 1,581,000       580,000       365,000       1,796,000  
 
Reserve for sales discounts
    545,000       1,508,000       568,000       1,485,000  
 
Reserve for sales returns
    1,245,000       7,104,000       6,618,000       1,731,000  
See accompanying report of independent registered public accounting firm.

78


Table of Contents

PART III
Item 10. Directors and Executive Officers of the Registrant
      We have adopted a written code of ethics that applies to our principal executive officer, principal financial and accounting officer, controller and persons performing similar functions. Our code of ethics is designed to meet the requirements of Section 406 of the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder. To the extent required by law, any amendments to, or waivers from, any provision of the code will be promptly disclosed publicly either on a report on Form 8-K or on our website at www.deckers.com.
      All additional information required by this item, including information relating to Directors and Executive Officers of the Registrant, is set forth in the Company’s definitive proxy statement relating to the Registrant’s 2005 annual meeting of stockholders, which will be filed pursuant to Regulation 14A within 120 days after the end of the Company’s fiscal year ended December 31, 2004, and such information is incorporated herein by reference.
Item 11. Executive Compensation
      Information relating to Executive Compensation is set forth under “Proposal No. 1 — Election of Directors” in the Company’s definitive proxy statement relating to the Registrant’s 2005 annual meeting of stockholders, which will be filed pursuant to Regulation 14A within 120 days after the end of the Company’s fiscal year ended December 31, 2004, and such information is incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
      Information relating to Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters is set forth under “Proposal No. 1 — Election of Directors” in the Company’s definitive proxy statement relating to the Registrant’s 2005 annual meeting of stockholders, which will be filed pursuant to Regulation 14A within 120 days after the end of the Company’s fiscal year ended December 31, 2004, and such information is incorporated herein by reference.
Item 13. Certain Relationships and Related Transactions
      Information relating to Certain Relationships and Related Transactions is set forth under “Proposal No. 1 — Election of Directors” in the Company’s definitive proxy statement relating to the Registrant’s 2005 annual meeting of stockholders, which will be filed pursuant to Regulation 14A within 120 days after the end of the Company’s fiscal year ended December 31, 2004, and such information is incorporated herein by reference.
Item 14. Principal Accountant Fees and Services
      Information relating to Principal Accountant Fees and Services is set forth under “Proposal No. 1 — Election of Directors” in the Company’s definitive proxy statement relating to the Registrant’s 2005 annual meeting of stockholders, which will be filed pursuant to Regulation 14A within 120 days after the end of the Company’s fiscal year ended December 31, 2004, and such information is incorporated herein by reference.
PART IV
Item 15. Exhibits and Financial Statement Schedules
      Consolidated Financial Statements and Schedules required to be filed hereunder are indexed on page 49 hereof.

79


Table of Contents

         
Exhibit    
     
  2.1     Certificate of Ownership and Merger Merging Deckers Corporation into Deckers Outdoor Corporation. (Exhibit 2.1 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  3.1     Amended and Restated Certificate of Incorporation of Deckers Outdoor Corporation. (Exhibit 3.1 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  3.2     Restated Bylaws of Deckers Outdoor Corporation. (Exhibit 3.2 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  #10.1     1993 Employee Stock Incentive Plan. (Exhibit 99 to the Registrant’s Registration Statement on Form S-8, File No. 33-47097 and incorporated by reference herein)
  #10.2     Form of Incentive Stock Option Agreement under 1993 Employee Stock Incentive Plan. (Exhibit 10.9 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  #10.3     Form of Non-Qualified Stock Option Agreement under 1993 Employee Stock Incentive Plan. (Exhibit 10.10 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  #10.4     Form of Restricted Stock Agreement. (Exhibit 10.11 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  #10.5     Employment Agreement with Douglas B. Otto. (Exhibit 10.13 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  #10.6     First Amendment to Employment Agreement with Douglas B. Otto. (Exhibit 10.14 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  #10.7     Second Amendment to Employment Agreement with Douglas B. Otto. (Exhibit 10.15 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  #10.8     Third Amendment to Employment Agreement with Douglas B. Otto. (Exhibit 10.30 to the Registrant’s Registration Statement on Form S-1, File No. 33-67248 and incorporated by reference herein)
  #10.9     Deckers Outdoor Corporation 1995 Employee Stock Purchase Plan. (Exhibit 4.4 to the Registrant’s Registration Statement on Form S-8, File No. 33-96850 and incorporated by reference herein)
  #10.10     Amended Compensation Plan for Outside Members of the Board of Directors. (Exhibit 10.42 to the Registrant’s Form 10-Q for the period ended September 30, 1996 and incorporated by reference herein)
  #10.11     Extension Agreement to Employment Agreement with Douglas B. Otto. (Exhibit 10.36 to the Registrant’s Form 10-K for the period ended December 31, 1996 and incorporated by reference herein)
  10.12     Shareholder Rights Agreement, dated as of November 12, 1998. (Exhibit 10.39 to the Registrant’s Form 10-Q for the period ended September 30, 1998 and incorporated by reference herein)
  10.13     Revolving Credit Agreement dated as of February 21, 2002 among Deckers Outdoor Corporation, UGG Holdings, Inc. and Comerica Bank — California. (Exhibit 10.21 to the Registrant’s Form 10-K for the year ended December 31, 2001 and incorporated by reference herein.)
  #10.14     Employment Agreement dated March 29, 2002 between Douglas B. Otto and Deckers Outdoor Corporation. (Exhibit 10.22 to the Registrant’s Form 10-Q for the period ended March 31, 2002 and incorporated by reference herein.)
  10.15     Asset Purchase Agreement dated as of October 9, 2002 by and Among Mark Thatcher, Teva Sport Sandals, Inc. and Deckers Outdoor Corporation. (Exhibit 2.1 to the Registrant’s Form 8-K/A filed February 7, 2003 and incorporated herein by reference.)
  10.16     Disclosure letter associated with the Asset Purchase Agreement. (Exhibit 2.2 to the Registrant’s Form 8-K/A filed February 7, 2003 and incorporated herein by reference.)+

80


Table of Contents

         
Exhibit    
     
  #10.17     Employment Agreement dated November 25, 2002 between John A. Kalinich and Deckers Outdoor Corporation. (Exhibit 10.20 to the Registrant’s Form 10-K for the period ended December 31, 2002 and incorporated by reference herein)
  #10.18     Employment Agreement dated November 25, 2002 between Mark Thatcher and Deckers Outdoor Corporation. (Exhibit 10.21 to the Registrant’s Form 10-K for the period ended December 31, 2002 and incorporated by reference herein)
  10.19     Unsecured Subordinated Promissory Note dated November 25, 2002 between Mark Thatcher and Deckers Outdoor Corporation. (Exhibit 10.22 to the Registrant’s Form 10-K for the period ended December 31, 2002 and incorporated by reference herein)
  10.20     Note Purchase Agreement dated as of November 25, 2002 by and among Deckers Outdoor Corporation and The Peninsula Fund III Limited Partnership. (Exhibit 10.23 to the Registrant’s Form 10-K for the period ended December 31, 2002 and incorporated by reference herein)
  10.21     Amended and Restated Credit Agreement, dated as of November 25, 2002, by and among Deckers Outdoor Corporation, UGG Holdings Inc., and Comerica Bank-California. (Exhibit 10.24 to the Registrant’s Form 10-K for the period ended December 31, 2002 and incorporated by reference herein)
  10.22     Amendment Number One to Amended and Restated Revolving Credit Agreement dated April 29, 2003. (Exhibit 10.1 to the Registrant’s Form 10-Q for the period ended June 30, 2003 and incorporated by reference herein)
  10.23     Amendment Number Two to Amended and Restated Revolving Credit Agreement dated June 27, 2003. (Exhibit 10.2 to the Registrant’s Form 10-Q for the period ended June 30, 2003 and incorporated by reference herein)
  10.24     Amendment Number One to Senior Subordination Agreement dated April 29, 2003. (Exhibit 10.3 to the Registrant’s Form 10-Q for the period ended June 30, 2003 and incorporated by reference herein).
  10.25     Amendment Number Two to Senior Subordination Agreement dated June 27, 2003. (Exhibit 10.4 to the Registrant’s Form 10-Q for the period ended June 30, 2003 and incorporated by reference herein)
  10.26     Amendment Number Three to Amended and Restated Revolving Credit Agreement between the Company and Comerica Bank — California dated as of August 6, 2003. (Exhibit 10.1 to the Registrant’s Form 10-Q for the period ended September 30, 2003 and incorporated by reference herein)
  10.27     Amendment Number Four to Amended and Restated Revolving Credit Agreement between the Company and Comerica Bank-California dated as of November 13, 2003 (Exhibit 10.27 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)
  10.28     Amendment Number Three to Senior Subordination Agreement dated November 13, 2003 (Exhibit 10.28 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)
  #10.29     Employment Agreement effective as of January 1, 2004 between Douglas B. Otto and Deckers Outdoor Corporation (Exhibit 10.29 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)
  #10.30     Employment Agreement effective as of January 1, 2004 between M. Scott Ash and Deckers Outdoor Corporation (Exhibit 10.30 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)
  #10.31     Employment Agreement effective as of January 1, 2004 between Patrick C. Devaney and Deckers Outdoor Corporation (Exhibit 10.31 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)
  #10.32     Employment Agreement effective as of January 1, 2004 between Constance X. Rishwain and Deckers Outdoor Corporation (Exhibit 10.32 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)

81


Table of Contents

         
Exhibit    
     
  #10.33     Employment Agreement effective as of January 1, 2004 between Robert P. Orlando and Deckers Outdoor Corporation (Exhibit 10.33 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)
  10.34     Lease Agreement dated November 1, 2003 between Ampersand Aviation, LLC and Deckers Outdoor Corporation for office building at 495-A South Fairview Avenue, Goleta, California, 93117 (Exhibit 10.34 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)
  10.35     Exclusive Independent Contractor Representation Agreement between Deckers Outdoor Corporation and BHPC Marketing, Inc. effective as of January 1, 2003 for representation of the Teva brand (Exhibit 10.35 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)
  10.36     *Amendment Number Five to Amended and Restated Credit Agreement between the Company and Comerica Bank — California dated as of February 28, 2005.
  10.37     *Lease Agreement dated September 15, 2004 between Mission Oaks Associates, LLC and Deckers Outdoor Corporation for distribution center at 3001 Mission Oaks Blvd., Camarillo, CA 93012
  10.38     *First Amendment to Lease Agreement between Mission Oaks Associates, LLC and Deckers Outdoor Corporation for distribution center at 3001 Mission Oaks Blvd., Camarillo, CA 93012, dated December 1, 2004.
  14.1     Deckers Outdoor Corporation’s Code of Ethics for Senior Officers, as approved by the Board of Directors on December 5, 2003. (Exhibit 14.1 to the Registrant’s Form 10-K for the period ended December 31, 2003 and incorporated by reference herein)
  21.1     *Subsidiaries of Registrant.
  23.1     *Consent of Independent Registered Public Accounting Firm.
  31.1     *Certification of the Chief Executive Officer pursuant to Rule 13A-14(a) under the Exchange Act, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31.2     *Certification of the Chief Financial Officer pursuant to Rule 13A-14(a) under the Exchange Act, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32.1     *Certification pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
Filed herewith.
Certain information in this Exhibit was omitted and filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request as to the omitted portions of the Exhibit.
 
Management contract or compensatory plan or arrangement.

82


Table of Contents

SIGNATURES
      Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
  DECKERS OUTDOOR CORPORATION
  (Registrant)
 
  /s/ Douglas B. Otto
 
 
  Douglas B. Otto
  Chief Executive Officer
Date: March 16, 2005
      Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
             
 
/s/ Douglas B. Otto
 
Douglas B. Otto
  Chairman of the Board, President and Chief Executive Officer   March 16, 2005
 
/s/ M. Scott Ash
 
M. Scott Ash
  Chief Financial Officer (Principal Financial and Accounting Officer)   March 16, 2005
 
/s/ Gene E. Burleson
 
Gene E. Burleson
  Director   March 16, 2005
 
/s/ John M. Gibbons
 
John M. Gibbons
  Director   March 16, 2005
 
/s/ Rex A. Licklider
 
Rex A. Licklider
  Director   March 16, 2005
 
/s/ Daniel L. Terheggen
 
Daniel L. Terheggen
  Director   March 16, 2005

83